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Chapter 1. General introduction 
Figure 1.1. Function of the multidrug/xenobiotic ABC transporters. 
Multidrug/xenobiotic ABC transporters reside in the plasma membrane and 
extrude various hydrophobic and/or amphipathic xenobiotics and metabolic 
products. MDR1/P-gp transports hydrophobic compounds (X), while MRP1 and 
ABCG2 can extrude both hydrophobic drugs and intra-cellularly formed 
metabolites, e.g., glutathione or glucuronide conjugates (C-X).(from Sarkadi et 
al. 2006)                      p. 59 
Figure 1.2. The functional anatomy of Daphnia (from Ebert 1995).             p.  69 
Figure 1.3. Life cycle of a Daphnia (from Ebert 1995)                         p. 72 
 
Chapter 2. Enhanced offspring production in Daphnia magna clones 
exposed to serotonin reuptake inhibitors and 4-nonylphenol. Stage- and 
food-dependent effects 
Figure 2.1. Survival curves of D. magna individuals from clones T (A, C) and F 
(B, D) exposed to the studied compounds in the life-table (A,B) and adult 
reproduction tests (C,D). Only those treatments with significant mortality 
(P<0.05, based on Wilcoxon-Gehan tests) were identified. N60, N80, N110 are 
60, 80, 110µg/L of 4-nonylphenol, respectively.                                  p. 100  
Figure 2.2.  Percentage (Mean±SE, N=8-10) of aborted embryos release by D. 
magna females in life-table (A) and adult reproduction tests (B) from clones F 
and T, respectively.                                                                             p. 100 
Figure 2.3. Life history responses (Mean±SE, N=8-10) of D. magna individuals 
from clones T and F exposed to the studied compounds from birth to the fourth 
brood. Each column of graph panel corresponds to one clone. Body length 
graphs include the length of first and fourth brood females, those of offspring 
number the values for first clutch and total offspring, and those of offspring size 
of neonates from third and fourth broods. *Significant (P<0.05) differences from 
solvent controls following ANOVA and Dunnet’s tests. C, SC; NP, FX, FV are 
Control, Solvent control, 4-nonylphenol, fluoxetine and fluvoxamine treatments, 
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respectively; r, intrinsic rate of population growth. For chemical treatments the 
numbers identify exposure levels.                 p. 104 
Figure 2.4. Life history responses (Mean±SE, N=10) of D. magna individuals 
from clone F exposed to the studied compounds from birth to the fourth brood at 
three different food level ratios (Low, L; intermediate, M; and high, H). In the 
Survival graphs only 4-nonylphenol treatments at low and intermediate food 
levels (NL, NM, respectively) with significant (P<0.05) mortality were identified. 
In the remained graphs significant (P<0.05) differences from solvent controls 
within food levels following ANOVA and Dunnet’s tests are indicated with an 
asterisks. C, SC; N15, Fx40, Fv 7 are control, solvent control, 15µg/l of 4-
nonylphenol, 40µg/l of fluoxetine and 7µg/l of fluvoxamine, respectively. r, 
intrinsic rate of population growth.       p. 105 
Figure 2.5. Life history responses (Mean±SE, N=10) of D. magna gravid 
females exposed to the studied compounds during three consecutive broods.  * 
significant (P<0.05) differences from solvent controls following one way ANOVA 
and Dunnet’s tests.  C, SC; NP, FX, FV are Control, Solvent control, 4-
nonylphenol, fluoxetine and fluvoxamine treatments, respectively; r, intrinsic rate 
of population growth. For chemical treatments the numbers identify exposure 
levels.                                                                                                  p. 107 
 
Chapter 3. Mechanisms of action of Selective Serotonin Reuptake 
inhibitors in Daphnia magna 
Figure 3.1. Flow chart showing the Human (left) and hypothesized D. magna 
(right) mechanism of action of SSRIs. Proposed experiments to test our four 
hypothesis premises are superimposed as numbers as follows. (1) 
Reproduction tests across food rations with fluoxetine and fluvoxamine to test 
the first premise that SSRIs should be able to switch D. magna life-history 
trajectories; (2) Reproduction tests with fluoxetine and the mammalian 5-HTs 
receptor antagonist, cyproheptadine to test that serotonin activity should be 
involved in these life-history changes; (3) Feeding, respiration assays and 
energy reserves studies to test the physiological consequences of observed life-
history changes; (4) Adult survival tests under starvation with normoxia and low 
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oxygen levels, to test for fitness costs. See the text for further information. Black 
arrows indicated the flow of events and dotted ones the location of D. magna 
food ± SSRI treatments.                                                                            p. 123 
Figure 3.2. Effects of fluoxetine (10, 40, 80μg/L) and fluvoxamine (3, 7, 30μg/L) 
on offspring size and number in exposed adult females. Values are Mean±SE; 
N=10. Numbers after Fx and Fv indicate exposure levels. * Total offspring 
significant (P<0.05) differences from solvent control treatments following 
ANOVA and Dunnet’s post hoc test      p. 132 
Figure 3.3. Effects of fluoxetine (40μg/L) and fluvoxamine (7μg/L) on offspring 
size and number (A) and age at first reproduction (B) on Daphnia individuals 
reared across food rations (1.6x10
5
, 3.3x10
5
, 6x10
5
 cells mL-1 of C. vulgaris, 
respectively).Values are Mean±SE, N=9-10; * significant (P<0.05) differences 
from solvent control treatments following ANOVA and Dunnet’s post-hoc tests.  
           p. 133 
Figure 3.4. Effects of Cyproheptadine (cy) alone (A) and of cyproheptadine (10, 
50µg/L) co-administered with fluoxetine (Fx 80µg/L (B) on offspring number. 
Values are mean±SE, N=10, * significant (P<0.05) differences from solvent 
control treatments following ANOVA and Dunnet’s post-Hoc tests.             p. 135 
Figure 3.5. Effects of cyproheptadine (cy) alone and of cyproheptadine (10, 
50μg/L) co-administered with fluoxetine (Fx, 8μg/L) on body length. Values are 
Mean±SE, N=10; * significant (P<0.05) differences from solvent control 
treatments following ANOVA and Dunnet’s post hoc tests.                       p. 135 
Figure 3.6. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on adult 
oxygen consumption rates. White and black bars correspond to responses 
without and with food. Values are Mean±SE: N=6. Different letters indicate 
significant (P<0.05) differences among treatment groups following ANOVA and 
Tukey’s post hoc tests.                                                                            p. 136 
Figure 3.7. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on 
proportional feeding rates relative to control treatments.  Values are Mean±SE; 
N=10.                                                                                                  p. 137 
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Figure 3.8. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on lipid, 
carbohydrate and protein levels of exposed adults. Values are Mean±SE. N=4; * 
significant (P<0.05) differences from solvent control treatments following 
ANOVA and Dunnet’s post hoc tests.                                                       p. 138 
Figure 3.9. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on survival 
responses of adults under starvation. For clarity, longevity responses of adults 
pre-exposed to the studied SSRI and starved in clean water (A) or in water plus 
SSRI (B) are separated.                                                                            p. 139 
Figure 3.10. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on survival 
responses of adults under starvation and anoxia.                        p. 139 
Figure 3.11. Alignment of a putative Daphnia pulex SERT 
(DAPPUDRAFT_314292) and its closest human relative (ref|NP_001036.1, 
sodium-dependent serotonin transporter). Identical residues (51%) are 
represented in the central row, "+" signs correspond to conservative amino acid 
changes (69% of total homology). Numbers correspond to the amino acid 
position in both sequences. Analysis performed using the BLAST server at 
http://www.ncbi.nlm.nih.gov/blast.                                                       p. 141 
 
CHAPTER 4. Identification of metabolic pathways in Daphnia magna 
explaining hormetic effects of Selective Serotonin Reuptake Inhibitors and 
4-nonylphenol using transcriptomic and phenotypic responses. 
Figure 4.1. Total offspring production (Mean±SE, N=4) of the four selected 
females exposed to the studied SSRI and 4-nonylphenol treatments. C, FV10, 
FX40, N20, N60 are solvent control, fluvoxamine at 7µg/L, fluoxetine at 40µg/L, 
4-nonylphenol at 20µg/L and 60µg/L, respectively. Asterisks indicate significant 
differences from solvent controls following ANOVA and Dunnett’s comparison 
tests.                                                                                p. 157 
 
Figure 4.2. Heat map and hierarchical clustering (Pearson correlation) base on 
log2 ratios of the differentially transcribed genes in Daphnia magna adults (A) 
and juveniles (B) across the experimental replicates for the SSRIs (FV, FX) and 
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4-nonylphenol (N20, N60) treatments. The four replicates are identify as 
A,B,C,D. Gene transcripts in red and green are up and down regulated and 
those in black unchanged. Colour scale spans from -2.5 to 2.5.             p. 159 
Figure 4.3. Self-Organizing Maps (SOM) of gene transcription responses of 
juveniles and adults across the experimental replicates for SSRIs (fluvoxamine, 
FV; fluoxetine, FX) and 4-nonylphenol (N20, N60) treatments. Results are 
depicted as Mean±SD of log2 ratios. Numbers of de-regulated genes are 
depicted between parentheses.                                                                  p. 160 
Figure 4.4. PLS-SR summary of results for the two different sample treatments 
(Figure 1A, SSRIs; Figure 1B, 4-nonylphenol) using differential expressed 
genes as predictors (X) and total offspring production as response (Y). First and 
second PLS bi-plots showing selected gene loadings (triangles) and offspring 
production scores (sample identification letters). Only genes with a selectivity 
ratio above the mean were considered. Annotated genes are indicated by 
numbers described in the Table 4.4. The four replicates are identified as 
A,B,C,D.                                                                                                  p. 162 
Figure 4.5. Confirmation of the array results with qPCR. Array and RT-qPCR 
results are represented as gene fold change ratios. Errors bars are standard 
errors of mean (SE, N=4).                                                                  p. 163 
Figure 4.6. KEGG diagram of metabolic pathways with the genes up and down 
regulated across SSRIs (in bold) and 4-nonylphenol (in grey) treatments in adult 
females. Arrows indicated de-regulation direction relative to control treatments. 
Further details of genes are in Table 4.7.                                             p. 166 
 
CHAPTER 5. Effects of nanoparticles of TiO2 on food depletion and life-
history responses of Daphnia magna 
Figure 5.1. SEM Images of algae cells in the presence of 1mg/L (A) and 
10mg/L (B) of P25-TiO2 at high food levels.                                             p. 191 
Figure 5.2 Mean algae and particle-algae aggregate sizes of the studied nano 
and micron-sized TiO2 particles at low (A, B) and high (C, D) food ration levels. 
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White, grey and black symbols correspond to 0, 1 and 10mg/L of particle 
suspension, respectively. Within each food level and particle suspension 
concentration different letters indicate significant (P<0.05) differences following 
ANOVA and Tukey’s test. Each assay was replicated three times. Errors are SE. 
           p. 192 
Figure 5.3. Algae and particle-algae size distributions of the studied nano and 
micron-sized TiO2 particles dosed at 1mg/L and 10mg/L at low (A, B) and high 
(C, D) food ration levels. White, grey and black symbols correspond to 0, 1 and 
10mg/L of particle suspension, respectively.      p. 193 
Figure 5.4 Algae concentrations measured as µg C/mL remaining in the test 
medium after 24 h across the tested particle suspensions at low (A) and high 
(B) food ration levels. Straight and dotted lines indicate non-limiting and limiting 
food levels, respectively, a is the location of the initial algae concentration 
levels. White, grey and black symbols correspond to 0, 1 and 10mg/L of particle 
suspension, respectively. Within each particle suspension level different Arabic 
(1mg/L) or Greek (10mg/L) letters indicate significant differences following 
ANOVA and Tukey’s test. Each experiment was replicated three times. Errors 
are SE.          p. 194 
Figure 5.5. Relationships between algae-particle aggregate size and algae 
sedimentation rates (expressed as concentration of algae remaining in the 
water column after 24h) at low and high food ration levels. Error bars are SE 
(N=9). White, grey and black symbols correspond to algae only, 1 and 10mg/L 
of particle suspensions, respectively.      p. 194 
Figure 5.6. Life-history responses of D. magna individuals exposed to the 
studied particle suspensions at low (L) and high (H) food ration levels in a 21d 
chronic test. White, grey and black bars correspond to 0, 1 and 10mg/L of 
particle suspension, respective respectively. Within each food level * indicates 
significant (P<0.05) differences from control treatments following ANOVA and 
Dunnett’s test. Errors are SE (N=10).      p. 196 
Figure 5.7. Life-history responses of D. magna individuals exposed to the 
studied particle suspensions at low (L) and high (H) food ration levels in 1L 
medium under semi-static and re-suspension conditions. Results from the food 
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ration experiment dosed at levels two fold lower than high food (H/2) and two 
and fourth fold lower than low food (L/2, L/4) are also depicted. For clarity in the 
food ration experiment results for H and L treatments are not included but are 
depicted in Table 5.4. White, grey and black symbols correspond to 0, 1 and 10 
mg/L of particle suspension, respectively. * indicates significant (P<0.05) 
differences of particle treatments from food only control treatments following 
ANOVA and Dunnett’s test. Errors are SE (N=10).     p. 197 
Figure 5.8. Significant (P<0.05, Table 5.3) relationships between algae-particle 
aggregate size or algae sedimentation rates (expressed as concentration of 
algae remaining in the water column after 24h) and fitness (r-responses) across 
food ration levels and experiments. Error bars are SE (N=9). White, grey and 
black symbols corresponds to algae only, 1 and 10mg/L of particle suspensions, 
respectively.           p. 200 
 
Chapter 6. First evidence for toxic defence in Daphnia magna by the 
multixenobiotic resistance mechanism 
Figure 6.1. Fluorescent microscopy images of D. magna juveniles exposed to 
Rh123 (A, D), RhB (B, E), Ca-AM (C, F). Images were taken after 1.5h for in 
vivo (A-C) and 2h for ex-vivo (D-F) incubation periods with 5µM RhB, 2.5µM 
Rh123 or 0.5µM Ca-AM. Images of a juvenile individual taken with the bright file 
is also included (G).         p. 218 
Figure 6.2. Effect of transported MXR inhibitors on the accumulation of Rh123 
(pmol/individual) and proportional filtering rates in D. magna juveniles. Symbols 
and error bars are mean±SD (n=10).                 p. 219 
Figure 6.3A. Alignment of the putative partial ABCB1, ABCC1-3-like sequences 
from D. magna with ABC nucleotide binding domains (NBD) of several 
organisms. Amino acid positions of the comparison ABC sequence stretches 
that align with the D. magna ABC sequences are indicated. The conserved 
motifs ABC signature and Walker B domain are highlighted in light and dark 
grey respectively. From all the ABC sequences only amino acids diverging from 
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the D. magna ABC sequences are given. Protein codes as those of NCBI.  
           p. 228 
Figure 6.3B. Alignment of the putative partial ABCC4, ABCC5-like sequences 
from D. magna with ABC nucleotide binding domains (NBD) of several 
organisms. Amino acid positions of the comparison ABC sequence stretches 
that align with the D. magna ABC sequences are indicated. The conserved 
motifs ABC signature and Walker B domain are highlighted in light and dark 
grey respectively. From all the ABC sequences only amino acids diverging from 
the D. magna ABC sequences are given. Percentage identity is also depicted. 
Protein codes as those of NCBI.        p. 229 
Figure 6.4A. Phylogenetic tree including the D. magna ABCB1 sequences with 
the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual 
phylogenetic position of the sequence in the tree. Clustering only considered 
the protein region equivalent to the one sequenced in the D. magna abcb1 gene 
identify as “p glycoprotein partial Daphnia magna”.     p. 230 
Figure 6.4B. Phylogenetic tree including the D. magna ABCC1-3 sequences 
with the first 100 identified sequence hits. Gene definitions are from the 
GenBank original description, without considering their adequacy to the actual 
phylogenetic position of the sequence in the tree. Clustering only considered 
the protein region equivalent to the one sequenced in the D. magna abcc1-3 
gene identify as “putative multidrug protein 1-3 partial Daphnia magna”.   
           p. 231 
Figure 6.4C. Phylogenetic tree including the D. magna ABCC4 sequences with 
the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual 
phylogenetic position of the sequence in the tree. Clustering only considered 
the protein region equivalent to the one sequenced in the D. magna abcc4 gene 
identify as “putative multidrug protein 4 partial Daphnia magna”.   p. 232 
Figure 6.4D. Phylogenetic tree including the D. magna ABCC5 sequences with 
the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual 
  Figure Index
 
19 
 
phylogenetic position of the sequence in the tree. Clustering only considered 
the protein region equivalent to the one sequenced in the D. magna abcc5 gene 
identify as “putative multidrug protein 5 partial Daphnia magna”.   p. 233 
Figure 6.5. Relative levels of putative abcb, abcc1/3, abcc4, abcc5 transporters 
depicted as relative mRNA abundance of 18S ribosomal (Mean ± SE, n =5-9) in 
D. magna eggs, embryos, newborn neonates, and juveniles of 4 days (A); and 
in juveniles of 4 days pre-exposed for 24 h to model inducers. Different low 
case letters in graph A or symbols in graph B indicate significantly (P<0.05) 
different sets of data after ANOVA and Tukey's or Dunnett’s posthoc tests, 
respectively. In graph B mercury (Hg) results have been contrasted with those 
of control, whereas those of dacthal and pentachlorophenol (PCP) with solvent 
controls.           p. 236 
Figure 6.6. Effect of transported MXR inhibitors on the accumulation of Ca-AM, 
(measured as calcein) (left), Rh123 (middle) and RhB (right graph pannel) 
(pmol/individual) in D. magna juveniles. Symbols are single measurements. 
Data were fitted to the four parameter dose-response Hill model of eq. 6.1. 
Solvent controls (C) are also included.       p. 238 
Figure 6.7. Effect of putative transported MXR inducers on the accumulation 
(Mean±SE, N=10) of Ca-AM, (measured as calcein), Rh123 and RhB in D. 
magna juveniles after 24h of exposure. Respective control (C) or solvent control 
(SC) treatments are also depicted. * significant (P<0.05) differences from 
controls or solvent controls after ANOVA and Dunnet’s posthoc tests.  p. 240 
Figure 6.8. Percentage of immobile D. magna juveniles after 24 and 48h of 
single exposure to the studied compounds. Each symbol corresponds to a 
single replicate. Responses have been fitted to the Hill regression model of eq. 
2 (see text). Horizontal axis is depicted in log scale. Open and black triangles or 
doted and strike lines correspond to 24 and 48h exposures, respectively. 
Triangles are single observations.       p. 244 
Figure 6.9. Percentage of immobile D. magna juveniles after 24 and 48h of 
exposures to equitoxic binary mixtures of mitoxantrone and cholambucil with 
REV205, MK571 and CsA. Each symbol corresponds to a single replicate. 
Concentration–responses curves predicted by the CA (black lines) and IA (grey 
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lines) concepts are also depicted. Fitted Hill curves (eq. 2) to observed joint 
effects are depicted as short dashed lines. Horizontal axis is depicted in log 
scale. Within each binary combination left and right graphs or open and black 
triangles correspond to 24 and 48 h exposures, respectively.   p. 247 
Figure 6.10. Effect of chlorambucil and mitoxantrone on the accumulation 
(Mean±SE, N=10) of Ca-AM, (measured as calcein), Rh123 and RhB in D. 
magna juveniles. Any of the treatments affected significantly (P<0.05, based on 
ANOVA) the accumulation of the studied dyes.     p. 249 
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Chapter 2. Enhanced offspring production in Daphnia magna clones 
exposed to serotonin reuptake inhibitors and 4-nonylphenol. Stage- and 
food-dependent effects. 
Table 2.1. Nominal and measured chemical concentrations (Mean and SD) in 
24h old tests solutions. Results for duplicated samples taken in each tests are 
pooled. N, sample size.         p. 100 
Table 2.2. Percentage of females taking six instars to mature in the life-table 
experiments performed between clones and across food levels. Chi square 
results testing for differences across treatments are also depicted. C, SC, L, M, 
H are control, solvent control treatments, low, intermediate and high food level 
ratios, respectively. NP, Fx, Fv are 4-nonylphenol, fluoxetine, fluvoxamine 
treatments, respectively, and the numbers after those names are the exposure 
levels. ns P> 0.05; ***P<0.01.        p. 102 
Table 2.3. ANOVA analysis results (degrees of freedom, df; Fisher’s ratio, F; 
and significant levels, Sig.) testing maturation instar (MI) and treatment (T) 
effects on life history traits responses of clones T and F in life-table tests. 1 at 
first reproduction; 4, at the fourth brood.      p. 103 
Table 2.4. ANOVA analysis results (degrees of freedom, df; Fisher’s ratio, F; 
and significant levels, Sig.) testing maturation instar (MI), treatment  (T) and 
food level (F) effects on life history traits responses of  clone F in the food life-
table test (Exp. 3).          p. 106 
 
Chapter 3. Mechanisms of action of Selective Serotonin Reuptake 
inhibitors in Daphnia magna. 
Table 3.1. ANOVA results testing the effects of food ration levels and treatment 
on selected life history responses of D. magna individuals exposed to the 
studied SSRIs at three food regimes. Offspring size analyses were performed 
on third and fourth clutch neonates. Only degrees of freedom (df), Fisher’s 
coefficient (F) and probability values (P) are depicted.    p. 134 
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Chapter 4. Identification of metabolic pathways in Daphnia magna 
explaining hormetic effects of Selective Serotonin Reuptake Inhibitors and 
4-nonylphenol using transcriptomic and phenotypic responses. 
Table 4.1. Primer pairs designed from existing sequences used for amplification 
of selected Daphnia magna partial gene sequences.     p. 155 
Table 4.2. Differentially expressed annotated genes. Available at 
http://pubs.acs.org/doi/suppl/10.1021/es4012299 and electronic file 
Table 4.3. Annotated and non-annotated genes of the SOM clusters. Full table 
available at http://pubs.acs.org/doi/suppl/10.1021/es4012299 and electronic file 
Table 4.4. Annotated and non-annotated genes selected in the PLS-SR 
analyses performed for SSRIs and 4-nonylphenol data. For annotated genes 
their name and associated cod number assigned in Fig 4.4 are reported. Only 
the probe name of non-annotated genes having significant (p<0.05) correlation 
coefficients of their relative expression with total offspring are depicted. * 
0.05<P<0.01; ** P<0.01, N=12.        p. 161 
Table 4.5. GO terms for the obtained six SOM and two PLS gene clusters for 
SSRI’s and 4-nonylphenol (N) treatments.      p. 165 
Table 4.6. GO terms for the obtained six SOM and two PLS-SR gene clusters 
for SSRIs and 4-nonylphenol (N) treatments. SOM clusters of juveniles (JUV 1, 
2, 3) and of adults (ADT 4, 5, 6) and PLS ones for SSRIs and 4-nonylphenol (N) 
are depicted in Fig 4.3 and Fig 4.4, respectively. *0.05<P<0.01; 
**0.01<P<0.001; ***P<0.001. Empty cells represent non-significant (P<0.05) 
GO. Available at http://pubs.acs.org/doi/suppl/10.1021/es4012299 and 
electronic file 
Table 4.7. Genes with their mean fold change ratios that were included in the 
metabolic KEGG paths of Fig 4.6. FV7, FX40, N20 and N60 are fluvoxamine, 
fluoxetine and 4-nonylphenol at 7, 40, 20 and 60µg/L, respectively.  p. 167 
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Chapter 5. Effects of nanoparticles of TiO2 on food depletion and life-
history responses of Daphnia magna. 
Table 5.1. Nano-Tio2 and micron sized particle characterization by dynamic light 
scattering (DLS) and particle concentration estimated from absorbance 
measurements at 348ηm. Pdi, Polydispersity index. Results are depicted as 
mean±SD.           p. 190 
Table 5.2. ANOVA results on D. magna traits for the three assays performed 
with the four particle suspensions (NM103, NM104, P-25, Tiona) dosed at two 
concentrations (1, 10 mg/L) across two food ration levels (low and high). 
Results from a forth experiment comparing D. magna life-history performance 
across five different ration levels are also included. Only degrees of freedom 
(df), Fisher’s coefficient (F), Chi-square (2) and significant levels are depicted. 
ns P≥ 0.05; *0.01<P<0.05, **P<0.01. Traits are: age at first reproduction (Age), 
clutch size at first reproduction (Fec 1st), body length at maturity (Size mat) 
fitness (r ), body length at the end of 21 d test (Size end), and total fecundity in 
21 d tests (Fec Tot).         p. 195 
Table 5.3. Pearson correlation coefficients between particle-algae aggregation 
size, sedimentation rates measured as algae concentration levels remaining in 
the water column after 24h and r values in the chronic, semi-static and re-
suspension assays at low and high food ration levels. *0.01<P<0.05; ** 0.01<, N 
=10.            p. 198 
Table 5.4. Life-history responses of D. magna cultured at different food ration 
levels matching those remaining in the water column at 24 h following 
nanoparticle treatments. High and low food ration levels have also been 
included for comparison purposes.       p. 199 
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Chapter 6. First evidence for toxic defence in Daphnia magna by the 
multixenobiotic resistance mechanism. 
Table 6.1. Primer pairs designed from D. pulex used for amplification of 
Daphnia magna ABCB and ABCC subfamilies partial sequences. Primers used 
to amplify reference D. magna genes are also included.    p. 216 
Table 6.2. Nominal and measured concentration levels (mg/L) of the studied 
compounds in ASTM hard water in freshly prepared (time 0) and old test 
solutions (24-48h). Protonated molecule of mitoxantrone was not detected and 
instead its transformation products TP1 and TP2 were analysed. Chlorambucil 
analyses include protonated molecule and transformation product 1 (TP1). BDL, 
below detection limit.         p. 226 
Table 6.3. Inhibition concentration (IC50) values based on nominal 
concentrations and its standard error (SE), maximal accumulation (Max, fold 
increase) of Ca-AM, Rh123 and RhB with the model inhibitors used. The lowest 
significant (P<0.05) concentration effect in dye accumulation levels relative to 
controls (LOEC) is also depicted. N, sample size, r2, r square. ns, P≥ 0.05: 
*0.01<P<0.01; ***P<0.001.        p. 239 
Table 6.4. Regression parameters according to eq. 6.2 of fitted models to single 
exposures of the studied chemicals. All regressions were significant (P<0.001). 
N, sample size, r2, r square. LC50 are based on nominal concentrations. p. 243 
Table 6.5. Summary of mixture assays showing estimated median lethal 
concentration effects referred to nominal concentrations; LC50s (95% CI) of 
observed joint responses according to the model of eq. 6.2 and those derived 
from the IA and CA concepts (eqs. 6.3, 6.5). Fold changes of median lethal 
effects due to antagonism (clear grey) and synergism (dark grey) are also 
shown. White coloured cells means that joint effects did not deviate from 
additivity since 95% CI overlap with mean predictive values according to either 
IA and CA. p. 248 
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Summary 
 
Assessing the risks of emerging pollutants requires an understanding of both 
the exposure regime and the effects of the chemical on different organisms. 
There is increasing evidence that the presence of many emerging pollutants in 
aquatic ecosystems may have detrimental effects on aquatic biota. Of special 
concern are those emerging pollutants that may act as putative endocrine 
disrupters in non-vertebrate species, causing unexpected effects that may pose 
a threat to the ecosystem sustainability, but also others that may act as 
chemosensitizers, i.e., by blocking active trans-membrane transporters, 
impairing detoxification mechanisms. Other contaminants, like engineered 
nanoparticles, are recently raising awareness among researchers, due to their 
small size, below 100nm, and aggregation properties. Several reviews claim 
that new toxicity procedures should be used to evaluate nanomaterial toxicity 
due to their unique size characteristics that for example may aggregate and 
sequestrate other contaminants or natural particles. 
 
In my studies, I used Daphnia magna, a historical and widely used test 
organism, to assess ecotoxicological effects of chemicals in freshwater. 
 
In chapters 2, 3 and 4, each one published as an original study (Campos et 
al., 2013a; Campos et al., 2012a; Campos et al., 2012b), I assessed the effects 
of two pharmaceuticals belonging to the group of “Selective Serotonin Reuptake 
Inhibitors”: fluoxetine and fluvoxamine, which are widely used to treat human 
depression, and the detergent 4-nonylphenol. These three chemicals have the 
property of enhancing offspring production in D. magna at low environmental 
levels. In order to understand, the Mode of Action (MoA) of these two very 
different families of chemicals several experiments were performed. Both the 
SSRIs and 4-nonylphenol increased offspring production and SSRIs also 
increased the juvenile developmental rates at limiting but not at high food ration 
levels. Factorial life-history experiments and reproductive assays showed that 
exposure to SSRIs increased juvenile development rate, clutch size, and 
decrease offspring size at low and intermediate levels of food rations. Such life-
history changes were interpreted as a shift towards higher food levels, that is, 
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SSRIs change the perception of food levels on exposed D. magna individuals 
making them to behave like they grew at higher food levels. Enhanced 
reproductive effects of SSRIs were reversed by the presence of the 5-HT 
antagonist cyproheptadine, indicating that in D. magna SSRIs targeted 
serotonin metabolic paths like in humans. Respirometry and survival assays 
and biochemical analyses of lipids, proteins and carbohydrate levels showed 
that adult females exposure to SSRIs increased oxygen consumption rates and 
decreased carbohydrate levels. These changes did not affect survival under 
starving conditions, but they significantly affected the capacity of the exposed 
animals to survive under anoxic conditions.  
Factorial life-history experiments and reproductive assays showed that low 
exposure levels of 4-nonylphenol increased offspring number but decreased 
offspring size and at higher exposure levels impaired severely reproduction. 
These responses have detrimental fitness effects since smaller offspring takes 
longer to mature and reproduce and having less offspring directly affects 
population growth rates.  
The analysis of the D. magna transcriptome showed that serotonin 
metabolism, neuronal developmental processes, and carbohydrates and lipid 
metabolism pathways appeared as selectively affected by SSRIs treatment, 
whereas 4-nonylphenol deregulated genes from the carbohydrate metabolism 
and the ecdysone regulatory pathway. These changes in physiological and 
metabolic pathways are consistent with previously reported SSRI and 4-
nonylphenol hormetic effects in D. magna. SSRIs show a MoA consistent with 
its pharmacological effect in humans while 4-nonylphenol effect seems to be 
performed through changes in the ecdysone regulatory pathways. 
 
In chapter 5, published in Campos et al. (2013b). I evaluated the extent to 
which different forms of nano-TiO2 aggregate with microalgae, decreasing food 
levels and consequently growth and reproduction of D. magna individuals. To 
accomplish my objective, I performed different experiments using three different 
types of nano-TiO2 differing in their coating or crystalline structure but of similar 
primary size (20nm) plus a micron-sized bulk material, two nano-TiO2 exposure 
levels (1 and10mg/L) and different food levels that included non-limiting and 
limiting food conditions. Effects were assessed using three different types of 
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assays. Assays included chronic reproduction 21-day tests using semi-static 
conditions that followed OECD protocols, but also custom designed tests 
performed in 1L bottles holding larger water columns. The latter included two 
exposure scenarios: semi-static and re-suspension of algae. Effects on D. 
magna were determined from growth and reproduction performance 
measurements. 
Results indicated that the high ion levels in culture medium lead to the 
aggregation of nanoparticles followed by particle destabilization. Nanoparticle 
aggregates interacted with the algae cells, forming clusters. Large TiO2 -algae 
agglomerates settled readily, dramatically depleting the concentration of 
available food for Daphnia. At limiting food rations, depletion of food by 
nanoparticle aggregation had dramatic effects on reproduction and fitness of 
exposed D. magna at 1mg/L irrespectively of the particle form. At high food 
rations effects were only observed for one of the nano-TiO2, P-25, at high 
exposure levels (10mg/L) under both semi-static and particle re-suspension 
conditions, which suggest that P-25 effects were mediated by clogging the gut 
and hence diminishing food acquisition. These results indicate that nano-TiO2 
may affect the transfer of energy throughout the planktonic aquatic food webs 
increasing the settlement of edible particles from the water column. 
 
In chapter 6, submitted to Aquatic Toxicology, I attempted to characterize the 
presence and activity of the multixenobiotic resistance proteins (MXR) in D. 
magna. This system has already been studied in several aquatic organisms, 
mainly bivalve species, whereas there is only a in silico study on D. pulex, a 
close relative of D. magna. I sequenced new partial sequences of four genes, 
coding for full transporters and studied their transcriptional pattern across life-
stages and with juveniles exposed to MXR inducers. All the genes were 
transcribed early in embryos and some of them were induced in juvenile stages 
by pentachlorophenol and mercury. Associated efflux activity was monitored 
using three fluorescent substrate dyes, which are specific of different 
mammalian transporter types, combined with specific MXR transporter inhibitors 
(chemosensitizers). Dye accumulation assays indicated that MXR is functional 
in juveniles and induced by pentachlorophenol, mercury and dacthal. Toxicity 
bioassays performed with model toxic substrates of ABCB1 (mitoxantrone) and 
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ABCC (chlorambucil) transporters applied in combination with the studied 
chemosensitizers showed joint toxic effects greater than additivity in most 
cases. This means that the MXR system in D. magna is active and plays an 
important role detoxifying contaminants.  
 
Published papers in this thesis: 
 
Campos, B., Garcia-Reyero, N., Rivetti, C., Escalon, L., Habib, T., Tauler, R., 
Tsakovski, S., Piña, B., Barata, C., 2013a. Identification of Metabolic 
Pathways in Daphnia magna Explaining Hormetic Effects of Selective 
Serotonin Reuptake Inhibitors and 4-Nonylphenol Using Transcriptomic 
and Phenotypic Responses. Environmental Science & technology 47, 
9434-9443. 
Campos, B., Piña, B., Carlos, B.C., 2012a. Mechanisms of action of selective 
serotonin reuptake inhibitors in Daphnia magna. Environmental Science 
and Technology 46, 2943-2950. 
Campos, B., Piña, B., Fernández-Sanjuán, M., Lacorte, S., Barata, C., 
2012b. Enhanced offspring production in Daphnia magna clones exposed 
to serotonin reuptake inhibitors and 4-nonylphenol. Stage- and food-
dependent effects. Aquatic Toxicology 109, 100-110. 
Campos, B., Rivetti, C., Rosenkranz, P., Navas, J.M., Barata, C., 2013b. 
Effects of nanoparticles of TiO2 on food depletion and life-history 
responses of Daphnia magna. Aquatic Toxicology 130-131, 174-183. 
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1. Background 
 
"Sustainable development is development that meets the needs of the 
present without compromising the ability of future generations to meet their own 
needs.” 
 
When the first green wave appeared in the mid and late 1960s, it was 
considered a feasible task to solve pollution problems. The visible problems 
were mostly limited to point sources, well defined, and a comprehensive 
environmental technology was available. It was even seriously discussed in 
some of the most industrialised and developed countries what was called “zero 
discharge” could be achieved (Kümmerer, 2010). Nevertheless, it became clear 
in the early 1970s that zero discharge would be too expensive and would 
possibly have an impact in society that was not acceptable.  
Meanwhile, it has been shown that what can be called “the environmental 
crisis” is much more complex than we initially thought.  
 
In 1987 the United Nations released a report, written under the auspices of 
the General Assembly, which was to serve as a keystone on the way how our 
society should manage the new challenges that were arising. This was known 
as the Brundtland Report, ”Our common future” (World Commission on and 
Development, 1987) and it highlighted the way how we should manage our 
society, by establishing beacon’s or objectives, that would allow us to keep our 
development needs while keeping in mind the needs of future generations, and 
taking into account economics, politics, engineering, culture and environmental 
concerns. 
According to the same report, Sustainable development and the way how it 
was defined contains within it two key concepts: 
-the concept of 'needs', in particular the essential needs of the world's poor, 
to which overriding priority should be given; and 
-the idea of limitations imposed by the state of technology and social 
organization on the environment's ability to meet present and future needs. 
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As at this moment there are more than 72 million organic and inorganic 
substances registered (CAS 2013), and more than 43 million are commercially 
available for purchase and usage. This shows us how we are a “chemical” 
society and surrounded at all moments by natural and synthetic substances, 
which may threaten the environment due to their more or less toxic effects on 
plants, animals, humans and entire ecosystems. In most industrialised countries 
comprehensive environmental legislation was introduced to regulate the wide 
spectrum of different pollution sources. Trillions of dollars have been invested in 
pollution abatement on a global scale, but it seems that two or more new 
problems emerge for each problem that is solved (Mitsch and Jørgensen, 
2003). 
 
1.1. How to deal with large number of chemicals surrounding us 
 
More than 100,000 chemicals have been introduced in the 20th century alone, 
that are used in our everyday life, either in households, industries or agriculture. 
We have “blindly” introduced these chemicals without realising the 
consequences for the environment and directly and indirectly for human health 
(Hartung, 2011). The EU started to list these chemicals in the late 1970s, and 
since the mid-1980s it has been compulsory to set up an environmental risk 
assessment (ERA) for all new chemicals. The original idea was to make 
environmental risk assessments for all the chemicals already in use, but it is 
going very slowly, and at the present rate, we shall not be able finish ERAs for 
all the applied chemicals in the next decade. Probably, it is necessary to speed 
up the evaluation of the chemicals in use, for instance by forging a closer 
cooperation between the environmental agencies and the chemical industry, in 
order to obtain a realistic picture of the environmental risk associated with the 
many chemicals we apply today. In order to achieve this, the EU started the 
Registration, Evaluation, Authorisation and Restriction of Chemical substances. 
(REACH). REACH is the European Community Regulation on chemicals and 
their safe use (EC 1907/2006). The law entered into force on 1 June 2007. The 
REACH Regulation places greater responsibility on industry to manage the risks 
from chemicals and to provide safety information on the substances. 
Manufacturers and importers are required to gather information on the 
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properties of their chemical substances, which will allow their safe handling, and 
to register the information in a central database. 
One of the main reasons for developing and adopting the REACH Regulation 
was the large number of substances that have been manufactured and placed 
on the market in Europe for many years, sometimes in very high amounts, and 
yet there is insufficient information on the hazards that they pose to human 
health and the environment.  
This makes urgent to fill these information gaps to ensure that industry is 
able to assess hazards and risks of the substances, and to identify and 
implement the risk management measures to protect humans and the 
environment and when possible to proceed to a gradual substitution of the most 
hazardous substances by others with less impact, on human health, but also on 
wildlife and ecosystems. 
 
1.2. Aquatic Ecosystems protection 
 
The aquatic ecosystem is one of the most affected natural systems by 
chemicals. Compounds that are used in industry, agriculture or household, have 
a high probability to end in ground waters, rivers, lakes, freshwater catchments, 
estuaries, reservoirs and marine waters. 
Many of the most used substances have been submitted to ERA, with a 
highlight on potential effects on aquatic species and have been organized in 
hazard lists according to their hazardous potential. One of the most important 
lists is the Prioritary substances, which were defined within the EU Water Frame 
Directive (WFD) (EU Directive 2000/60/EC). The WFD objectives are to reduce 
and/or eliminate the potential emission sources of the catalogued chemicals 
and remove them from the environment. By making use of the available 
information on the effects and occurrence of chemicals, the priority chemicals 
list was proposed by the EU, taking into account the expert judgment of 
scientific comities and research programs and following the recommendations 
of other European political and civil institutions. 
This list included originally 33 priority substances and 8 other pollutants 
(Decision 2455/2001/EC). More recently it was proposed to increase this list 
with another 15 additional priority substances, 6 of them designated as priority 
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hazardous substances. But also to add other considerations about some other 
chemicals: 
 the introduction of biota standards (Environmental Quality Standards, 
(EQS) for several substances; 
 provisions to improve the efficiency of monitoring and the clarity of 
reporting with regard to certain substances behaving as ubiquitous, 
persistent, bio accumulative and toxic (PBT) substances; 
 provision for a watch-list mechanism designed to allow targeted EU-
wide monitoring of substances of possible concern to support the 
prioritisation process in future reviews of the priority substances list. 
 
This approach is useful, but unfortunately left out a great number of 
chemicals that are raising concerns, as the standard ERA evaluations do not 
cover specific sublethal effects that may have high impacts at ecological levels. 
 
1.3. Emerging contaminants 
 
In the last decades there has been a major development in analytical 
chemistry technologies, allowing scientists to detect chemicals in the range of 
the low part per trillion, or nanogram per litre (ηg/L) and even picogram/L (ρg/L). 
With these increased capabilities, we have now overwhelming evidence that 
“new” xenobiotic substances have been produced over the last decades and 
are nowadays ubiquitous in the aquatic environment. These substances, 
referred to as “emerging pollutants”, include a wide array of different 
compounds (as well as metabolites and transformation products). These “new” 
environmentally relevant chemicals are now often referred as Emerging 
Contaminants or contaminants of Emerging Concern (EC). (Barceló, 2003)), 
defined emerging pollutants as:” pollutants that are not yet regulated but may be 
candidates for future regulation depending on research, on their potential health 
effects and monitoring data regarding their occurrence in ecosystems, and 
since their high transformation or removal rates can be compensated by their 
continuous introduction into the environment, they do not need to be persistent 
in the environment to be present in the ecosystems”. 
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Broadly, they can be described also, as any synthetic or naturally occurring 
chemical that is not commonly monitored in the environment, but has been 
recently detected and is now raising awareness. 
Emerging contaminants are not actually new. They can be present in the 
environment for decades, but only now we have the technology that allows us to 
detect them. Nevertheless, due to their large numbers, only few of these 
compounds are toxicologically evaluated, and most of them superficially.  In 
view of that, the scientific community is becoming aware of the risks of ECs, 
and it is without surprise that these chemicals are now recollecting most of the 
resources for research, together with the priority chemicals for an in-depth ERA.  
Nevertheless, it should be kept in mind that there is a big difference between 
priority and emerging chemicals. The former are or may pose a serious risk 
both for human populations or the environment, either by the high concentration 
levels or persistence. They are mostly well characterized and because they are 
mainly used in big volumes in industry and agriculture, they have well defined 
points of entrance to the environment and are somehow easy to track. ECs 
represent a shift in the traditional way how we face chemical pollution, being 
that many are industrially produced, they are incorporated in daily life products 
and their dispersion into the environment is diffuse, from domestic, commercial, 
industrial and agricultural runoffs and adequate data do not exist to determine 
their risks (Drewes and Shore, 2001; Younos, 2005). 
 
Our ability to detect ECs in the environment may often exceed our ability to 
understand their risks. Initial studies of EC occurrence focused on locations 
where they were expected to occur, such as those downstream from intense 
urbanization or livestock production (Kolpin et al., 2002). Several research 
documents show that ECs are present in the environment on a global scale and 
can occur in relatively undeveloped areas (Ashton et al., 2004; Bendz et al., 
2005). 
Are some ECs potentially harmful to ecological or human health? How do we 
allocate the scarce funds to study or control exposure to ECs when risks are 
poorly defined? Are there safe limits of exposure or ingestion? How do we 
respond to new compounds and new modes of action? These are some key 
questions that need answers (Glassmeyer, 2007). 
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Because many ECs are designed molecules, the diversity of effects that can 
be caused is very broad. Some ECs can act as endocrine disrupting chemicals 
(EDCs) and be a serious threat to the environment. EDCs have the potential to 
affect hormonal driven processes, such as reproduction and aquatic organisms 
are particularly susceptible to EDCs, because their entire life cycles are spent in 
continuous contact with these substances in water. Some ECs (hormones and 
pharmaceuticals) are produced to have biological effects and hence may have 
effects on non-target organisms at very low (ppb-ppt) levels.  
 
Emerging Contaminants include the following wide range of substances 
including  pharmaceuticals and personal care products (PPCPs), illicit drugs 
and drug of abuse, hormones and steroids, benzothiazoles, benzotriazoles, 
polychlorinated naphthalenes (PCNs), perfluorochemicals (PFCs), 
polychlorinated alkanes (PCAs), polydimethylsiloxanes (PDMSs), synthetic 
musks, quaternary ammonium compounds (QACs), bisphenol A (BPA), 
triclosan (TCS), triclocarban (TCC), as well as polar pesticides, veterinary 
products, industrial compounds/by-products, food additives and engineered 
nano-materials (Lapworth et al., 2012). 
For most emerging contaminants, there is currently little information 
regarding their potential toxicological significance in ecosystems particularly 
regarding effects from long-term, low-level environmental exposures.  
There are thousands of chemicals and substances available for industrial 
processes and consumer goods, with additional chemicals being developed 
every day. Because many of these chemicals are relatively new, the effects of 
many on human health and the environment are not known.  
The ever increasing need to conserve and reuse water can lead to increases 
in the number and concentration of many ECs and underlines the need for more 
scientific assessment to better understand the sources of ECs, the 
effectiveness of removal by wastewater and drinking-water-treatment 
processes, the transport and environmental fate of these compounds, and their 
potential for physiological effects on humans and wildlife. New scientific 
evidence about the exposure pathways and potential impacts of some of these 
compounds on human or environmental health is regularly being published 
(Claessens et al., 2013; Cristale et al., 2013; Drewes et al., 2005; Gibs et al., 
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2007; Hutchinson et al., 2013; Kinney et al., 2006; Veldhoen et al., 2006; 
Woodling et al., 2006). They are products that we regularly use (or create) in 
our homes, businesses, farms and industry and yet adequate data are lacking 
to determine their actual risk (Hutchinson, 2007; Soin and Smagghe, 2007; 
Younos, 2005). Recent news headlines have declared potential human health 
and ecological concerns regarding the occurrence of personal care products 
and pharmaceuticals in the environment and the society is slowly becoming 
aware of the problems that we may face, due to a heavy consumption and use 
of ECs and disregarded disposal of them. 
 
Due to the high number of substances that can be classified within ECs and 
the very different characteristics that they present, we will focus in this work in 
three classes: 
Pharmaceuticals and Personal Care Products (PPCPs) 
Alkylphenols (4-Nonylphenol) 
Engineered Nano-Materials 
Musks and chemosensitizer chemicals 
 
1.3.1. Pharmaceuticals and personal care products (PPCPs) 
In our daily life we use a high number of products, which make our life easier 
and/or better and more comfortable. Either it’s the shampoo, toothpaste, 
deodorant, medicines or even our clothes; we are using hundreds of different 
chemical components that will then be disposed with our garbage or 
wastewater.  
As long as pharmaceuticals and personal care products (PPCPs) have been 
used, they have been present in the environment. However, many of them are 
becoming persistent in the environment, due to the fact that as they degrade, 
more are added in a continuous way and our ever increasing use of PPCPs. 
The consumption of pharmaceuticals is increasing in European countries, as 
in the rest of the world. It is estimated that the consumption of pharmaceuticals 
will increase at a 3-4% rate in weight per year (Daughton, 2004), and some 
specific groups of compounds may even be higher. Studies performed in OECD 
countries showed that antidepressants consumption increased by more than 
200% from 2000 to 2007 (OECD, 2012) even though recent reports show a 
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significant delay of this increase in the last years, possibly due to the economic 
crisis and government budget cuts in health. Then again, the use of other 
personal care products are increasing even more, with the rise of emerging 
economies and millions of new consumers having access to consumer 
products. Due to persistence and increasing levels of many PPCPs, scientists 
are beginning to notice harmful effects in the environment.  
 
PPCPs are molecules designed  to have low cellular toxicity, and very 
specific effects and because of that the normal toxicological evaluation 
according to the guidelines, will more often than not, underestimate the effects 
on ecosystem level. Often, similar target biomolecules are present in non-
mammalian organisms and so PPCPs can have adverse effects across species. 
Unless more is known about possible chronic effects of individual 
pharmaceuticals and other personal care products, conclusions concerning 
hazard potential or risks to the aquatic ecosystem are premature. 
PPCPs can induce unexpected effects in non-mammalian organisms based 
on the difference in pharmacokinetics and pharmacodynamics, important 
parameters for occurring species. Disturbances of the reproductive and 
hormonal system, immune depression, neurobehavioral changes just to name 
some key targets, may have far reaching effects at the population level. This 
has become evident for endocrine disrupters such as steroid hormones used in 
contraceptives resulting in important adverse effects at environmentally relevant 
concentrations (Jobling et al., 1998; Länge et al., 2001; Parrott and Blunt, 
2005). Pharmaceuticals can reach water bodies through sewage systems, 
industrial discharges, effluents from sewage treatment plants (STPs), 
aquaculture and livestock farming. Pharmaceuticals include hundreds of 
substances which are very different regarding physical-chemical properties and 
environmental behaviour. 
 
Presently, pharmaceuticals can be detected in surface waters at the levels of 
ηg/L to mg/L and some are considered ubiquitous (Oosterhuis et al., 2013). 
Nevertheless, their presence in the aquatic environment and impact on aquatic 
biota has not yet been studied adequately. Experimental evidence indicates that 
pharmaceuticals may cause harmful effects, such as morphological, metabolic 
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and sex alterations on aquatic species, induction of antibiotic resistance in 
aquatic pathogenic microorganisms, and disruption of biodegradation activities 
in STPs (Bottoni et al., 2010). Risk assessment studies and evaluations are in 
progress and new information is brought to attention every day. Nevertheless, 
the available scientific data are consistent with the introduction of some 
pharmaceutical indicators in extensive water monitoring to better define their 
actual impact on aquatic organisms and humans. Under these perspectives, the 
inclusion of emerging pharmaceuticals in the revision of EU List of Priority 
Substances under the Water Framework Directive 2000/60/EC should be 
implemented as well as the definition of respective environmental quality 
standards.  
Nevertheless, there is a general lack of chronic toxicity data of PPCPs on 
non-target species and specially, pharmaceuticals need more investigation 
about potential long-term ecotoxicological effects, particularly with respect to 
potential disturbances in hormonal homeostasis (endocrine disruption), 
reproductive outputs, immunological status, gene activation and/or silencing 
during long-term, low doses exposure.  
 
In-depth understanding of possible effects needs a mechanism-based 
approach focused on target molecules should yield more meaningful results and 
insights than traditional acute toxicity testing. Current data on acute and chronic 
toxicity of pharmaceuticals support to the conclusion that more target, or mode-
of-action based investigations, will allow more relevant insights into effects on 
survival, growth and reproduction than traditional standard ecotoxicity testing. A 
useful new tool can be the Adverse Outcome Pathways (AOP) analysis, a 
conceptual analysis that tries to correlate effects and mode-of-action (Ankley et 
al., 2010). 
Current tests cover only a small set of laboratory organisms, and are often 
not sensitive enough thus not able to unravel adverse effects of 
pharmaceuticals due to their design. As a consequence, more specific tests are 
needed. Only chronic toxicity investigations using more specific toxicity 
parameters will lead to a more meaningful ecological risk assessment. When 
evaluating the effects of PPCPs on non-target species, we should keep in mind 
that, by design, these are biologically active molecules, that may or may not 
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have similar effects in non-target species, as many species share the structure 
of the target, due to evolutionary conservation. But they can also have 
unexpected effects in other organisms due to biological and physiological 
differences that will alter the pharmacodynamics and/or pharmacokinetics. 
 
The first pharmaceuticals molecules were detected in the environment in the 
1980’s (Richardson and Bowron, 1985; Waggott, 1981). However, concerns 
over the presence and effects of this medical substances and their metabolites, 
increased in the last years of the 20th century. After the publication of the first 
reviews on the emerging concerns and the state of the art of PPCPs in 
freshwater systems (Daughton and Ternes, 1999; Fent et al., 2006; Halling-
Sørensen et al., 1998; Heberer, 2002), the scientific community started directing 
their efforts towards the characterization of hazard potential of these 
substances. 
Pharmaceuticals are designed to target specific metabolic and molecular 
pathways in humans and animals, but they often have important side effects. 
When introduced into the environment they may affect the same pathways in 
animals having identical or similar target organs, tissues, cells or biomolecules. 
Certain receptors in lower animals resemble those in humans, others however, 
are different or lacking, which means that dissimilar modes of actions may occur 
in lower animals or provoke unexpected effects due to biological differences 
and organization throughout all the levels of life on earth. It is important in this 
respect to recognize that for many drugs, their specific modes of actions are not 
well known and often not only one, but many different modes of actions occur 
simultaneously. Among other reasons, this makes specific toxicity analysis in 
lower animals difficult to perform. Despite this, toxicity experiments should be 
targeted and designed for specific targets of the pharmaceutical even in lower 
vertebrates and invertebrates, based on the hypothesis of similarity of modes of 
actions. However, current toxicity testing is not designed in this way, rather 
general and established test systems and traditional organisms according to 
guidelines are being used and traditional end points such as mortality are 
assessed (Fent et al., 2006). 
Pharmaceuticals are assessed for their acute toxicity by traditional standard 
tests according to established guidelines (e.g. OECD, U.S. EPA, ISO) using 
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established laboratory organisms such as algae, zooplankton and other 
invertebrates and fish. Acute toxicity data of pharmaceuticals were compiled by 
(Halling-Sørensen et al., 1998) and (Webb, 2001), making a list of about 100 
human pharmaceuticals from different sources. In the attempt to compare the 
different classes of pharmaceuticals in terms of acute toxicity, (Webb, 
2001) noted that the most toxic classes were antidepressants, antibacterial and 
antipsychotics, but the range of responses within each of these categories was 
large, typically several orders of magnitude, and did not took into the equation 
the sublethal effects that can impair the ecosystem. (Heckmann et al., 2007) 
studied the effects of ibuprofen on Daphnia magna. The previous authors 
showed that even though D. magna had a high tolerance to acute doses of 
Ibuprofen, offspring production was impaired at much lower doses. This drug, 
reduces female fertility by affecting the eicosanoid pathway, its intended 
pharmacological target in humans, thus, leading to a decrease of the population 
and a high impact at population level (Heckmann et al., 2008b). This is a clear 
example of an unexpected effect of a pharmaceutical. 
 
1.3.2. Anti-depressants 
Anti-depressants consumption in human society is growing. The new 
generation anti-depressants are a group of molecules known as Selective 
Serotonin Reuptake inihibitors (SSRIs). 
SSRIs are a widely used antidepressant class, which acts by inhibiting the re-
uptake of serotonin (Hyttel, 1994). The neurotransmitter serotonin is involved in 
many mechanisms, both hormonal and neuronal, and it is also important in 
functions such as food intake and sexual behaviour. A pump directs serotonin 
from the synaptic space back to the pre-synapse, and SSRIs inhibit this pump, 
thus increasing the serotonin level in the synaptic cleft. Serotonin as a 
neurotransmitter occurs in vertebrates and invertebrates (Fong, 1998), 
however, the effects associated with this transmitter are different, and so are 
the effects of SSRIs. The role of serotonin in reproduction varies between 
different phyla. Besides having important functions as a neurotransmitter, 
serotonin may directly act on the immune system, alters appetite, influences 
behaviour and modulates sexual function, altering the nervous and associated 
hormonal systems. Serotonin mediates, among other processes, endocrine 
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functions in aquatic organisms such as parturition in fingernail clams Sphaerium 
striatinum (Fong et al., 1998) and egg production, rate of fertilization and 
spawning in Japanese medaka Oryzias latipes (Foran et al., 2004). SSRIs, by 
affecting the concentration of serotonin in the synaptic cleft, has been shown to 
have several effects already described in different phyla. 
The SSRIs (fluoxetine and fluvoxamine) led to induction of parturition in 
fingernail clams and an induction of spawning in zebra mussels at 
concentrations as low as 32 ng/L (Fong, 1998; Fong et al., 1998). More recently 
it was found that fluoxetine reduced the number of oocytes and spermatozoa of 
zebra mussel gonads at concentrations of 10ng/L (Lazzara et al., 2012). 
Serotonin may stimulate ecdysteroids, ecdysone and juvenile hormone, 
responsible for controlling oogenesis and vitellogenesis (Nation, 2002), thus, it 
is expected that SSRIs may have an effect also in arthropod species. Indeed 
SSRIs are known to increase reproduction in D. magna and C. dubia at low 
doses (Flaherty et al., 2001), and reduced them at high doses.  An evaluation of 
five SSRIs (fluoxetine, fluvoxamine, paroxetine, citalopram, sertraline) showed 
negative effects on C. dubia reproduction by reduction of the number of 
neonates or brood per female after 7–8 days of exposure(Henry et al., 2004).  
Fluoxetine, the active compound of PROZAC, has been detected in sewage 
and stream water at concentrations of 12ng/L (Kolpin et al., 2002) and 99ng/L 
(Metcalfe et al., 2003) respectively. Fluoxetine maximal measure concentrations 
(100ng/L) were near the LOEC for zooplankton and other benthic organisms, so 
the margin of safety is very thin, and chronic effects at this point cannot be 
disregarded, in particular when the combined effects of pharmaceutical mixtures 
are taken into account. It should be noted, however, that more experimental 
data on chronic toxicity and on the bioaccumulation potential is needed to fully 
judge the environmental risk posed by individual pharmaceuticals. 
 
 
1.3.3. Alkylphenols 
Alkylphenols (APs) are starting materials for the production of many 
surfactants and antioxidants stabilizers used in commercial products like 
detergents, plastics and textiles. Namely, APs are used in the synthesis of 
alkylphenolethoxylates (APEs) and are also generated by the decomposition of 
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these substances in the environment. APEs are one of the most widely used 
classes of non-ionic surfactants in domestic and industrial products (Shang et 
al., 1999). Among them, the most representative are nonylphenols (NPs), with a 
C9-alkyl group and octylphenols (OPs), with a C8-alkyl group. NP is the most 
commercially prevalent of the APs family, representing approximately 85% of 
the APs market, is present in many household products, even though it has 
been banned in Europe. 
 
Long-chain APEs are susceptible to metabolism in natural environment, 
leading to the formation of APEs with short ethoxylate chain length (typically 1-
3) such as APs and carboxylated APEs, which are more toxic and persistent 
than their precursor (Ahel et al., 1994). The environmental fate of these 
metabolites is of significant interest because of their potential endocrine 
disrupting effects (Bennie et al., 1998). For instance, NP ethoxylates are easily 
transformed to their main metabolite, NP, under anaerobic conditions, which is 
approximately 10 times more toxic than its ethoxylate precursor (Renner, 1997) 
and is known to disrupt normal hormonal function (Dachs et al., 1999; Johnson 
and Sumpter, 2001). Of all APEs metabolites, OP is the strongest xeno-
estrogen and can induce significant effects in fish at concentrations of 3 µg/L 
(Jobling et al., 1996). On the other hand, NP is active at concentrations of 8 
µg/L (Harris et al., 2001). 
Since 1998, 4-NP and 4-OP are listed by OSPAR as chemicals for priority 
action (OSPAR-Commission, 2011) and both APs are present in the Water 
Framework Directive (Directive 2000/60/EC) of substances and substance 
groups prioritized for action to achieve good quality surface water (Toyama et 
al., 2010a; Toyama et al., 2010b). The aim of these regulations is to ensure that 
emissions and losses of these substances to surface waters must be reduced to 
zero within the next two decades. 
 
Whereas APs are worldwide distributed, the concentration detected in waters 
are geographic and legislation dependant. Water policy as well as water 
treatment facilities play an important role in the residues detected in each site. 
Furthermore, the monitoring of APs is basically restricted to OP and NP, and 
very little information is available on the fate of these common APs in the water. 
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APs were monitored in rivers and estuaries in England and Wales during 1993 
(Blackburn and Waldock, 1995). Dissolved NP (and total extractable NP) 
ranged from 0.2 (0.5) to 53 (180) µg/L. Concentrations of NP were one order of 
magnitude lower in estuaries than in rivers, reflecting dispersion and dilution 
processes (Blackburn and Waldock, 1995).(Matthiessen and Law, 2002) 
reviewed the biological effects of contaminants in British estuaries and coastal 
waters for the last 100 years. Until 1970, the major pollution impacts on 
estuarine organisms was probably attributed to poorly treated sewage and 
oxygen depletion, whereas since the installation of wastewater treatment plants 
(WWTPs), the release of toxic micro-pollutants became a serious environmental 
problem and NP was identified in Tyne and Tees estuaries as contributing to 
toxic effects in the copepod Tisbe battagliai. 
In the NE Spain, Wastewater Treatment Plants (WWTP) and river outflows 
were identified as a major source of organic micro-pollutants to coastal waters. 
Among other contaminants, OP, NP and NP monoethoxylated were identified 
as the major contaminants with concentrations from 0.013 to 0.061 µg/L for OP 
and NP in river water and 0.395 and 1.021 µg/L for OP and NP in wastewater 
effluents, respectively (Sánchez-Avila et al., 2012).  
Toxicological information on NPs is extensive but mainly focused on 
estrogenic and/or mammalian effects. The most abundant and studied 
compound is 4-n-NP. There is a general consensus among regulators that NP 
is estrogenic and hence it should be banned. Nevertheless, it is of paramount 
importance to determine the detrimental effects on multiple aquatic species. NP 
is metabolized in the liver and its metabolites excreted in the bile, mainly as 
glucuronide conjugates. However, extraction of faecal samples revealed that 
faeces mainly contained NP itself (Green et al., 2003; Zalko et al., 2003). 
NP is considered a weak xeno-estrogen around 100 times less potent than 
17-ß-estradiol (Routledge and Sumpter, 1997). This means that it has the 
potential to be estrogenic but at high concentrations. Thus, it is not surprising to 
find that in rats, NP impaired first and second generation reproductive traits in 
males at doses of 150 mg/kg/day, which are quite high compared to those of 
17-β-estradiol (0.1 mg/kg/day) (Chapin et al., 1999; Nagao et al., 2001; Tyl et 
al., 2006). In the above mentioned studies systemic toxicity, however, occurred 
at lower doses (15 mg/kg/day), which also indicates that probably the dominant 
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mode of action of NP to mammals and ultimately to humans is systemic and not 
estrogenic.  
Environmental health effects of NP in non-mammalian species have also 
been extensively studied in the aquatic environment. Like most APs, NPs are 
relatively soluble in water and are present in surface waters at quite high 
concentrations when compared with other pollutants. Concentrations of NP of 
4.35µg/L have been measured in some coastal areas and Mediterranean rivers 
(Petrovic et al., 2002a; Petrovic et al., 2002b). Fish should also be susceptible 
to estrogenic effects by NP. There is experimental evidence that NP may cause 
estrogenic related effects (increase plasma/liver vitellogenin levels in males, 
impair male reproduction, alter sex characteristics and mating behaviour) on 
fish between 10 and 100 µg/L in long term exposures but there is also evidence 
that NP impair non estrogenic endpoints such as growth and reproduction of 
fish at the same range. Thus again, it is not clear in the above reported studies 
if NP effects are systemic or truly estrogenic. Indeed, new evidence indicates 
that NP may interact with the lipidogenic pathways and act as an obesogen 
(Hao et al., 2012). 
In river locations, downstream discharges of effluents from WWTPs located 
nearby Barcelona city, in vitro estrogenic tests have identified NP as the most 
estrogenic compound present in surface waters (Céspedes et al., 2004; Quirós 
et al., 2005). This result contradicts those reported earlier in waste water 
effluents from England (Desbrow et al., 1998) that found that estrogenic effects 
on rivers, downstream WWTP effluents were caused by steroid hormones like 
estradiol. The above mentioned discrepancies, however, could be explained by 
the fact that in most cases Spanish treatment plants have tertiary treatments 
that remove hormones whereas those of UK do not. These results have also 
been extrapolated in the field in the Llobregat river (NE, Spain) where authors 
reported high levels of vitellogenin in males collected after waste water plant 
effluent discharges (Solé et al., 2000). Nevertheless, again, it is difficult to 
establish a close link between in vitro test and in vivo responses due to the co-
existence in the field of many chemicals that can be estrogenic as well. A piece 
of evidence that may support the weakness of the estrogenic arguments in fish 
is the fact that today despite that NP is still present at high amounts in certain 
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parts of rivers within Spain there are not clear reported effects in fish (González 
et al., 2012). 
In aquatic invertebrates, NP appears to be quite toxic to small crustaceans at 
around 10µg/L. The mechanism of action of NP to aquatic invertebrates is 
unclear. According to (Barata et al., 2004), most studies that have reported 
endocrine disruption effects of NP to aquatic invertebrates misinterpreted the 
results since observed inhibitory effects on growth and reproduction could be 
associated with feeding impairment, which is a general toxicity mechanism quite 
common across pollutants. Nevertheless, there is experimental data that 
indicates that NP at high exposure levels (> 100 µg/L) may affect the 
metabolism of ecdysteroids impairing embryo survival (LeBlanc et al., 2000a).  
 
Information on pollutants able to disrupt reproduction in an unexpected way, 
enhancing reproduction rather than inhibit it, are scarce and contradictory. 
Enhanced offspring production in Daphnia females exposed to pollutants has 
been reported for fluoxetine, 4-nonylphenol and dispersogen A (Brooks et al., 
2003a; Brooks et al., 2003b; Flaherty and Dodson, 2005; Hammers‐Wirtz and 
Ratte, 2000; LeBlanc et al., 2000b), although inhibitory effects on reproduction 
have also been found for the first two chemicals. 4-Nonylphenol, has been 
reported having a similar effect, increasing reproduction. Indeed recent studies 
indicate that 4-nonylphenol may inhibit, un-change or enhance offspring 
production in D. magna (Brooks et al., 2003a; Brooks et al., 2003b; Flaherty and 
Dodson, 2005; Hammers‐Wirtz and Ratte, 2000; LeBlanc et al., 2000b). 
 
1.3.4. Engineered Nanomaterials 
Manufactured nanomaterials (MNMs) are a relatively new class of elemental 
metals, chemical compounds, and engineered materials with particle sizes in 
the nanometer range (<100 ηm). Several classes of MNMs are now globally 
manufactured in hundreds to thousands of metric tons per year. These include 
MNMs for structural applications (ceramics, catalysts, films and coatings, and 
composite metals), skin care products (metal oxides), information and 
communication technologies (nanoelectronic and optoelectronic materials, 
organic light emitters, and nanophosphors), biotechnology (drug delivery, 
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diagnostic markers, and biosensors) and environmental technologies 
(nanofiltration and membranes) (Borm and Berube, 2008).  
Naturally occurring (geogenic) nanomagnetite exists in some bacteria, which 
use this mineral to sense the Earth’s magnetic field (Faivre et al., 2005). 
Primary geogenic nanoparticles also occur as aerosols from ocean spray (salts 
and sulfates), volcanic emissions (sulfate aerosols), forest fires (soot and 
elemental carbon, and polycyclic aromatic hydrocarbons or PAHs) (Lucas and 
Akimoto, 2007). Primary anthropogenic nanoparticles are similar in composition 
to geogenic nanoparticles, ranging from less than PM1 (≤1,000 ηm) to ultrafine 
particles (UFP) (≤100ηm). Sulfate, hydrogensulfate, and nitrate nanoparticles 
are emitted to the atmosphere from industrial sources and power plants, and 
nanocarbons are emitted from internal combustion (primarily diesel) engines. 
Major MNM sources with potential impacts to air, soil, surface water and 
groundwater are from industrial production, including amorphous silica, carbon 
blacks and fullerenes, and titanium and zinc oxides(Borm and Kreyling, 2004; 
Lucas and Akimoto, 2007). 
MNMs is one of the fastest growing industries and it was estimated to be 
worth a trillion US Dollars in the near future (Nel et al., 2006). Nanotechnology 
has the potential to deliver considerable benefits to the society, but at the same 
time, nanomaterials are at the centre of the discussion about risks of possible 
releases of very small particles in the environment and how can affect human 
health. 
It is widely accepted that there is a need to analyse the risks associated with 
nanotechnology in order for nanotechnology and nanomaterials to be developed 
responsibly. Despite that manufactured nanomaterials are covered by the 
Directive 67/548/EEC, 793/93 and REACH, there is an unclear situation 
regarding requirements for risk assessment. The traditional risk assessment 
methodology has not yet been applied to nanoparticles, and there are no official 
guidelines on what constitutes an appropriate testing regimen. Another point is 
that the regulation of REACH, based on tons, needs to consider that there are 
many more nanoparticles in one ton than would be the case for larger particles. 
With regard to effects, there is insufficient data available to identify any generic 
rules governing the likely toxicology and ecotoxicology of nanoparticles. A new 
sub-discipline of toxicology, nanotoxicology, has emerged with the aim of 
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addressing the effects that may be associated with nanosized materials. There 
is also an urgent need for harmonized terminology and nomenclature for 
defining the physical characteristics of nanoparticles and their general 
properties. The measurement of specific properties and exposure levels is 
necessary. For those objectives, methods that measure physicochemical 
properties and that reliably detect nanoparticles in the environment are needed. 
There is a serious lack of information about relevant monitoring studies focused 
on the occurrence in the environment. Analytical methodologies are now 
beginning to be applied for the detection of nanoparticles in environmental 
samples. Nanotechnology is becoming an important policy area in the EU. The 
first step has been given by the Seventh Framework Program for research, 
which set aside an indicative budget for research into nanosciences and 
nanotechnologies and financed several European projects on an integrated 
perspective, clustered together under the 7th Framework Program of the EU 
(http://www.nanosafetycluster.eu/).  
 
The study of the ecotoxicity of manufactured nanomaterials to aquatic 
organisms has a relative recent history when compared with that of other toxic 
substances (Baun et al., 2008). Several reviews claim that new toxicity 
procedures should be used to evaluate MNM toxicity due to their unique 
characteristics of size being below 100 ηm, the extremely high ratio 
surface/volume and their inherent toxicity (Handy et al., 2012; Handy et al., 
2008a; Handy et al., 2008b). At present, most studies have been focused in 
determining the bio-availability of MNM and their direct toxicity to cells, aquatic 
invertebrates and fish (Baun et al., 2008). Fewer ones, however, have 
addressed indirect effects that MNM may have in aquatic biota such as in water 
column invertebrates due to their aggregation properties in aqueous solutions 
(Li et al., 2011), that can lead to interactions with microscopic (phytoplankton, 
zooplankton) food particles. Although colloidal particles of geochemical and 
biological origin are abundant in the aquatic environment, unknown toxicological 
effects especially of engineered nanoparticles on organisms require 
comprehensive multi-disciplinary investigations. Numerous toxicological studies 
with nanomaterials had been conducted (Powers et al., 2013; Sun et al., 2013). 
The results of these eco-toxicological studies, however, are not consistent. 
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There is reported evidence that MNM like those of titanium dioxide (nano-
TiO2), fullerenes (C60), or single walled carbon nanotubes aggregate to 
microalgae, copepods and Daphnia cell surfaces or carapaces, impairing their 
growth or swimming behaviour (Baun et al., 2008; Li et al., 2011; Metzler et al., 
2011; Oberdörster et al., 2006).  
Most nano-toxicity studies followed conventional protocols designed to test 
dissolved chemical species that may not be totally applicable to nanoparticles 
(Handy et al., 2012). For example, many MNM form aggregates in water, thus 
experimental protocols designs to test toxicity effects of dissolved chemical 
products may not be valid.  
 
1.4. Multidrug Resistance system (MDR) 
 
More than four decades ago oncologists started realizing that many tumours 
presented an inherent resistance pattern, while other tumours were able to 
develop resistance through the time of treatments, against many of the 
chemotherapeutic drugs. This phenotype was described as being a multidrug-
resistance pattern. After these findings, scientist from over the globe have 
established that this protection mechanism is due to the presence in the 
plasmatic membrane of transporter proteins that actively expel various cytotoxic 
agents from cancer cells, thus allowing the tumours to have an overtime 
resistance to chemotherapeutic treatments. This mechanism of resistance was 
named Multidrug/Multixenobiotic Resistance mechanism (Dano, 1973; Sarkadi 
et al., 2006). In the following decades, researchers have been trying to clarify 
the mechanism behind this resistance and nowadays the role of these 
transporters is well defined both pharmacologically and in cell biology literature. 
Multixenobiotic Resistance transporters belong to the evolutionary highly 
conserved superfamily of the ATP Binding Cassette (ABC) proteins, present in 
almost all living organisms, from prokaryotes to mammals (Sarkadi et al., 2006), 
which suggests they are of ancestral origins. For example,  in silico studies of 
several genomes, have identified many putative transporters, including 48 ABC 
transporters in the human genome, 41 in Danio rerio (Dean and Annilo, 2005a), 
64 in the Daphnia pulex (Sturm et al., 2009) and 65 in the sea urchin 
Strongylocentrotus purpuratus (Sodergren et al., 2006). 
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In addition to Multidrug/Multixenobiotic transporters, ABC proteins also 
include ion channels, regulators of ion channels, receptors and proteins with 
roles in ribosome assembly and translation (Dean and Allikmets, 2001; Dean 
and Annilo, 2005b; Gottesman and Ambudkar, 2001). According to their domain 
architecture and sequence, metazoan ABC transporters are divided into 
subfamilies. The most important ones belong to seven subfamilies named 
ABCA to ABCG (Klein et al., 1999). 
ABC transporters are large membrane bound proteins, with specific and 
highly conserved nucleotide binding domains, one or two (NBDs,) which include 
two signatures, the ABC signature motif and the Walker B domain (Sturm et al., 
2009). The presence of these two signature sequences allows for the 
identification of the NBDs through all the families. It’s in the NBDs that occurs 
the hydrolysis of ATP, releasing the energy that is needed for substrate 
transport, enabling conformational changes of the transporter, thus allowing for 
the efflux of the xenobiotics and/or metabolites out of the cells (Ramachandra et 
al., 1998). Apart from the NBDs, the functional operation of ABC transporters 
also requires two or three trans-membrane domains (TMDs), where is located 
the substrate binding site. All eukaryotic ABC proteins are, either, full 
transporters combining all the required domains (2 NBDs and 2/3 TMDs) in one 
polypeptide, or half transporters consisting of 1TMD and one NBD that need to 
form homo- or heterodimers to be functional (Sturm et al., 2009). 
Out of the seven ABC families,  three of them are directly involved in the 
efflux of xenobiotics and/or metabolites and thus they are the most relevant for 
toxicity studies. These are: the ABCB family, also known as P-glycoprotein (P-
gp); the ABCC or Multidrug Resistance Protein (MRP) and the ABCG or Breast 
Cancer Resistance Protein (BCRP) (Figure 1.1) 
Earlier studies associated MXR transporter activity only to the P-gp (ABCB) 
transporter proteins, however, recent studies have shown that MRP and BCRP 
(ABCG2) transporter proteins are also directly involved in the multidrug 
resistance mechanism. These proteins are expressed in tissues with important 
role for absorption, i.e. lung and gut, but also elimination and metabolism, like 
kidney and liver (Leslie et al., 2005).  
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P-gp and MRP transporters are already described as active in several aquatic 
organisms including marine mussels (Luckenbach and Epel, 2005; Luedeking 
and Koehler, 2004), freshwater mussels (Faria et al., 2011), sea urchins 
(Kurelec, 1992) and fish (Bard, 2000). Transcriptomic analyses of those 
transporters show high homology between them and humans (Sturm et al., 
2009). 
In environmental sciences the majority of the research efforts have been 
focused in xenobiotic transformation and elimination. These transporters 
constitute the first and last line of defence against contaminants. In the first line 
are ABCB (P-gp transporters) and some ABCC (MRP ones) that effluxed out 
chemicals when enter to the cell. MRP transporters are also known to effluxed 
out xenobiotic metabolites and conjugates (Epel et al., 2008), acting as a last 
line of defence.  
 
Figure 1.1. Function of the multidrug/xenobiotic ABC transporters. Multidrug/xenobiotic ABC 
transporters reside in the plasma membrane and extrude various hydrophobic and/or 
amphipatic xenobiotics and metabolic products. MDR1/Pgp transports hydrophobic 
compounds (X), while MRP1 and ABCG2 can extrude both hydrophobic drugs and 
intracellularly formed metabolites, e.g., glutathione or glucuronide conjugates (C-X). 
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1.4.1. ABCB family (P-Glycoprotein or p-gp) 
The P-gp is the best studied eukaryotic ABC transporter. It is responsible for 
multidrug resistance (MDR) phenomenon involved in tumour cells resistance to 
most chemotherapeutic drugs. 
In aquatic organisms, the first report of P-gp (MDR1 like) mediated toxicant 
resistance was in the freshwater mussel Anodonta cygnea (Kurelec and 
Pivčević, 1989). Since then it has been identified in up to 35 aquatic organisms 
such as, marine and freshwater mussels, clams, crabs, fishes, worms, sea 
urchins among others (Bard, 2000; Faria et al., 2011; Smital et al., 2003). P-gp 
is a 170kda size transporter protein and recognizes an extraordinary wide 
spectrum of chemicals which is also characteristic of other MXR transporters; 
the subfamily contains both full and half transporters (Dean and Allikmets, 2001; 
Sturm et al., 2009). P-gp is remarkably non-specific with respect to its 
substrates. This lack of specificity is of high adaptive importance and generates 
protection against many novel anthropogenic  products.  
Contrary to other ABC transporters, P-gp does not efflux metabolites, but the 
parent compound alone is the transporter substrate. P-gp localization within the 
membrane suggests its action on the substrate shortly after it enters the 
cytoplasm. P-gp has high affinity to moderated hydrophobic, amphipathic 
(somewhat soluble in both water and lipids) chemicals of low molecular weight, 
cationic or neutral, planar with basic nitrogen atoms, and natural products 
(Endicott and Ling, 1989; Gottesman and Pastan, 1988; Gottesman et al., 
1994). In humans P-gp proteins and RNA are detected in high levels in liver, 
kidney, small bowel, colon, pancreas, adrenal cortex, placenta, blood brain 
barrier tissues (Cordon-Cardo et al., 1990; Fojo et al., 1987; Sugawara, 1990; 
Sugawara et al., 1988). In aquatic invertebrates it has been identified in tissues 
involved in absorption, secretion and barrier function, such as gills, anterior 
digestive tract and epidermal tissue of worms, cell membranes of sponges and 
others (Bard, 2000). 
 
 
1.4.2. ABCC family (Multiresistance protein or MRP) 
Multiresistance proteins (MRPs) belong to the C family of ABC transporters. 
ABCC subfamily consists of a diverse group of 190kDa glycoproteins. In this 
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family there is also full and half transporters with 3 TMDs (Bard, 2000; Sturm et 
al., 2009). The MRP have a very broad substrate specificity which includes 
many organic anion conjugates of structurally different compounds such as 
endogenous substrates that are natural products of the metabolism and 
xenobiotic metabolites resulting from phase I and II of the biotransformation 
metabolism. The transport of several of these conjugates has been shown to 
depend on the presence of reduced Glutathione (GSH) (Cole and Deeley, 
2006). Other functional properties also include iron transport, cell surface 
receptors and toxin secretion activities. Additionally, some members of the MRP 
family also contribute to the efflux of unmodified hydrophobic compounds, thus 
acting in a similar way as P-gp. 
 
1.4.3. ABCG family (Breast Cancer Resistance protein or BCRP) 
ABCG is composed of several members, where ABCG2 is the most 
prominent and better characterized. BCRP/ABCG2 confers resistance to a 
narrower range of substances than P-gp or MRP. ABCG is a 72kDa “half 
transporter” protein, consisting of only one NBD and one TMD (Sturm et al., 
2009; Wakabayashi et al., 2006). To achieve full function, two of these half 
transporters have to dimerize in order to form a fully active transporter (Ewart 
and Howells, 1998). Like P-gp, BCRP is not dependent on GSH complexation 
for recognition and transport of its substrates. ABCG2 is prominently expressed 
in apical membranes of polarized epithelial cells of different organs involved in 
absorption (small intestine), distribution (placenta and blood brain barrier) and 
elimination (liver)(Ito et al., 2005), indicating its important role in excretion of 
xenobiotics. It is also implicated in the transport of important physiological 
molecules like cholesterol, and has been shown playing an important role in the 
metabolism of haeme groups (Doyle and Ross, 2003; Latunde-Dada et al., 
2006). 
 
 
 
1.4.4. Chemosensitization related to MXR 
A large number of anthropogenic pollutants such as PAHs, PCBs, DDT, 
musks and their metabolites can either induce or inhibit the transporter activity 
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of these proteins in fish, invertebrates and mammals (Luedeking and Koehler, 
2004; Minier et al., 1993). Chemicals able to inhibit MXR/MDR transporter 
activities are termed chemosensitizers (Cornwall et al., 1995; Smital et al., 
2003) and the phenomenon is called chemosensitization. A consequence of 
chemosensitization is the increase accumulation of xenobiotics and metabolites 
inside the cell, and therefore enhanced toxic effects. Chemosensitizers can be 
chemicals that are not necessarily toxic themselves, but are also substrates of 
the transport system and thus compete with other more toxic xenobiotics 
saturating the transport system and compromising the MXR defence(Kurelec et 
al., 2000). Chemosensitizers tend to be more lipophilic than other substrates 
(Sharom, 1997). Xenobiotics that are substrates of the MXR transporters are 
found experimentally to diffuse very slowly across membranes on the order of 
minutes to hours when compared to chemosensitizers, which transverse 
membranes much faster (Eytan and Kuchel, 1999). Other chemosensitizers 
may not be substrates to the transporters pumps, but nevertheless inhibit their 
activity through some indirect effects (i.e. inhibiting ATP) (Epel et al., 2008). 
Chemicals that can interact with these efflux transporters may not only 
modulate the toxic potential of the xenobiotics but may also interfere with 
important biological processes. (Luckenbach et al., 2004) have shown that 
synthetic musk’s have the effect of blocking these transporters in mussels. 
These musks are used as fragrances in many personal care products and end 
in the wastewaters, thus they may pose a serious environmental threat, by 
changing how aquatic organisms are able to deal with other xenobiotics and 
even their own metabolites. 
Chemosensitization mechanisms can be of extreme importance on how 
organism deal with toxicity and any substance that can impair this system can 
be of extreme importance. Often, the chemosensitizer agent is not toxic itself, 
but in a mixture with other toxic compounds, will increasing their accumulation 
within cells and hence enhancing their toxicity. These factors are even more 
important in aquatic organisms and can only be addressed if we change our 
common assessment of the impact of any given chemical individually, by adding 
also mixture testing methodologies.  
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1.4.5. Chemosensitization and Mixture toxicity  
In natural environments, organisms are frequently exposed to mixtures of 
pollutants (Sharom, 1997) and are relatively uncommon to find sites polluted 
with only one substance (Walker, 2001). Some chemicals are highly persistent, 
some are applied repeatedly or continuously, and others are applied as 
mixtures to increase efficiency or reduce costs (Marking, 1977). Due to the 
large number of different chemical compounds present in the environmental 
matrices, the individual testing of each component is not fully representative of 
the total mixture effect. Thus, robust predictive toxicity models are needed, in 
order to estimate their toxicity with acceptable accuracy (Lydy and Austin, 2004; 
Vighi et al., 2003). 
In order to address the effect of a toxic mixture, the observed combined toxic 
effect can be compared with an expected combined effect calculated from the 
single component toxicity, using specific reference models. Specifically in 
environmental toxicology, there are two well established conceptual non-
interactive models, termed Independent Action or response addition (IA) and 
Concentration Addition (CA), derived from pharmacological sciences. These 
two models describe general relations between the effects of single substances 
and their corresponding mixtures, for dissimilar and similar acting chemicals 
(Barata et al., 2007). 
The Independent action (IA) model is a statement about the relationships 
between the probability of the response, whereas the concentration addition 
(CA) model refers to relative toxicities (De March, 1987). In other words, 
independent action addresses the question whether the probability of response 
to one chemical may be independent from the probability of response of 
another, while concentration addition addresses the question if the relative 
toxicity of the mixture is the same as the sum of the toxicities of the individual 
compounds. In aquatic toxicology the IA and CA have been successfully used 
to predict non interacting joint effects of mixtures of dissimilar and similar acting 
compounds(Altenburger et al., 2000; Backhaus et al., 2000; Barata et al., 2007; 
Faust et al., 2003; Faust et al., 2000; Scholze et al., 2001). 
To predict accurately joint effects of mixtures it is crucial to estimate 
accurately the predicted values for individual and mixture combinations 
(Scholze et al., 2001). Predicted values for the studied individual components 
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can be estimated using several approaches and models. One of them is to use 
the best fit model (Scholze et al., 2001). One of the most used models is the 
non-linear Hill equation (eq1), which according to the rate theory(Eyring, 1935) 
can be used to describe the inhibition of a biological process as a function of 
toxicant concentration using a sigmoid type function. When considering 
mortality values that range between 0 and 100 the Hill model become that of Eq 
1.1. 
1.1.
)/(1
100)(%
50
eq
xEC
inhE p  
with E=effect in %; p=slope; EC=effect concentration; x=concentration (µM). 
On the basis of the concentration–response functions of individual 
compounds, predictions of concentration addition were calculated for mixture 
containing binary combinations in a definite ratio (based on EC50 or EC10). A 
total concentration of the mixture, at which a certain effect is generated, can be 
calculated using concentration addition according to Eq 1.2: 
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In this equation ECxmix is the total concentration of the mixture provoking 
X% effect; ECxi is the concentration of component i provoking the x% effect, 
when applied singly; and pi denotes the fraction of component I in the mixture. 
The calculation of total mixture concentrations for various effect levels lead to a 
complete iteration of an expected concentration–effect relationship. 
The prediction concept IA allows explicit calculation of combined effects 
according to Eq 3: 
  3.1.)(11)(
1
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The effect at the total concentration of the mixture, E(cmix), is based on the 
effects of the components which they generate at concentration x at which they 
are present in the mixture (E(ci)). If the latter is expressed as a fraction (pi) of 
the total mixture concentration, it holds Eq 4: 
  4.1.)(11)(
1
eqcpEcE
n
i
miximix 

  
This allows calculation of an effect expected according to the concept of IA 
for any concentration of the mixture. 
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These models can be of key importance when trying to characterize the 
toxicological role of MXR system, allowing to understand if the inhibitors, by 
blocking the capacity of transport, increases the toxicity of the substrates (Faria 
et al., 2011). 
 
1.5. Ecotoxicology and genomic tools. 
 
The biological impact of pollutants on ecosystems is the result of a cascade 
of events that begins with their introduction into the environment. Environmental 
pollution affects different biological processes within the exposed organisms 
causing adverse effects in target tissues, whole organism and eventually in 
entire ecosystems (Piña et al., 2007). When toxic pollutants enter an organism 
they trigger physiological responses aimed to maintain homeostasis. The first 
response is at gene level and then transferred to higher organizational levels 
until a final, ecosystem level (Van der Oost et al., 2003). 
A major mechanism underlying almost all the responses to environmental 
change is mediated by a shift in the transcription of genes. 
 
Genes, the building blocks of life, are regions of the DNA chain, that contain 
the blueprint for proteins. According to the fundamental dogma of biology, 
genes are transcribed to mRNA (messenger RNA), and this is then translated 
into proteins. Proteins are the elements that determine structure and 
functionality of all living organisms, therefore, every response to change, 
chemical or not, always requires a change of the gene transcription. 
A major step for our ability to study and understand, the transcriptional 
patterns of genes came with the development of PCR (Polymerase Chain 
Reaction), developed by Kary Mullis and Michael Smith in 1983 (Bartlett and 
Stirling, 2003). This technique revolutionized the way how we were able to 
study genomic processes. With PCR, and more recently with quantitative Real-
Time PCR (qPCR), we became able to study many new potential genetic 
biomarkers, being that every gene is a potential biomarker of any given change: 
life-cycle changes, chemical changes, etc. 
In 2004 the term “Ecotoxicogenomics” was introduced and defined as the 
integration of genomic based science into ecotoxicology studies (Snape et al., 
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2004). The first obvious advantage of using genomic information was the 
increase of the information that we could extract from an experiment, thus 
allowing for better and more accurate conclusions. This would also allow us to 
link molecular biomarkers with higher level population and ecosystem 
responses, and that way anticipate potential risks. This new branch is now 
developing into a key tool for the assessment of environmental impacts and 
Environmental Risk Assessment, because of its potential to highlight toxicant 
specific gene expression patterns that can be used to identify major change 
inducing chemicals. Genomic technologies are also having a decisive 
contribution to the development of new biomarkers, and the determination of 
new and more accurate Mode-of-Action (Piña and Barata, 2011). 
 
Microarrays are small, solid supports hosting thousands of single stranded 
DNA sequences called probes, in which each probe represents a gene of 
interest. Supports are normally glass slides, silicon chips or nylon membranes, 
and probes are printed or attached in a known and fixed location. Hybridization 
between these probes and complementary target sequences labelled with a 
fluorescent dye is the principle behind microarrays technique. 
Conditions in which hybridization and subsequent washings are carried out, 
promote the formation of only strongly paired strands, that is, those with a high 
number of complementary base pairs, avoiding non-specific interactions. Total 
fluorescent signal emitted by each spot depends upon the amount of target 
sequence binding to the probes present on that spot. Scanning of the 
microarray and subsequent analysis of the resulting image allows the 
quantification of the intensity values from each spot, which are proportional to 
the initial amount of target sequence in the sample. 
Microarray-based gene expression analysis can be used to identify multiple 
genes whose expression change due to a particular influence factor. Target 
sequences are obtained by reverse transcription and labelling of mRNA isolated 
from the samples that will be compared. Fluorescence intensity values obtained 
by the analysis of images represent the expression levels of genes in a given 
condition. Comparison of these gene expression patterns allows the 
identification of genes whose expression change due to the factor under study. 
Although microarray technology has a very high throughput interrogating 
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thousands of genes simultaneously, the process includes numerous sources of 
variability being necessary to apply statistical tools in experimental design and 
in data analysis. This is essential to obtain high quality results from microarray 
experiments (Draghici et al., 2003). Final confirmation of the interest genes 
quantitative change may be done using qPCR, for a more robust analysis. 
A full genome gene analysis can be made with only one chip, giving the 
researchers a very comprehensive dataset. One of the most appealing 
characteristic of the microarrays technique is that it’s main, and probably single 
limitation is our knowledge of the analysed species (Piña and Barata, 2011). 
 
The final step of the microarray experiments is linking the gene effects to 
biological functions. With the development of bioinformatics tools like Gene 
Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEEG), we 
are now able to better understand how the exposure scenario changes the gene 
transcriptional patterns and link these to metabolic and regulatory pathways. 
Genes modify their expression as to maintain cell homeostasis in a compatible 
way with the external impact, and this process implies that genes sharing a 
common pathway or under the same control mechanism, would change their 
transcription in a coordinated manner (Piña and Barata, 2011). 
The GO (www.geneontology.org) principle, is that genes with the same 
biological and/or molecular functions are grouped together through a controlled 
vocabulary of terms, which can be used across species taking into account the 
gene product attributes. By analysing the Differentially Expressed Genes (DEG) 
in this way, we are able to have a better understanding of the potential 
pathways and functions affected, thus, giving a much robust sight of the MoA. 
The KEEG (http://www.genome.jp/kegg/) analysis works in a similar way, with 
the advantage of allowing us to position our genes in molecular pathways and 
understand the potential up and downstream effects. 
Genomic tools results evidence important achievements such as an 
increased ability to characterize toxicant specific genes expression patterns, 
selecting new molecular biomarkers and in many cases in determining putative 
mechanisms of action (Piña and Barata, 2011). 
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1.6. Biomonitoring of aquatic organisms 
 
 Assessing the ecological risks of emerging pollutants requires an 
understanding of both the exposure regime and the effects of the chemical on 
different organisms (Fent et al., 2006). For example, some ECs can act as 
endocrine disrupting chemicals (EDCs), with the potential to affect hormonal 
driven processes, such as reproduction and/or development. Aquatic organisms 
are particularly susceptible to EDCs, because their entire life cycles are spent in 
continuous contact with water. Despite that ED mechanisms are well known in 
vertebrate species, little is known on invertebrates (Barata et al., 2004). 
According to the previous authors, reported inhibitory effects on reproduction 
and/or growth were likely to be related to toxic effects on energy supply or 
demand, rather than to a disruption of the endocrine system itself. However, 
several emerging pollutants may affect aquatic invertebrates in unexpected 
ways, more similar to the canonical endocrine disruption as defined in 
vertebrates, like increasing male production or the reproductive output (Flaherty 
and Dodson, 2005; LeBlanc et al., 2000b; Olmstead and LeBlanc, 2000). In 
relation to this, there is an urgent need to develop sensitive bioassays to 
measure unambiguously specific effects from emerging contaminants (Barata et 
al., 2004) and then, to study the underlying mechanisms. 
There is an increase degradation of the water bodies worldwide, due to the 
release of chemicals, including the ones of emerging concern, which may be 
posing new threats on the ecosystems, affecting their health and balance. In 
this context elucidating potential adverse effects of complex mixtures of 
chemicals, together with confounding factors constitutes a new challenge for the 
scientific community.  
The inherent difficulties of field studies, where potential interactions among 
chemicals might occur, together with the scarce information available on the 
development, physiology, biochemistry and genomics of most non-model 
aquatic organisms, make the identification of sublethal toxic effects extremely 
challenging. Mitigation of these problems requires an increased knowledge 
about the physiology of the test animals. 
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1.7. Daphnia magna as a test organism 
 
For the execution of this thesis, we use Daphnia magna as model organism. 
Daphnia is one of the most used organisms in environmental research. A 
simple search in the WEB OF KNOWLEDGE retrieves more than 12000 papers 
published from the year 2000 to present, with reference to Daphnia of which, 
more than half are related to D. magna. The taxonomy classification of Daphnia 
magna Strauss, accordingly to the World Register Of Marine Species (Boxshall, 
2013) is as follows: 
 Kingdom: Animalia 
 Phylum: Arthropoda 
 Class: Branchiopoda 
 Subclass: Phyllopoda 
 Order: Diplostraca 
 Suborder: Cladocera 
 Infraorder: Anomopoda 
 Family: Daphniidae 
 Genus: Daphnia O.F. Muller, 1785 
 Species: Daphnia Magna Straus, 1820 
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D. magna is a brackish and freshwater organism. Anatomy and morphology 
are shown in Fig 1.2. Like all crustaceans, it possesses an exoskeleton, 
consisting of a dimerous chitinous carapax, with multiple tissue layers, 
surrounding the thorax and abdomen. Like most crustaceans, the carapax is 
non-elastic, as a consequence of which growth is possible only by regular 
renewals of it, a phenomenon known as molting (Ebert and Jacobs, 1991). D. 
magna has two pairs of antennas: the first is known to function as sensory 
organ and the second are modified for swimming. Due to the position and 
movement of the second antenna, Daphnia is mainly restricted to vertical 
movements, presenting its characteristic movement of hop-and-sink. 
In the head region, there are the composed eye, the brain, connected to the 
naupilus eye and the gut opening. Directly in front of the gut opening, there is a 
pair of maxillae, rigid, which are able to triturate, to a certain degree, the food 
particles. The gut has an upward orientation in this section, making a U in its 
Figure 1.2. The functional anatomy of Daphnia (From Richard Fox, Lander 
University) 
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higher point, and then directing towards the posterior section of the body. In the 
head region, connected to the gut, there is a pair of caeca, which are 
homologous to a hepato-pancreas (Ebert and Jacobs, 1991).  
In the thoracic region are present the filter setae, used as filters, retaining the 
food particles and directing them to the maxillary glands, epipodites (long 
regarded as gills, but actually are sites of haemoglobin production;(Goldmann et 
al., 1999)), heart and 2 ovaries, flanking the gut; and the brood pouch, an 
opening on the back of the animals where the embryos will be deposit and 
develop till birth. The post-abdomen is bent ventrally (as the entire animal) and 
forward, finishing in a spine. It possesses a claw and spines, which uses to 
clean the thoracic appendages and carapax, and to keep the eggs in the brood 
pouch (Ebert and Jacobs, 1991). 
D. magna has a Holarctic distribution, living in small or medium size shallow 
freshwater ponds with low fish predation pressure (De Gelas and De Meester, 
2005). It represents a large part of the zoo-planktonic community, being a 
keystone species in the freshwater ecosystems. It’s one of the most important 
primary consumers, being fundamental to control algae blooms, while is also 
important as a food source for both invertebrates and vertebrates predators. 
The presence of Daphnia has considerable implications for the maintenance of 
the ecological quality status of aquatic systems (Hebert, 1978). Daphnia 
species are non-selective filter feeders, using their thoracic appendages to 
create water current through the interior of the carapax using their fine setae to 
retain particles, which are then transported to the maxillae. Daphnia sp. mainly 
feed on algae, but will retain all the suspended particles that can be withheld by 
their filtering apparatus (>1um), Ingesting any suspended particles (Gillis et al. 
2005). 
 
D. magna reproduces through cyclical parthenogenesis (Zaffagnini, 1987). 
During the parthenogenic phase, the population is composed exclusively by 
females, which produce diploid eggs in the ovary (Figure 1.3). Oogenesis is not 
fully meiotic nor strictly mitotic resolving in diploid eggs identical to the mother. 
The eggs are then deposited in the brood pouch, in which they will develop to 
clones that are genetically identical to the mother. They maturation is complete 
in around 3 days (at 20ºC) and are released to the environment by contraction 
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of the post abdominal part of the body (Ebert, 1994). Neonates are similar to the 
adult, with around 0.6-1 mm in length (top of the head to start of the abdominal 
spine). The neonates will then undergo 4-5 molting stages, and will be sexually 
mature at 6-8 days at 20º and optimal food conditions (Ebert, 1994). 
 
 
Even though Daphnia mainly reproduces through parthenogenesis, certain 
environmental triggers like food limitation, high population densities, short 
photoperiod or desiccation of the habitat can activate sexual reproduction. The 
males are formed during a special parthenogenetic event, and therefore they 
are genetically identical to the mothers (Figure 1.3). They are identical to the 
females in aspect, but are of smaller size, and have the first antenna much 
more developed. Subsequently, females produce haploid eggs (2 per brood) 
Figure 1.3. Life cycle of a Daphnia (from Ebert 1995)
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that are deposited in the brood pouch, which are then fertilized by male haploid 
spermatozoa and then undergo a further development to resting eggs, also 
called ephipia (figure 1.3). These resting eggs are encapsulated by multiple 
layers, formed by a transformation of the brood pouch in order to protect the 
eggs inside against adverse environmental conditions. They are able to resist in 
dormant status for up to hundred years (Jeppesen et al., 2001). When the 
conditions become favourable, the ephipia develop to parthenogenically 
reproducing females, and a new population is established. 
 
In laboratory, optimal conditions for the Daphnia development can be 
maintained continuously, allowing the elimination of sexual reproduction events 
and creating the possibility of keeping clones indefinitely. This give to 
researchers a very important tool that is the possibility of studying an organism 
that is a perfect genetic clone, with all its implications at the level of 
reproducibility of experiments and constancy of results between tests and a 
good model for studying genomic variations without the problem of normal 
variation in species with sexual reproduction events. 
 
D. magna has been studied for almost three centuries in the fields of 
taxonomy, physiology and limnology, which has provided useful information for 
all the modern research. Daphnia can be found in freshwater ecosystems all 
around the world, playing a key ecological role in the food web, resulting in the 
recognition of the ecological relevance of testing. The lifecycle is ideally suited 
for experiments, due to its short reproduction time, when compared to most 
eukaryotic model species: the reproductive maturity is reached within six to ten 
days and a reproductive batch occur every three days hereafter (Ebert, 1992). 
Through asexual parthenogenic reproduction, it is possible to produce 
genetically constant clonal lines, hereby reducing genetic variability, which can 
be a factor of interest in many experiments. On the other hand, different clones 
can be maintained to create experimental populations with controlled genetic 
variation. 
 D. magna is the most frequently used invertebrate in standard acute and 
chronic aquatic toxicity testing. Bioassays with D. magna are formally endorsed 
by major international institutions such as the European Union, EPA, the OECD 
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and ISO. Results from these assays have been used in environmental risk 
assessment screenings of almost all substances. 
 
1.7.1. Genomic information and molecular tools available 
The genome of the related species D. pulex has been sequenced recently by 
the joint efforts of several research groups integrating the Daphnia Genomics 
Consortium (Colbourne et al., 2011). The D. pulex genome has more than 
31000 genes detected, with an estimation of 8000 not detected. For D. magna 
there is an on-going effort for sequencing the whole genome and this is planned 
to be accomplished in short time. Nevertheless, there is extensive data on 
genomics of D. magna, with more than 15000 EST (Expressed sequence tags) 
and more than 1600 protein sequences. 
D. magna microarrays have been developed since 2004 by different groups. 
The first microarray was developed in the University of Antwerp. It was a cDNA 
microarray, based on energy, molting and reproduction related cDNA libraries 
obtained by SSH (suppressive subtractive hybridization)(Soetaert et al., 2006; 
Soetaert et al., 2007a). This technique allows for the selective amplification of 
differentially expressed transcripts, e.g., between neonates and adult 
reproducing population (reproduction), while suppressing the amplification of 
the transcripts that are present in both populations. The same method was 
followed for the other two libraries. These microarrays were subsequently 
successfully used in ecotoxicogenomics studies with D. magna (De 
Schamphelaere et al., 2008; Dom et al., 2012; Soetaert et al., 2007a; Soetaert 
et al., 2007b; Vandenbrouck et al., 2009). Another group has developed an 
Oligonucleotide microarray, based on ESTs (expressed sequence 
tags)(Watanabe et al., 2007). This database was developed during studies in 
which double stranded cDNA was derived from RNA of three to four weeks old 
daphnids. These cDNA fragments were then cloned and sequenced, and 
obtained 7210 EST of which almost 3000 were non redundant. Of these 
fragments 41% displayed homology to genes deposited in the NCBI database 
(Watanabe et al., 2008). This set of EST was then combined with the previous 
Belgium libraries and enriched with cDNA obtained with SSH from populations 
exposed to different toxicants, pH and calcium limitations to build a larger 
microarray (Connon et al., 2008). This version of the microarray was then used 
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in a systems biology approach to detect transcriptomic and phenotypic stress 
responses, in order to unravel the MoA (mode of Action) of D. magna exposed 
to ibuprofen (Heckmann et al., 2006; Heckmann et al., 2008a). Another step 
forward was made by a group in the United States, which developed a custom 
cDNA microarray, based on a random selection of 5000 cDNA clones from the 
Daphnia Genomics Consortium (Poynton et al., 2008), enriched with 2681 
cDNA transcripts, obtained by SSH from daphnids exposed to munitions 
constituents and metals with success in many studies after (Garcia-Reyero et 
al., 2012; Poynton et al., 2012). 
 
 
 
1.8. Objectives: 
 
Environmental Risk Assessment (ERA) of emerging pollutants requires the 
development of bioassays able to detect novel mechanisms of action of 
Emerging Contaminants. This approach puts a new focus on the study of 
sublethal effects with an ever increasing sensitivity of the assays used. 
 
During the development of this thesis, I will focus on detecting and 
understanding sublethal effects and propose to develop and use novel 
bioassays to unravel the Mode of Action (MoA) of several Emerging 
Contaminants, namely pharmaceuticals, 4-nonylphenol and nanoparticles in 
Daphnia magna. 
For all the studies planned, I aim to use standard tests, coupled with new 
custom designed ones, in order to achieve the sensitivity levels needed to 
detect the potential sublethal effects. 
Il divide this thesis in three main objectives:  
 
Objective one:  
Study the effects of two antidepressants (Selective Serotonin Reuptake 
Inhibitors) and 4-nonylphenol in Daphnia magna. Linking population, 
physiological and genomic studies to unravel Modes of Action. 
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Chapters 2, 3 and 4 present data obtained from several experiments 
executed to assess responses at the individual and population level, but also at 
the physiological and genomic levels, of animals exposed to the SSRIs 
(fluoxetine and fluvoxamine) and 4-nonylphenol. The  proposed experimental 
framework allowed determining the Mode of action (MoA) of these substances 
across biological levels of organization using D. magna as a model organism.  
 
Objective 2:  
Study the effects of Titanium dioxide Engineered Nano Particles on 
food depletion and life history responses of Daphnia magna. 
In chapter five, I attempt to discriminate the toxic effects of NM to D. magna, 
by distinguishing direct toxicity from indirect effects due to their aggregation with 
edible particles, depleting food levels and hence causing starvation of exposed 
individuals. I also propose to develop new assays that can be used to 
characterize other NM and its aggregation mediated effects to other water 
column grazers such as many zoo-planktonic species. 
 
Objective 3:  
Characterize the Multixenobiotic Resistance system (MXR) in Daphnia 
magna and its toxicological role” 
In chapter six I propose to characterize the MXR system in D. magna for the 
first time. The study was performed at the gene level sequencing partial 
sequences of the more important genes and studying their transcriptional 
patterns across developmental stages and inducers. The development of 
transporter assays using fluorescence dyes allowed to assess the functionality 
of the new sequenced genes. Finally the use of binary mixture toxicity assays 
combined toxic substrates of the different MXR system with specific inhibitors of 
that pumps help me to study the toxicological role of the MXR system in D. 
magna. 
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Abstract 
Risk assessment of emerging pollutants requires the development of 
bioassays able to detect and understand novel mechanisms of action. This 
study tested the hypothesis that the increase of offspring production in Daphnia 
magna induced by certain pollutants may be mediated through different 
mechanisms, depending on development stages, clones and food rations. The 
study included two selective serotonin reuptake inhibitors (SSRIs), fluoxetine 
and fluvoxamine, and the detergent metabolite 4-nonylphenol. Organisms were 
exposed from birth to adulthood or only during adulthood at low and high food 
ration levels. Results indicated that low exposure levels of the three studied 
substances increased offspring production and/or juvenile developmental rates 
similarly for all studied clones, but the responses differed among life-stages and 
food rations. When individuals were exposed to the studied chemicals from 
birth, enhanced offspring production per female was observed only at low and 
intermediate food rations. On the contrary, when exposures started in gravid 
females most treatments increased offspring production. Results obtained with 
SSRIs support previous findings, where it was stated that these compounds 
may amplify serotoninergic signalling in D. magna. 4-Nonylphenol effects may 
be related to the reported alteration of this compound in Daphnia ecdysteroid 
metabolism. Further investigations are necessary to resolve the biochemical 
mechanism of SSRIs and 4-nonylphenol enhancing offspring production.  
 
Keywords: Pharmaceuticals, 4-Nonylphenol, Reproduction, Growth, 
Selective Serotonin Reuptake Inhibitors (SSRIs), Daphnia 
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2.1. Introduction  
 
Assessing the risks of emerging pollutants requires an understanding of both 
the exposure regime and the effects of the chemical on different organisms 
(Fent et al., 2006). Of special concern are those emerging pollutants that may 
act as putative endocrine disrupters in invertebrate species (Barata et al., 
2004). Most known vertebrate endocrine disruptors act in a dose or 
concentration response fashion in aquatic invertebrates by impairing survival, 
growth or/and reproduction (Barata et al., 2004). According to the previous 
review, reported inhibitory effects on reproduction and/or growth were likely to 
be related to toxic effects on energy supply or demand, rather than to a 
disruption of the endocrine system itself. However, several emerging pollutants 
may affect aquatic invertebrates in unexpected ways, more similar to the 
canonical endocrine disruption as defined in vertebrates, like increasing male 
production or the reproductive output (Flaherty and Dodson, 2005; LeBlanc et 
al., 2000a; Olmstead and LeBlanc, 2003). The latter is usually referred as a 
hormesis effect in ecotoxicological evaluations (Calabrese, 2008) and should be 
carefully analysed in the context of endocrine disruption (Barata et al., 2004) 
and life-history evolution (Forbes, 2000). In relation to this, there is an urgent 
need to develop sensitive bioassays to measure unambiguously specific effects 
from emerging contaminants (Barata et al., 2004) and, then, to study the 
underlying mechanisms. Daphnia magna is an excellent model species to study 
unknown mechanisms of action of emerging pollutants. D. magna is widely 
used in aquatic toxicology and ecology, thus its expected response to a broad 
diversity of contaminants and environmental factors is well known. Several 
recent studies have characterized with great detail specific effects of pollutants 
that disrupted juvenile and moulting endocrine systems in D. magna. These 
studies have shown that endocrine disruptors act differently on eggs, juveniles 
and adults, disrupting egg development, juvenile growth and the sex of offspring 
(Leblanc and Mclachlan, 1999; LeBlanc et al., 2000b; Mu and LeBlanc, 2002; 
Olmstead and Leblanc, 2002, 2003). On the other hand, information on 
pollutants able to disrupt reproduction in an unexpected way, enhancing 
reproduction rather than inhibit it, are scarce and contradictory. Enhanced 
offspring production in Daphnia females exposed to pollutants has been 
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reported for fluoxetine, 4-nonylphenol and dispersogen A (Brooks et al., 2003a; 
Brooks et al., 2003b; Hammers‐Wirtz and Ratte, 2000; LeBlanc et al., 2000b), 
although inhibitory effects on reproduction have also been found for the first two 
chemicals (Baldwin et al., 1997; Hansen et al., 2008). These contradictory 
results may indicate that these chemicals may act differently across 
developmental stages, clones and/or exposure levels. For example, it could be 
hypothesized that they target key processes which control growth and 
reproduction and, consequently, they may act differently during pre-adult and 
adult stages, when energy allocation to growth and reproduction are prioritized, 
respectively (Nogueira et al., 2004). Alternatively, as pointed out by Brooks et 
al., 2003b, stage-specific toxic effects of fluoxetine could be associated with an 
age-dependent developmental increase in its P-450 metabolism, to produce the 
active metabolite, norfluoxetine. Similarly, clones having different growth and 
reproductive performance under laboratory conditions may also be affected 
differently by pollutants targeting those processes (Baird et al., 1990). Food 
quantity also affects growth and reproduction of D. magna (Barata and Baird, 
1998). As the above mentioned chemicals and food affect the same life-history 
traits, we might expect interactions among them. According to the life-history 
theory (Sibly and Calow, 1986), organisms optimize their key physiological 
functions: maintenance, growth and reproduction, to maximize their fitness 
under a limited food resource environment. As a result, life-history responses 
are constrained within narrow limits due to the existence of trade-offs. Important 
ones are reproduction versus growth and offspring size and number. This 
means that in an environment with given food resources, increasing investment 
in reproduction is counteracted by reduced growth and mothers may produce 
more but smaller offspring. Additionally, D. magna has the ability to vary the 
number of developmental instars (here-after referred as maturation instars) 
invested until maturity and hence the timing, body and clutch size at first 
reproduction (Barata and Baird, 1998; Ebert, 1994). In conclusion, toxic 
chemicals may enhance offspring production at expenses of growth and 
offspring size. There are few studies reporting that enhanced offspring 
production in D. magna was related with smaller offspring or decreased 
fecundity with increasing growth (Hammers‐Wirtz and Ratte, 2000; Heckmann 
et al., 2007). This study aims to test the hypothesis that effects of contaminants 
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with reported evidence for increasing offspring production in D. magna are 
stage-dependent (juvenile vs. adults) and that the effects vary across clones 
and food rations (from low to high). Selected pollutants included two selective 
serotonin reuptake inhibitors (SSRIs), fluoxetine and fluvoxamine. Despite their 
different chemical structure, both chemicals have the same common mode of 
action by blocking the re-uptake of serotonin in the nerve synapses. This effect 
is used worldwide to treat clinical depression in humans (Rang et al., 1995), 
and, consequently, these compounds are nowadays widespread in the 
environment. For example, fluoxetine and other SSRIs have been detected 
broadly in water and tissues of organisms (Brooks et al., 2005; Chu and 
Metcalfe, 2007; Ramirez et al., 2009; Schultz and Furlong, 2008; Schultz et al., 
2010), and surveys in US have reported levels of 12–540 ng/L of fluoxetine in 
surface waters and effluents (Kolpin et al., 2002). 4-Nonylphenol is used as an 
industrial detergent or as a co-adjuvant for many pesticide formulations and is 
present in great amounts in surface waters, reaching levels as high as 8 µg/L in 
surface Spanish waters (Navarro et al., 2009). It is also produced by the 
degradation of industrial surfactants, like nonylphenol ethoxylates and 
carboxylates. Fluoxetine is known to increase reproduction in Daphnia (Flaherty 
and Dodson, 2005). Despite that fluvoxamine reproductive effects have not 
been tested in D. magna, it is ten-fold more active than fluoxetine inducing 
spawning in zebra mussel (Fong, 1998). 4-Nonylphenol is known to act as a 
weak estrogenic compound in vertebrates but its ecotoxicological mode of 
action in Daphnia is uncertain (Barata et al., 2004). Indeed recent studies 
indicate that 4-nonylphenol may inhibit, unchange or enhance off-spring 
production in D. magna (Baldwin et al., 1997; Brennan et al., 2006; LeBlanc et 
al., 2000b). 
 
2.2. Material and methods 
 
2.2.1. Chemicals  
The substances employed in toxicity experiments were: 4-nonylphenol (CAS 
No 104-40-5, PESTANAL® analytical grade standard, 98.4% purity, Riedel-de-
Haen, Germany); fluoxetine hydrochloride (CAS-No 56296-78-7; analytical 
standard, purity 100% Sigma–Aldrich, USA), and fluvoxamine maleate (CAS-No 
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61718-82-9, analytical standard, purity 100%, Sigma–Aldrich, Netherlands). All 
other chemicals were analytical grade and were obtained from Merck 
(Germany).  
 
2.2.2. Experimental animals  
Two clones of D. magna were selected. Two laboratory clones hereafter 
referred as T, cultured in the laboratory since 1999 (Barata et al., 2006), and 
clone F, which has been the subject of many investigations (Barata and Baird, 
2000). Clones T and F are characterized by having low and high reproductive 
outputs under laboratory conditions, respectively. For each clone, individual or 
bulk cultures of 10 animals/L were maintained in ASTM hard synthetic water 
(ASTM, 1995) as described by Barata and Baird, 2000. Individual or bulk 
cultures were fed daily with Chorella vulgaris Beijerinck (5×105 or 106 cells/mL, 
respectively, corresponding to 1.8 or 3.6µg C/mL (Barata and Baird, 1998). The 
culture medium was changed every other day, and neonates were removed 
within 24 h. Photoperiod was set to 14h light: 10h dark cycle and temperature at 
20±1ºC. 
 
2.2.3. Experimental design  
Five distinct reproduction tests were conducted over one year to study clonal, 
stage- and food-dependent contaminant effects on growth and reproduction 
traits. Experiments included three life-table and two adult reproduction 
experiments that followed OECD guidelines (OECD, 1981) and (Barata and 
Baird, 2000) procedures.  
 
2.2.3.1. Life-table tests  
Life-table tests allowed the determination of the effects of the studied 
compounds on growth, reproduction and on population growth rates of juveniles 
exposed from birth until their fourth brood. In the first two life-table experiments, 
neonates (<24h old) of clones T and F were exposed until their fourth brood 
(approximately 21–23 days at 20ºC) to 10, 20, 40, 60, 80, 110µg/L of 4-
nonylphenol; 10, 40, 80µg/L of fluoxetine and 3, 7 and 30µg/L of fluvoxamine, at 
the food ration of 5×105 cells/mL of C. vulgaris. In the third one, neonates (<24h 
old) of clone F were exposed until their fourth brood to 15, 40 and 7µg/L of 4-
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nonylphenol, fluoxetine and fluvoxamine, respectively, at three food rations 
(1.6×105, 3.3×105 and 6×105 cells/mL of C. vulgaris; referred as low, 
intermediate and high, respectively). For each individual, its survival, the 
number of maturation instars, age, body length and the size of each clutch were 
monitored. In the third and fourth brood, the body length and sex of at least 10 
neonates were also considered. Body length measurements were performed 
from the head to the base of the spine using a Nikon stereoscope microscope 
(SMZ 150, Nikon, Barcelona, Spain) and the ImageJ software 
(http://rsb.info.nih.gov/ij/). The intrinsic rate of increase (r) was computed 
iteratively from the Lotka equation (eq. 1.1) 
)1.1.(1
0
e eqbml xx
x
rx 


  
where lx is the proportion of the females surviving to age x (days) and mx is the 
number of juveniles produced per surviving female between the ages x and 
x+1. The age at birth was set to 0. The 95% confidence intervals were 
estimated by the Jackknife method (Meyer et al., 1986).  
 
2.2.3.2. Adult reproduction tests  
Adult reproduction tests allowed the determination of the effects of pollutants 
on growth and reproduction rates on adult stages. In two consecutive 
experiments, nine to ten gravid females of clones T and F were separately 
exposed to the same concentrations of 4-nonylphenol, fluoxetine and 
fluvoxamine described for life-table tests using a food ration of 5×105 cells/mL of 
C. vulgaris. Experiments started with 8–9-day-old gravid females, which were 
exposed during three consecutive broods to the studied chemicals (10–14 
days). Cultures of 100–150 individuals (<24h old neonates) were initiated and 
maintained in bulk cultures as described above. Within 24h of deposition of the 
first clutch into the brood chamber, single females were removed and randomly 
assigned to each treatment. The first batch of neonates (hatching within the first 
48–72h) was always discarded and not evaluated, as these animals were not 
exposed to the tested chemicals during their entire developmental period 
(Barata and Baird, 2000). Thus, only neonates from the second, third and fourth 
broods were counted for assessing effects on total offspring production. The 
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body length of each individual female and of 10 neonates released in the third 
and fourth brood were also measured to assess effects on growth and on 
reproductive investment per offspring, respectively. Neonate sex was also 
accounted for.  
Contributions of the measured fecundity rates on population growth rates 
λ=er were also evaluated using the simplified 2-stage model of (Sibly et al., 
2000) (eq. 2.2) that assumes age-independent birth (n), juvenile (pj) and adult 
(pa) mortality rates.  
Selected parameters were as follow: pj and pa were set to 1 since no 
mortality occurred during the experiments; age at first reproduction (tj) was 
similar within experiments and was set to 11 and 10.5 days for clones T and F, 
respectively. The number of offspring produced daily per female (n) was 
determined for each female considering the offspring produced in the second, 
third and four clutches, during a time period of 8 days. A time unit of 1 day was 
employed for all treatments because reproductive output was measured every 
day. The 95% confidence intervals were estimated by the Jackknife method 
(Meyer et al., 1986).  
 
2.2.3.3. Test solutions  
In all five experiments, test solutions were prepared by adding appropriate 
amounts of a concentrated stock solution to ASTM hard water, mixing 
thoroughly. Acetone (HPLC grade; <0.1mL/L) was used as carrier solvent. To 
remove any potential confounding effect, the same concentration of acetone 
was added to all treatments, including the solvent control. A control without 
acetone was also used to assess the possibility of carrier effects. Individuals 
were maintained in 150mL of ASTM hard water, in 200mL screw top glass jars, 
with the addition of a standard organic extract (Barata and Baird, 2000). 
Exposure solutions with algae were changed every day.  
 
2.2.4. Chemical water analyses  
Duplicated water samples of freshly prepared and old (24h) test solutions 
were collected at the beginning and end of the tests to determine that measured 
2.2)(eq.1ppn 1a
tt
j
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oxygen levels and pH were within the limit established by OECD guidelines 
(OECD, 1981). Dissolved oxygen concentration (DO) was measured using a 
polarographic oxygen electrode coupled to a CyberScan DO 300/3001 
EUTECH model meter (Lab Process Distributions, Calella, Barcelona, Spain). 
The pH was determined using an epoxy-body combination electrode, coupled to 
a Crison micro pH 2001 meter and calibrated with standard pH buffer solutions 
(Sigma, Madrid, Spain). In all tests, oxygen levels were within 90% of air 
saturation and pH values varied between 7.5 and 8. Stability of the compounds 
during the test was confirmed using HPLC. Analysis of 4-nonylphenol, 
fluoxetine and fluvoxamine was restricted to two or three concentrations of final 
test solutions (24h). Selected exposure levels included 15, 20 and 40µg/L of 4-
nonylphenol; 10, 40 and 80µg/L for fluoxetine and 7 and 30µg/L of fluvoxamine. 
For the analysis of 4-nonylphenol, Oasis 200mg cartridges were conditioned 
with 10mL of dichloromethane, 10mL of methanol and 10mL of water and after 
pre-concentration, elution was performed with 10mL of acetone: 
dichloromethane (1:1). This extract was then reduced under nitrogen to incipient 
dryness and reconstituted with 500µL of ethyl acetate. Analysis was performed 
by gas chromatography coupled to mass spectrometry (GC–MS) on a Thermo 
Finnigan Trace GC/MS 2000 Series (i.e. low resolution MS) with a 30m HP-5-
MS, 0.25mm ID, 0.25µm film thickness 220 column (Agilent, ref. 19091S-433), 
following the gradient reported in a previous study where 4-nonylphenol eluted 
at 12.44 min (Fernández-Sanjuan et al., 2009). For the pre-concentration of 
fluoxetine and fluvoxamine, Oasis 60mg SPE cartridges were conditioned with 
10mL of methanol followed by 10mL of water. A volume of 100mL of water were 
pre-concentrated at a flow rate of 10mL/min and eluted with 2×4 mL of 
methanol. This extract was then reduced under nitrogen to incipient dryness 
and reconstituted with 500µL of the mobile phase. Fluoxetine and fluvoxamine 
were analysed by high performance liquid chromatography coupled to diode 
array detection (HPLC–DAD) with an Agilent Technologies 1200 series and 
detector DAD G1315D. A volume of 50µL of extract was injected on a 
50×4.6mm XBridge TM C18 column of 3.5µm of particle diameter (Waters, 
USA). A gradient elution starting at 70:30 water (pH 4.0)–acetonitrile to 100% 
acetonitrile in 20 min was used at a flow rate of 0.8mL/min. Acquisition was 
done at a wavelength of 226 and 252ηm. Under those conditions, fluvoxamine 
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and fluoxetine eluted at 3.56 and 4.15 min, respectively. Recoveries (mean±SE) 
of 4-nonylphenol, fluoxetine and fluvoxamine from water samples were 
determined using external standard quantification.  
 
2.2.5. Data analyses 
Each experiment was analysed separately to exclude confounding effects of 
inter-trial variation (Barata and Baird, 1998). In the three life-table experiments, 
not all individuals invested the same number of developmental instars to 
maturity (Table 2.2), thus maturation instar was also considered as a fixed 
factor in the ANOVA analyses to further differentiate treatment from non-
treatment (maturation instar) effects on life-history responses. However, some 
of the treatments showed no variation in maturation instar (Table 2.2), and a full 
factorial ANOVA design including maturation instar interactions was not 
possible. To overcome problems in the interpretation of interactions obtained 
from multi-factorial designs with missing cells (Sokal and Rohlf, 1995), 
treatment versus maturation instar or treatment versus maturation instar versus 
food ration interactions were not considered. When significant (P<0.05) 
treatments effects occurred, post-hoc Dunnet’s tests were performed to 
compare exposure treatments with solvent controls. In the adult reproduction 
tests, differences across solvent control and the rest of treatments in life-history 
responses were compared using one way ANOVA followed by Dunnet’s 
multiple comparison tests. Prior to analysis, all data except age at first 
reproduction were log transformed to improve normality and variance 
homoscedasticity (Sokal and Rohlf, 1995). Effects of treatment and maturation 
instar in age at first reproduction were analysed by non-parametric Kruskal-
Wallis and Mann-Whitney tests, respectively. Analyses of r were based on 
Jackknife pseudo-values (Meyer et al., 1986) obtained using the full data set; 
thus it was not possible to differentiate between treatment and maturation instar 
effects. To further investigate contributions of maturation instar on r responses, 
for each clone or food ration, the proportion of females maturing in five or six 
instars was computed and maturation instar Jackknife pseudo-values were 
compared using Student’s t or ANOVA tests. Tests were conducted with the aid 
of the statistical package IBM SPSS v19 and General Linear Models were used 
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instead of conventional ANOVA when more than two factors or unequal 
replicates across treatments were considered.  
 
2.3. Results 
 
2.3.1. Contaminant analyses 
Nominal versus measured test concentrations of the studied compounds are 
depicted in Table 2.1. 
 
Differences in sample size are due to the fact that not all exposure levels 
measured were used in all experiments (i.e. 15µg/L of 4-nonylphenol was only 
used in the life-table food test). Mean recoveries of 4-nonylphenol were 88%, 
those of fluoxetine were 97% and 93.5% for fluvoxamine. For clarity, all results 
are depicted in nominal concentrations.  
 
2.3.2. Life-table tests (clone effects) 
High 4-nonylphenol levels impaired significantly the survival of exposed 
individuals and embryos in life-table experiments (P<0.05, Wilcoxon–Gehan 
tests). All individuals died before reproduction at 110µg/L and, in clone F, only 
few individuals reproduced at 60 and 80µg/L (Figure 2.1). Embryo survival, 
measured as the percentage of aborted eggs, was also severely impaired at 60 
and 80µg/L in clone F (Figure 2.2). These treatments were excluded from the 
Table 2.1. Nominal and measured chemical concentrations (Mean and SD) in 24h old tests 
solutions. Results for duplicated samples taken in each tests are polluted. N, sample size. 
Measured 
Chemical Nominal   N Mean SD 
4 Nonylphenol 15   2 12.9 1.2 
20 8 17.4 1.8 
40 8 36.0 2.7 
Fluoxetine 10 10 9.5 0.3 
40 8 38.7 2.4 
80 8 79.5 4.8 
Fluvoxamine 7 10 6.3 0.4 
  30   8 28.6 1.8 
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estimation of total offspring production per female since only females that 
release fourth clutches fully alive were considered. 
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Figure 2.1. Survival curves of D. magna individuals from clones T (A, C) and F (B, D) 
exposed to the studied compounds in the life-table (A, B) and adult reproduction tests 
(C,D). Only those treatments with significant mortality (P<0.05, based on Wilcoxon-
Gehan tests) were identified. N60, N80, N110 are 60, 80, 110µg/l of 4-nonylphenol, 
respectively.  
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Figure 2.2. Percentage (Mean±SE, N=8-10) of aborted embryos release by D. magna 
females in life-table (A) and adult reproduction tests (B) from clones F and T, respectively.  
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Treatment and maturation instar effects on the selected life-history traits 
depicted in Figure. 2.3 are indicated in Tables 2.2 and 2.3. In experiment 1 and 
2 both clones had the same percentage of females investing six developmental 
instars until maturity (there were no significant differences (P<0.05, Chi square 
tests; Table 2.2). 
Maturation instar effects on the studied life-history traits were evident for age at 
first reproduction with females investing an additional instar reproducing later. 
Only in clone F, maturation instar also affected significantly (P<0.05) female 
body length and offspring production, with females maturing later being larger 
and producing more offspring than those maturing earlier. Interestingly, females 
maturing earlier in clone T had also higher population growth rates than those 
whose maturity was delayed. Significant (P<0.05) treatment effects were 
observed for all traits but female body length at the fourth brood. In clone T 
there was significant (P<0.05) treatment effects on age at first reproduction 
(P<0.05, Kruskal–Wallis tests) since females exposed to fluvoxamine matured 
earlier than those of controls (Fig. 2.3). 
 Exp1 Exp2  Exp 3  
Exposure Clone T Clone F  Food Exposure Clone F 
C 55.6 90  L C 22.2
SC 60 60   SC 33.3
NP10 55.6 90   NP15 100
NP20 100 60   Fx 40 80
NP40 70 70   Fv 7 55.6
NP60 90 70 M C 16.7
NP80 80 70   SC 60
Fx 10 100 80   NP15 57.1
Fx 40 100 40   Fx 40 30
Fx 80 88.9 70   Fv 7 33.3
Fv 3 66.7 80  H C 10
Fv 7 90 80   SC 10
Fv 30 66.7 88.9   NP15 20
   Fx 40 50
     Fv 7 10
       
Chi-square 19.6 ns 12.6 ns    33.2 ***
 
Table 2.2. Percentage of females taking six instars to mature in the life-table experiments 
performed between clones and across food levels. Chi square results testing for differences 
across treatments are also depicted. C, SC, L, M, H are control, solvent control treatments, 
Low, intermediate and high food level ratios, respectively. NP, Fx, Fv are 4-nonylphenol, 
fluoxetine, fluvoxamine treatments, respectively, and the numbers after those names are the 
exposure levels. ns P> 0.05; *** P<0.01 
Chapter 2 
103 
 
Females of clone T exposed to 20 and 40µg/L of 4-nonylphenol produced more 
offspring than solvent and control treatments. In clone F, females exposed to 10 
and 40µg/L of 4-nonylphenol released more and less offspring than controls, 
respectively. Neither SSRIs nor 4-nonylphenol affected offspring sex (all 
neonates were females). In both clones, females exposed to high 4-nonylphenol 
levels produced smaller offspring than those of solvent controls. Population 
growth rates were only significantly (P<0.05) affected by exposure treatment in 
clone F, with females exposed to 40, 60 and 80µg/L of 4-nonylphenol having 
lower values than solvent controls. 
 
2.3.3. Life-table tests (food effects)  
Food ration alone, treatment or its interaction and/or maturation instar 
affected all the studied life-history traits. Survival of individuals exposed to 4-
nonylphenol was significantly affected at low and intermediate food (P<0.05; 
Wilcoxon–Gehan test; Fig 2.3). There were significant differences (P<0.05, Chi 
square tests) in the percentage of females investing six developmental instars 
until maturity across food levels (Table 2.2). Increasing food rations decreased 
the number of females maturing in six instars (Table 2.2). 
 Non parametric Kruskal-Wallis and Mann-Whitman tests;  two way ANOVA tests without 
interactions terms; γ, separate one way ANOVA tests 
 Effect df F Sig.   df F Sig. 
Life Table test (Exp1)    Life Table test (Exp 2)    
Clone T     Clone F     
Age  T 12 32.6 <0.01 Age  T 12 10.3 0.59 
 MI 1 194.0 <0.02  MI 1 739.0 <0.01
Body length 1st  T 12,107 0.9 0.58 Body length 1st   12,114 2.7 <0.01
 MI 1,107 1.3 0.26   1,114 587.0 <0.01
Clutch size 1st  T 12,107 2.1 0.026 Clutch size 1st  T 12,107 19.9 <0.01
 MI 1,107 2.3 0.13  MI 1,108 30.1 <0.01
Body length 4th  T 12,106 0.9 0.52 Body length 4th  T 11,97 0.8 0.67 
 MI 1,106 0.0 0.89  MI 1,97 26.4 <0.01
Total Offspring  T 12,100 3.0 <0.01 Total Offspring  T 10,94 10.9 <0.01
 MI 1,100 1.9 0.17  MI 1,94 15.7 <0.01
Offspring size  T 12,208 16.9 <0.01 Offspring size  T 11,189 22.1 .000 
 MI 1, 208 11.3 <0.01  MI 1, 189 3.9 .050 
r γ T 12,110 1.1 0.41 r γ T 12,109 8.9 <0.01
 MI 121 8.3 <0.01  MI 120 0.1 0.90 
Table 2.3. ANOVA analysis results (degrees of freedom, df; Fisher’s ratio, F; and significant 
levels, Sig.) testing maturation instar (MI) and treatment (T) effects on life history traits 
responses of clones T and F in life-table tests. 1st, at first reproduction; 4th, at the fourth 
brood 
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Figure. 2.3. Life history responses (Mean±SE, N=8-10) of D. magna individuals from 
clones T and F exposed to the studied compounds from birth to the fourth brood. Each 
column of graph panel corresponds to one clone. Body length graphs include the length of 
first and fourth brood females; those of offspring number, the values for first clutch and total 
offspring, and those of offspring size of neonates from third and fourth broods. * Significant 
(P<0.05) differences from solvent controls following ANOVA and Dunnet’s tests. C, SC; 
NP, FX, FV are Control, Solvent control, 4-nonylphenol, fluoxetine and fluvoxamine 
treatments, respectively; r, intrinsic rate of population growth. For chemical treatments the 
numbers identify exposure levels. 
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Figure 2.4. Life history responses (Mean±SE, N=10) of D. magna individuals from clone F 
exposed to the studied compounds from birth to the fourth brood at three different food level 
ratios (Low, L; intermediate, M; and high, H). In the Survival graphs only 4-nonylphenol 
treatments at low and intermediate food levels (NL, NM, respectively) with significant 
(P<0.05) mortality were identified. In the remained graphs significant (P<0.05) differences 
from solvent controls within food levels following ANOVA and Dunnet’s tests are indicated 
with an asterisks. C, SC; N15, Fx40, Fv 7 are control, solvent control, 15µg/l of 4-
nonylphenol, 40µg/l of fluoxetine and 7µg/l of fluvoxamine, respectively. r, intrinsic rate of 
population growth. 
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   Effect df F Sig. 
Age   F  2 28.9 <0.01 
   T  4 10.3 0.036 
   MI  1 140. <0.01 
   FxT  14 49.5 <0.02 
        
Total Offspring   F  2.102 325. <0.01 
   T  4.102 3.7 <0.01 
   MI  1.102 2.0 0.156 
   FxT  2.102 12.7 <0.01 
   F xMI 8.102 1.1 0.389 
   T xMI 4.102 2.5 0.048 
        
Body length 4rth   F  2.106 320. <0.01 
   T  4.106 0.4 0.798 
   MI  1.106 31.0 <0.01 
   FxT  2.106 0.6 0.539 
   F xMI 8.106 1.9 0.071 
   T xMI 4.106 0.7 0.619 
        
Offspring size € Fec  1.85 14.7 <0.01 
   F  2.85 3.0 0.060 
   T  4.85 1.1 0.375 
   MI  1.85 9.6 <0.01 
   FxT  2.85 3.0 0.060 
   F xMI 8.85 2.2 0.034 
   T xMI 4.85 0.2 0.935 
        
r γ1  F   2.126 66.6 <0.01 
   T  4.126 9.0 <0.01 
   F x T 8.126 3.6 <0.01 
     
r γ2  F  2.135 49.2 <0.01 
   MI  1.135 0.2 0.688 
   F x MI 2.135 1.4 0.238 
Table 2.4. ANOVA analysis results (degrees of freedom. df; Fisher’s ratio. F; and significant 
levels. Sig.) testing maturation instar (MI). Treatment (T) and food level (F) effects on life 
history traits responses of clone F in the food life-table test (Exp. 3). 
 Non parametric Kruskal-Wallis and Mann-Whitman tests;  three way ANOVA tests without 
three factor interactions terms; €. three way ANCOVA results considering clutch size (Fec) as 
as covariate. γ Separate two way ANOVAS testing for Food and treatment (γ1) or food and 
maturation instar (γ2) effects  
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Also, increasing food rations increased significantly (P<0.05; Table 2.4; Fig. 2.4) 
total offspring production, final body length and population growth rates and 
decreased age at first reproduction and offspring size. Significant (P<0.05, 
Table 2.4) maturation instar effects on the studied life-history traits were evident 
for age at maturity and body length of fourth brood females. As a result 
individuals investing an additional instar were larger and start reproduction later 
(Fig. 2.4). Significant (P<0.05) treatment and treatment by food interaction 
effects were also observed for total offspring production (Table 2.4), 
withfemales exposed to 4-nonylphenol and fluoxetine producing more offspring 
only at low and intermediate food rations (Fig. 2.4). Within a food ration, 
population  
 
 
Table 2.4. ANOVA analysis results (degrees of freedom, df; Fisher’s ratio, F; and significant 
levels, Sig.) testing maturation instar (MI), treatment (T) and food level (F) effects on life 
 Non parametric Kruskal-Wallis and Mann-Whitman tests;  three way ANOVA tests without 
three factor interactions terms; €, three way ANCOVA results considering clutch size (Fec) 
as covariate. γ Separate two way ANOVAS testing for Food and treatment (γ1) or food and 
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Figure 2.5. Life history responses (Mean±SE, N=10) of D. magna gravid females exposed 
to the studied compounds during three consecutive broods. * significant (P<0.05) 
differences from solvent controls following one way ANOVA and Dunnet’s tests. C, SC; NP, 
FX, FV are Control, Solvent control, 4-nonylphenol, fluoxetine and fluvoxamine treatments, 
respectively; r, intrinsic rate of population growth. For chemical treatments the numbers 
identify exposure levels. 
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Also, increasing food rations increased significantly (P<0.05, table 2.4, Fig. 2.4) 
total offspring production, final body length and population growth rates and 
decreased age at first reproduction and offspring size. Significant (P<0.05, 
Table 2.4) maturation instar effects on the studied life-history traits were evident 
for age at maturity and body length of fourth brood females. As a result 
individuals investing an additional instar were larger and start reproduction later 
(Figure 2.3) significant (P<0.05) treatment and treatment by food interaction 
effects were also observed for total offspring production (Table 2.4) with 
females exposed to 4-nonylphenol and fluoxetine producing more offspring only 
at low and intermediate food rations(Fig. 2.4). Within a food ration, population 
growth rates were similar across treatments except for those individuals 
exposed to 4-nonylphenol at low and intermediate food rations, that were lower 
(Table 2.4, Fig. 2.4). The sex of offspring was unaffected by treatment, and 
offspring size was inversely related to offspring number irrespectively of food 
ration and exposure treatment (Table 2.4, Fig. 2.5).  
 
2.3.4. Adult reproduction tests  
At 110µg/L of 4-nonylphenol, no adult females from clone F survive long 
enough to reproduce and substantial embryo mortality (up to 30%) occurred 
within females of clone T (Fig 2.1). Statistical results obtained from the 
reproduction experiment performed on adult females of clones T and F, denoted 
mainly significant (P<0.05) treatment effects on both the number and size of 
offspring (Fig. 2.5). The final body length of all females tested was similar for all 
treatments, except for daphnids of clone T exposed to 110µg/L of 4-
nonylphenol, which were smaller. Total offspring increased in 9 out of the 12 
exposure treatments for both clones, relative to solvent controls. Treatments did 
not affect offspring sex and the size of neonates decrease significantly (P<0.05) 
with increasing 4-nonylphenol exposure levels. Observed differences in 
reproduction rates mirrored in significant population growth rate differences 
between exposed and non-exposed adult females.  
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2.4. Discussion 
 
The results obtained in this study indicated different modes of action of the 
studied chemicals when individuals were exposed from birth or during 
adulthood. Life-history effects also varied at low and high food rations. Juveniles 
and adults of clone T were more tolerant to 4-nonylphenol than those of clone 
F. When exposed during both juvenile and adult stages in the typical 
standardized 21 days reproduction assay, the number of maturation instars 
taken to maturity together with exposure treatments, affected differently growth- 
and reproductive-related traits in the two clones studied. Thus, it was not always 
possible to differentiate maturation instar effects from those caused by the 
studied chemicals, since individuals did not take either five or six instars to 
mature in all treatments. Females that invested an additional instar to mature 
were older at first reproduction and in clone F were also larger in size and 
produced more offspring than those maturing in five instars. When maturation 
instar effects were accounted for, the most important contaminant effects were 
as follows: fluvoxamine increased juvenile developmental rates relative to 
control treatments (i.e. females reproduced earlier) and females exposed to low 
levels of 4-nonylphenol (20, 40µg/L for clone T; 10µg/L for clone F) produced 
more but smaller offspring than control treatments. The previous life-history 
pollutant effects, however, did not translate into higher population growth rates. 
In clone F, reduced offspring production and population growth rates of females 
exposed to 40, 60 and 80µg/L of 4-nonylphenol were likely related to general 
toxic effects, since at 60 and 80µg/L severe effects on adult and embryo 
survival were observed. Thus, 4-nonylphenol caused a bi-phasic response 
enhancing offspring production at low concentrations and impairing survival, 
growth and reproduction at high concentrations. The size and number of 
offspring and age at first reproduction are strongly affected by food rations in D. 
magna (Barata and Baird, 1998; Barata et al., 2001). D. magna females growth 
less, reproduce latter, produced fewer but larger offspring and have lower 
population growth rates at low than at high food rations. This is a well-known 
adaptive strategy that allows D. magna to regulate its growth and per offspring 
reproductive investment, to maximize its fitness under variable food conditions. 
In the present study, the third life-table experiment was specifically designed to 
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assess how food rations could affect the observed life-history responses of 
individuals from clone F across the studied pollutants. As expected, food 
affected all the studied traits with females maturing earlier, being bigger and 
producing more and smaller offspring at high food rations. The availability of 
food also affected pollutant effects on the studied life-history traits. Survival of 
individuals exposed to 15µg/L of 4-nonylphenol decreased dramatically at the 
low food ration. These findings agree with recent results indicating that low and 
realistic exposure levels of 4-nonylphenol (10µg/L) impaired D. magna survival 
at low food rations (Beklioglu et al., 2010). Only at low and intermediate food 
rations, fluvoxamine increased juvenile developmental rates and 4-nonylphenol 
and fluoxetine increased offspring production relatively to control treatments. 
When the previous life-history changes were computed to estimate population 
growth rates, only those 4-nonylphenol treatments that showed high mortality 
rates had lower population growth rates than control treatments. Interestingly, a 
change just as little as two fold in food rations, within the range of 3.3×105 and 
6×105 cells/mL of C. vulgaris, affected dramatically the observed pollutant 
effects. Thus, slight variations in food rations could explain the reported 
discrepancies in the effects of 4-nonylphenol and fluoxetine on D. magna 
reproduction responses in 21 days chronic assays (Baldwin et al., 1997; 
Comber et al., 1993; Flaherty and Dodson, 2005; Hansen et al., 2008). Such 
small variations on food rations are very difficult to control experimentally and 
may have major effects on life-history responses (Barata and Baird, 1998). 
Another important finding of the food life-table experiment was that neither food 
nor pollutant levels affected the inverse relationship between offspring size and 
clutch size. This means that 4-nonylphenol and fluoxetine at low doses (15 and 
40µg/L, respectively) increased offspring production without affecting per 
offspring reproductive investment (i.e. neonate size). This finding, however, did 
not occur at higher 4-nonylphenol doses (adult reproduction tests with clones T 
and F), where females produced smaller offspring than controls. In summary, 
life-table experiments showed negligible population growth effects associated to 
the increased juvenile developmental rates or offspring production induced by 
pollutants. Conversely, concentrations high enough to impair offspring 
production and/or adult and embryo survival did affect negatively population 
growth rates. Nevertheless, and according to previous studies (Boersma, 1997; 
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Hammers‐Wirtz and Ratte, 2000), the offspring produced under 4-nonylphenol 
exposures should be less fitted than those produced under control and SSRIs, 
because of their smaller size. This prediction agrees with the observation that 
second generation females were more sensitive to 4-nonylphenol than first 
generation ones (Brennan et al., 2006). Exposure of adults to the studied 
chemicals increased total offspring production and population growth rates, with 
the only exception of females exposed to 110µg/L of 4-nonylphenol. 
Interestingly, per offspring reproductive investment (neonate body length) 
decreased in a concentration related manner in 4-nonylphenol treatments but 
not under exposure to fluoxetine and fluvoxamine, a result compatible with the 
data from life-table experiments. Responses to 4-nonylphenol agree with the 
“Principle of Allocation” that states that the amount of energy an individual can 
invest in maintenance, growth and reproduction is limited within a given energy 
input (Sibly and Calow, 1986). Under 4-nonylphenol exposures, females 
produced more but smaller offspring thus maintained or even reduced total 
reproductive investment and the gains on current fitness in terms of population 
growth rates of exposed adult females was counteracted by reduced offspring 
fitness (smaller offspring). Under fluoxetine and fluvoxamine exposures, 
however, females produced more offspring of apparently similar size to control 
treatments. This means that there was not a clear fitness pay-off of producing 
more offspring. Enhanced offspring production and altered per offspring 
reproductive investment and embryo toxicity of females exposed to 4-
nonylphenol have been previously reported (LeBlanc et al., 2000b). Similarly, 
increased fecundity of females exposed to fluoxetine has also been reported for 
in D. magna and Ceriodaphnia dubia (Brooks et al., 2003a; Flaherty and 
Dodson, 2005). With our current knowledge, it is difficult to provide a plausible 
hypothesis explaining the observed differences on life-history responses 
between life-table and adult tests, across food levels and between 4-
nonylphenol and SSRIs. One possible physiological explanation is that the 
studied SSRIs acted altering the activity of serotonin in D. magna by inhibiting 
the uptake of this chemical at the receptor like in mammalian species. 
Consistent with this hypothesis, sublethal concentrations of SSRIs have been 
found to alter the reproductive physiology of D. magna and other invertebrates 
(Brooks et al., 2003a; Flaherty and Dodson, 2005; Hansen et al., 2008). In 
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molluscs, SSRIs alterations were associated with increased levels of serotonin 
(Fong, 1998). The increase of SSRI effects on juvenile developmental rates and 
offspring production at low food rations, as found in our study, indicates that 
these animals might reduce their production of serotonin at low food rations, 
whereas at high food rations, serotonin levels might be maximal. As a result 
SSRIs increased serotonin activity at low food but not at high food rations where 
serotoninergic receptors may be already saturated. This hypothesis reflects the 
main pharmacological role of SSRIs in mammals, as they block the presynaptic 
membrane serotonin transporter, thereby inhibiting synaptic reuptake and 
recycling of serotonin (Wong et al., 1995). In addition to its anti-depressive 
effects, chronic exposures to SSRIs may also induce desensitization of 
serotoninergic receptors (Le Poul et al., 2000; Vidal et al., 2009). If translated to 
D. magna, a similar effect could explain the results from juveniles exposed to 
SSRIs in life-table tests, thus making adult stages insensitive to SSRIs 
exposures. Although the regulatory role of serotonin in controlling D. magna 
growth and reproduction is not known, there is increasing evidence that 
serotonin/biogenic amines are present and might regulate fecundity in 
crustaceans (Barthélémy et al., 2006; Bellon‐Humbert and Van Herp, 1988; 
Mazurová et al., 2008; Wongprasert et al., 2006). According to LeBlanc et al. 
(2000b) the increase in offspring production and the decrease in neonate size 
and embryo viability induced by 4-nonylphenol, may indicate that this com-
pound stimulates egg production without increasing some critical developmental 
component provided to the eggs by the maternal organisms, such as 
ecdysteroids, essential fatty acids or triglycerides. Alternatively, LeBlanc et al. 
(2000b) also stated that the metabolic effects of 4-nonylphenol characterized 
previously by Baldwin et al. (1997) using testosterone as a substrate, might also 
be relevant to endogenous substrates (such as ecdysone), resulting in 
perturbations in their provision to the newly produced eggs as well as in adults. 
Ecdysteroids play a critical role in developing embryos (Subramoniam, 2000). A 
close correlation between haemolymph ecdysteroid levels and ovarian 
maturation and vitellogenin synthesis, has been reported in some crustacean 
species (Okumura, 1992). A recent study showed that 4-nonylphenol was able 
to disrupt ecdysone levels in the mysid crustacean Americamysis bahia during 
the intermolt period (Hirano et al., 2009) and as a result disrupted growth. 
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Therefore, both hypotheses are equally valid to explain at least part of the 
observed reproductive features of 4-nonylphenol. Nevertheless, both 4-
nonylphenol and SSRIs may interact with multiple targets in mammals and as 
such are likely to do so also in D. magna. Therefore, future investigations need 
to be performed to elucidate the mechanisms of action of these chemicals in D. 
magna and other aquatic organism. In summary, the results reported in this 
study indicate that the three studied substances were able to increase offspring 
production and/or juvenile developmental rates similarly across the studied 
clones and that exposure stage scenarios, and food rations modified the 
observed responses. For both, SSRIs and 4-nonylphenol, observed effects 
occurred at low concentration levels (3–15µg/L). Surveys in US have reported 
levels of 12–540ng/L of fluoxetine in surface waters and effluents (Kolpin et al., 
2002) but total concentrations of SSRIs in aquatic systems were measured in 
the range of 840ng/L (Vasskog et al., 2008) to 3.2µg/L (Metcalfe et al., 2010). 4-
Nonylphenol levels in surface waters as high as 8µg/L have been reported in 
surface waters (Navarro et al., 2009). Therefore, the observed responses 
measured in this present study occurred at realistic field exposure levels. 
Moreover, in real field situations the occurrence of SSRI mixtures (Christensen 
et al., 2007) of different enantiomers and metabolites and acidic and basic 
water conditions are likely to affect dramatically bio-availability and toxicity of 
SSRIs to aquatic organisms (Oakes et al., 2010). Fluoxetine and other SSRIs 
are weak bases, which ionize in water at ambient pHs (Oakes et al., 2010). 
Ionized forms are more soluble in water than non-ionized ones and, hence, 
should be more toxic and bio-available to organisms. This is the case for 
fluoxetine, its major metabolite norfluoxetine and other SSRIs as reported by 
Nakamura et al. (2008) and Valenti et al. (2009) in fish. Enantiomer and major 
metabolite specific effects of SSRIs should also be considered, although 
previous studies indicate that, contrary to mammals and fish, such effects are 
marginal in Daphnia and algae (Neuwoehner et al., 2009; Stanley et al., 2007). 
In the present study, the studied SSRI compounds should have been present in 
their more bio-available ionized form since experiments were performed in weak 
basic conditions (pH around 8). The used pH levels as well as high hardness 
water conditions are common in many semiarid and Mediterranean 
overpopulated rivers across Europe, America and Australia, which makes that 
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our results may be extrapolated to these river systems. Interestingly for 4-
nonylphenol the observed responses were biphasic, enhancing reproduction at 
low doses and decreasing it at high doses. The two studied SSRIs only showed 
a monophasic response in the studied low concentration range, but previous 
studies indicate that they inhibited survival and reproduction at higher 
concentrations (Hansen et al., 2008; Henry et al., 2004; Stanley et al., 2007). 
These results, thus, support the view of Calabrese (2008) that hormesis 
responses should be considered in ecotoxicological evaluations and are of 
interest for environmental toxicology, as studies investigating the long term 
effects of low doses of drugs are an identified research need (Fent et al., 2006).  
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Abstract  
Selective serotonin reuptake inhibitors (SSRIs) are known to increase 
offspring production in Daphnia magna. This study tested the hypothesis that 
the increase of serotonin post-synaptic activity by SSRIs changes the 
perception of the food environment and switches life-history responses towards 
higher food level: females reproduced earlier, producing more but smaller 
offspring. D. magna reproduction tests, respiration, feeding and survival-
starvation assays and studies of lipids, proteins and carbohydrate levels of 
unexposed and exposed females to the SSRIs fluoxetine and fluvoxamine and 
the 5-HT serotonin receptor antagonist cyproheptadine were conducted. 
Factorial life-history experiments and reproductive assays showed that 
exposure to SSRIs increased juvenile development rate, clutch size and 
decrease offspring size at low and intermediate levels of food rations. These 
effects were reversed by the presence of cyproheptadine, indicating that 5-HT 
function was essential to the SSRIs effects on Daphnia and linking them to the 
pharmacological effects of SSRIs in humans. Respirometry and survival assays 
and biochemical analyses of lipids, proteins and carbohydrate levels showed 
that exposure to SSRIs increased oxygen consumption rates and decreased 
carbohydrate levels in adult females. These changes did not affect survival 
under starving conditions, but they significantly affected the capacity of the 
exposed animals to survive under anoxic conditions. These results suggest that 
SSRIs increased aerobic catabolism in D. magna making exposed individuals 
apparently more able to exploit food resources under normoxic conditions, but 
at the cost of being more sensitive to low oxygen levels, a common situation in 
natural environments. 
  
Keywords: Selective serotonin reuptake inhibitors-SSRIs, Daphnia, 
mechanisms of action, carbohydrate metabolism, serotonin, reproduction.
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3.1. Introduction 
 
Assessing the risks of long-term exposure to low doses of pharmaceuticals is 
an identified research need (Fent et al., 2006), particularly for those that may 
act as neural disruptors in non-vertebrate species (Barata et al., 2004; Brooks 
et al., 2003). For example, selective serotonin reuptake inhibitors (SSRIs) act by 
blocking the re-uptake of serotonin in the nerve synapses, increasing the 
effective concentration of serotonin in the intra-synaptic space and therefore 
stimulating serotoninergic neurons. This effect is used worldwide to treat clinical 
depression in humans (Rang et al., 1995), with the consequence of their 
widespread release into the environment. Fluoxetine levels of 12-540ng/L has 
been reported in US surface waters and effluents (Kolpin et al., 2002), and total 
concentrations of SSRIs in aquatic systems were measured in the range of 
840ng/L to 3.2µg/L (Metcalfe et al., 2010; Vasskog et al., 2008). 
Serotonin acts through multiple receptors to mediate a great variety of 
functions in vertebrates and invertebrates. Different serotonin receptors, or 5-
HT receptors, have been cloned in arthropods, molluscs, and nematodes 
(Tierney, 2001). Similarly, serotonin transporters, or SERTs, the 
pharmacological target of SSRIs, have been identified essentially in Metazoans 
(Caveney et al., 2006). Whereas 5-HT receptors from arthropods (and other 
invertebrates) and vertebrates show structural differences that may have 
functional consequences (Tierney, 2001). SERTs sequences are highly 
conserved in different key domains (Caveney et al., 2006). Not surprisingly, 
SSRIs designed to interact with human SERTs also exert different physiological 
effects in invertebrates. 
SSRIs have been found to alter the reproductive physiology of D. magna and 
other invertebrates in a biphasic way (Brooks et al., 2003; Flaherty and Dodson, 
2005; Hansen et al., 2008). Low levels of fluoxetine stimulated offspring 
production in D. magna and Ceriodaphnia dubia at 36 and 50µg/l, respectively 
(Brooks et al., 2003; Flaherty and Dodson, 2005), but higher exposure levels 
inhibited reproduction in the same species (Christensen et al., 2007; Hansen et 
al., 2008; Henry et al., 2004). Several SSRIs, including fluvoxamine, fluoxetine 
and paroxetine, induce spawning in zebra mussel (Dreissenna polymorpha) 
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within the nM and µM range, but inhibited it at the mM range, an effect linked to 
the increase of serotonin activity (Fong et al., 2003).  
 
Serotonin may stimulate ecdysteroids and juvenile hormone in insects, which 
are responsible for controlling oogenesis and vitellogenesis (Nation, 2002). 
Figure 3.1. Flow chart showing the Human (left) and hypothesized D. magna (right) 
mechanism of action of SSRIs. Proposed experiments to test our four hypothesis premises 
are superimposed as numbers as follows. (1) Reproduction tests across food rations with 
fluoxetine and fluvoxamine to test the first premise that SSRIs should be able to switch D. 
magna life-history trajectories; (2) Reproduction tests with fluoxetine with the mammalian 5-
HTs receptor antagonist, cyproheptadine to test that serotonin activity should be involved in 
these life-history changes; (3) Feeding, respiration assays and energy reserves studies to 
test the physiological consequences of observed life-history changes; (4) Adult survival tests 
under starvation with normoxia and low oxygen levels, to test for fitness costs. See the text 
for further information. Black arrows indicated the flow of events and dotted ones the location 
of D. magna food ± SSRI treatments. 
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Although serotoninergic effects in crustacean growth and reproduction 
hormones is less understood, there is evidence, that monoamine 
neurotransmitters (serotonin, dopamine) control the secretion of peptide 
hormones belonging to the hyperglycaemic hormone family in malacostracean 
crustaceans. These hormones regulate carbohydrate metabolism, 
synthesis/secretion of ecdysteroids and terpenoids and hence moulting, embryo 
development and gonadal maturation (LeBlanc, 2007). Fluoxetine and serotonin 
stimulate ovarian and testicular development and increase the size of ovaries 
and oocytes in decapod crustaceans (Kulkarni and Fingerman, 1992; Sarojini et 
al., 1993). Both compounds increase aggressive behaviour and carbohydrate 
metabolism in decapods and enhance ventilation and locomotion behaviour in 
amphipods (De Lange et al., 2009; Huber and Delago, 1998; Kulkarni and 
Fingerman, 1992; McDonald et al., 2011; Santos et al., 2001; Sarojini et al., 
1993). Thus, it is possible that the observed stimulation of fecundity in D. 
magna or C. dubia may result from increased synaptic serotonin levels. 
However, since reproduction is energetically costly, such an increase in D. 
magna and C. dubia offspring production should not necessarily be associated 
with maintenance of offspring viability or fitness.  
In this study we explore the hypothesis that SSRIs can affect D. magna 
juvenile developmental rates and offspring production depending on food 
rations and that such effects are related to the changes in serotonin activity. We 
tested four key aspects of this model that are summarized in Figure 3.1). In D. 
magna exposed to SSRIs under limiting food ration levels, life history 
trajectories will resemble conditions consistent with ample food conditions 
(Barata and Baird, 1998; Barata et al., 2002); 2) serotonin should be involved in 
these life-history changes; 3) these induced changes should have a 
physiological impact as follows: increasing offspring production may increase 
metabolic rates and decrease energy reserves (carbohydrates and lipids left 
after reproduction); 4) observed physiological impacts should have a fitness 
cost, for example, compromising survival under stressful conditions such as 
starving or/and anoxia.  
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3.2. Experimental Section 
 
3.2.1. Chemicals 
Fluoxetine hydrochloride (CAS-No 56296-78-7; analytical standard, purity 
100%) Sigma-Aldricht, USA), and Fluvoxamine maleate (CAS-No 61718-82-9, 
analytical standard, purity 100%) were purchased from Sigma-Aldrich 
(USA/Netherlands). All other chemicals were analytical grade and were 
obtained from Merck (Germany).  
 
3.2.2. Experimental animals  
All experiments were performed using a well-characterized single clone of D. 
magna (Clone F), maintained indefinitely as pure parthenogenetic cultures 
(Barata and Baird, 2000a). Individual or bulk cultures of 10 animals/L were 
maintained in ASTM hard synthetic water (ASTM, 1999) as described in Barata 
and Baird (2000b). Individual or bulk cultures were fed daily with Chorella 
vulgaris Beijerinck (5x105 cells/mL, respectively, corresponding to 1.8µg C/mL; 
(Barata and Baird, 1998)). C. vulgaris was grown axenically in 
Jaworski/Euglena gracilis 1:1 medium (CCAP, 1989). Algae were harvested in 
the exponential phase of growth, centrifuged and then re-suspended in ASTM 
hard water. The number of algal cells in freshly prepared medium was checked 
daily from absorbance measurements at =650ηm in a dual-beam 
spectrophotometer (Uvikon 941) using standard calibration curves based on at 
least 20 data points, with an r2>0.98. The culture medium was changed every 
day, and neonates were removed within 24 h. Photoperiod was set to 14h light: 
10h dark cycle and temperature at 20±1ºC. 
 
3.2.3. Experimental design 
Data from four distinct assay-experiments was considered to test the 
proposed mechanistic model shown in Fig 3.1: 
Experiment 1: SSRIs effects on D. magna life-history trajectories across 
food rations were studied in two bioassays. Firstly, SSRIs effects on the number 
and size of offspring was studied in adults exposed to three concentrations of 
fluvoxamine (3, 7, 30µg/L) and fluoxetine (10, 40, 80µg/L) using a food ration 
level of 5x105 cells/mL of C. vulgaris. Acetone was used as a carrier solvent 
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(100µL/L final concentration), thus treatments also included a control and a 
solvent control. These experiments, hereafter referred to adult reproduction 
assays, started with ten 8-9 day old gravid females, which were exposed during 
three consecutive broods to the studied chemicals (10-14 days). Experimental 
adults were obtained from bulk cultures of 100 individuals reared in 10L of 
ASTM as described above (section 3.2.2.). Within 24h of deposition of the first 
clutch into the brood chamber, single females were removed and randomly 
assigned to each treatment. The first batch of neonates (hatching within the first 
48-72h) was always discarded and not evaluated as these animals were not 
exposed to the tested chemicals during their entire developmental period 
(Barata and Baird, 2000a). Thus only neonates from the second, third and 
fourth broods were counted for assessing effects on total offspring production. 
In the third and fourth brood, body lengths of at least 10 neonates were also 
measured to estimate reproductive investment per offspring. Body length 
measurements were performed from the head to the base of the spine using a 
Nikon stereoscope microscope (SMZ 150, Nikon Co., Tokyo, Japan) and the 
ImageJ software (http://rsb.info.nih.gov/ij/)  
In the food life-history experiment neonates (<24h old) were exposed until 
their fourth brood to 7 and 40µg/L of fluvoxamine and fluoxetine, respectively, at 
three food ration levels: 1.6x105, 3.3x105 and 6x105 cells*mL-1 of C. vulgaris, 
which are equivalent to 0.6, 1.2 and 2.2 1.8µg C/ml, respectively (Barata and 
Baird, 1998). Hereafter this food ration will be referred as low, intermediate and 
high, respectively, and correspond to limiting, incipient limiting and non-limiting 
food ration levels (Barata and Baird, 1998). Test mediums were changed daily 
and C. vulgaris was grown, harvested and counted as depicted at section 3.2.2. 
For each individual, age at first reproduction and total offspring production were 
monitored. In the third and fourth brood, the body lengths of at least 10 
neonates were also considered.  
Experiment 2: Role of serotonin levels in the pharmacological action of 
SSRIs in D. magna. These experiments aimed to test whether the 
enhancement in offspring production under SSRIs treatments could be reverted 
by the co-administration of a mammalian 5-HTs receptor antagonist. Gravid 
females were separately exposed to single and combined exposures of 
fluoxetine (80µg/L) and the mammalian 5-HTs receptor antagonist 
Chapter 3 
127 
 
cyproheptadine (10-400µg/L), at a food ration of 5x105 cells/mL of C. vulgaris. 
The experimental set up was identical to that of adult reproduction assays and 
effects on total offspring production and female body length were measured.  
Experiment 3. Effects of SSRIs administration on oxygen consumption, 
feeding rates and protein, carbohydrate and lipid levels. Gravid females 
were exposed to fluoxetine and fluvoxamine at 80 and 30µg/L, respectively, in a 
setup similar to the adult reproduction assays, but with 32 replicates for each 
treatment to achieve the critical mass required for determining protein, 
carbohydrate and lipid levels. Females that allocated the first brood of eggs into 
the brood pouch (hereafter referred as first brood females) were randomly 
distributed to SSRIs, control and solvent control treatments.  
Feeding assays were conducted during the tests in third brood females 
following the same experimental protocol described for adult reproduction tests. 
Females were transferred into individual test vessels filled with the appropriate 
treatment solution plus food. Three replicate test vessels filled with the same 
culture medium but with no animals added were used as blank replicates. The 
mean initial algal cell concentration of the experimental vessels at the start of 
the experiment (time t0) was determined from three 5mL samples obtained from 
the treatment medium before it was distributed into the experimental vessels. 
After 24h, 5mL samples of the medium from nine vessels were selected 
randomly to assess the final algal cell concentration (time t24). Individual 
feeding rates (cells*animal-1*h-1) were determined as the change in cell density 
during 24h according to the method given by (Allen et al., 1995) and converted 
to proportional feeding rates relative to control treatments. Algal cell density was 
estimated from absorbance measurements as described above.  
Biochemical and Respirometry assays: Just after releasing their fourth clutch 
into the brood pouch, eggs were gently flushed from the brood pouch of freshly 
CO2 anesthetized females following the technique of Glazier and Calow (1992). 
Twenty of these females were immediately frozen in liquid N2 and stored at -
80ºC for biochemical determinations; whereas 12 de-brooded females were 
allowed to recover for 24h and then used for oxygen determination. This 
protocol, by using only de-brooded females excludes the contribution of 
developing embryos on oxygen consumption rates or on biochemical 
determinations (Glazier and Calow, 1992). Furthermore, the use of de-brooded 
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adults in the first hours of their intermolt instar ensured that the levels of lipids, 
carbohydrates and proteins of females were mostly somatic, as the ovaries are 
empty at the beginning of each instar (Glazier and Calow, 1992). 
Oxygen consumption assays were performed with and without food (5x105 
cells/mL of C. vulgaris). Food is known to increase oxygen consumption rates 
due to the metabolic costs of ingestion and digestion (Barber et al., 1994). 
According to the mechanistic model proposed in Figure 3.1, D. magna exposed 
to SSRIs should increase swimming/locomotion activities and hence oxygen 
consumption rates irrespectively of food. Exposure levels of fluoxetine (80µg/L) 
and fluvoxamine (30µg/L) plus a control and solvent controls were tested with 
six replicates each. Oxygen consumption assays were performed using 
standard respirometry methods with 50mL gas-tight syringes (Hamilton, USA) 
as described in Agra et al. (2011), and expressed as µg O2 consumed per 
organism per hour. Six syringes were used per treatment and food levels. They 
were filled with 30mL of the appropriate test solution and with one fourth brood 
adult. The remaining air was expelled from each syringe, which was left in the 
dark in a water bath (20ºC) for 24 h. After the first 2h of exposure, initial O2 
concentrations were measured with the aid of an oxygen meter (Model 782 
Strathkelvin Instruments, Glasgow) provided with an oxygen electrode (model 
1302, Strathkelvin Instruments, Glasgow) and after 24h from the start of the 
test, the final O2 concentrations were measured in the same way. The oxygen 
consumption was given by the differences in the oxygen content of water before 
(T0=2 h) and after (T final=24 h) the exposure period. Respiration rate was 
expressed as ug O2 consumed per organism per hour. Within each experiment 
three blank controls (syringes with no organisms) were tested for every 
treatment to correct for the ambient O2 depletion due to factors other than 
organism’s respiration. The depletion in the oxygen content on these blank 
controls was used as a correction factor for the appropriate treatments. 
Total lipids, carbohydrates, and proteins were extracted as described in 
Cheng et al. (2011 and De Coen and Janssen (1997). Pools of 5 adults were 
used to achieve sample requirements with a total of 4 replicates per treatment. 
Groups of 5 adult females were homogenized in 800μL ice-cold 100mM 
phosphate buffer (PBS), pH 7.4. After homogenization, 500 and 200µL of 
homogenate were used for lipid contend and carbohydrate and protein 
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determination, respectively. Lipids were extracted with chloroform: methanol 1: 
1. After centrifugation at 10,000g the top phase was removed and the solvent 
evaporated at 90ºC. After addition of concentrated H2SO4, the mixture was 
heated for 20 min at 90ºC. 50µL of vanillin-phosphoric acid was added and left 
to develop colour for 10 minutes. The total lipid content expressed as µg per 
individual was determined at 540nm using trypalmitin as standard (Cheng et al., 
2011). To determine total protein and carbohydrate (sugar) content, 15% 
trichloroacetic acid (TCA) was added to homogenates and samples were 
incubated at −20ºC for 10 min. After centrifugation at 10,000g, the pellet formed 
was washed with 5% TCA and both supernatant fractions were combined and 
used for the total sugar analysis. The remaining pellet was re-suspended in 
NaOH and incubated at 60ºC for 30 min and then neutralized with HCl. Total 
protein content was determined using the Bradford’s method (Bradford, 1976) 
and bovine serum albumin as standard. Total carbohydrate content of the 
supernatant fraction was quantified by adding 5% phenol and H2SO4 to the 
extract. After 30min incubation at 20ºC, the absorbance was measured using 
glucose as a standard at 492ηm. The protein and carbohydrate content was 
expressed as µg per animal. All measurements were performed with the Multi-
Detection Micro- plate Reader, BioTek® (Vermont, USA). 
Experiment 4: Effects of SSRIs on adult survival under starving 
conditions. Two separate experiments were performed to tests survival 
responses under normoxia and low oxygen levels, respectively. In the first 
bioassay first brood females (20 replicates per treatment) were randomly 
distributed to SSRIs (80µg/L fluoxetine and 30µg/L fluvoxamine), control and 
solvent control treatments. Just after releasing their fourth brood into the brood 
pouch ten females of each treatment were randomly assigned to control or 
treatment medium without food. Survival of exposed organisms was monitored 
at 12h intervals until all individuals died. 
The experimental set up for the second bioassay was identical to the 
previous one but females were starved to the same treatment medium under 
low oxygen levels (1mg/L). Low oxygen levels were obtained by bubbling N2 
into the test medium and maintained animals in 100mL sealed glass bottles until 
death. Survival of exposed and control organisms were monitored at 8h 
intervals until all individuals died. 
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3.2.4. Physical-chemical analyses 
Duplicated water samples of freshly prepared and old (24 h) test solutions 
were collected at the beginning and end of the tests to determine that measured 
oxygen levels and pH were within the limit established by OECD guidelines 
(OECD, 1981). Dissolved oxygen concentration (DO) was measured using an 
oxygen electrode model 1302 (Strathkelvin Instruments, Glasgow) and pH was 
measured using an epoxy-body combination electrode, coupled to a Crison 
micro pH 2001 meter and calibrated with standard pH buffer solutions (Sigma, 
Madrid, Spain). Mean oxygen levels were 95±3.4 % of saturation and pH values 
7.3±0.2 for all experiments, except for those conducted under anoxia, in which 
mean initial and final oxygen levels were 1.4±0.2 and 0.4±0.04 mg O2/L, 
respectively.  
Stability of the compounds during the test was confirmed using solid-phase 
extraction and liquid chromatography-tandem mass spectrometry (LC-MS-MS). 
Analysis of fluoxetine 10,40, 80µg/L and fluvoxamine 3,7, 30µg/L was restricted 
to final test solutions (24h) in experiments 1-3 and to initial ones in experiments 
4-5 and conducted with the method of Gómez et al., (2006). For the pre-
concentration of fluoxetine and fluvoxamine, Oasis 60mg SPE cartridges were 
conditioned with 10mL of methanol followed by 10mL of water. 100mL of water 
were pre-concentrated at a flow rate of 10ml/min and eluted with 2x4mL of 
methanol. This extract was then reduced under nitrogen to incipient dryness 
and reconstituted in 1mL with methanol. Solid phase extraction recoveries were 
determined using appropriate amounts of analytes spiked into water before 
extraction and in 1ml of the extracts after extraction.  
The LC analysis were performed using a Waters 2690 HPLC separations 
module (Mildford, MA, USA) equipped with a Purospher Star RP-18 end-capped 
column (125mm×2.0mm, particle size 5µm) and C18 guard cartridge supplied 
by Merck (Darmstadt, Germany). The following gradient was chosen for HPLC 
separation at room temperature: eluent A was acetonitrile and eluent B was 
formic acid 0.1% in MilliQ water at a flow rate of 0.2mL/min. The elution started 
with 10% of eluent A, followed by a 25-min gradient to 80% of eluent A and a 3-
min gradient to 100% of eluent A and then back to the initial conditions within 4 
min. An injection volume of 10µL was used. The tandem MS analyses were 
carried out on a Micromass Quattro triple quadrupole mass spectrometer 
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equipped with a Z-spray electrospray interface (Manchester, UK). Instrument 
control, data acquisition and evaluation were done with the Masslynx NT 
software (v.3.4). The parameters for the analysis were: electrospray source 
block and desolvation temperature: 150 and 350ºC, respectively; capillary and 
cone voltages: 2.8kV and 30V, respectively; argon collision gas 2.5×10−3mbar; 
cone nitrogen gas flow and desolvation gas: 43 and 628L/h. Mass spectrometer 
was operated in the multiple reaction monitoring MRM mode with unit mass 
resolution on both mass analyser. 
Identification criterion of the target compounds was based on: (a) LC 
retention time of the analyte compared to that of a standard (±2%) and (b) the 
ration of abundances of two specific precursor ion to product ion transitions 
(within 10% of the rations obtained for the standard). Mass to charge rations 
used for MS quantification and identification were m/z 310 to 44 and 148 for 
fluoxetine and m/z 319 to 71 and 200 for fluvoxamine. Quantification was based 
on external calibration standard 8 point curves (r2>0.98). Limits of detection and 
quantification defined as the minimum detectable amount of analyte with a 
signal to noise ratio of 3:1 and 10:1, respectively, were determined from the 
spiked water samples. 
Mean retention time was 12.91 and 19.90 min for fluvoxamine and fluoxetine, 
respectively.  
3.2.5. Data analyses 
The effect of food rations and treatment or of treatment on measured life 
history and physiological responses were analysed by two and one way 
ANOVA. When significant (P<0.05) treatments effects occurred, post-hoc 
Dunnet’s tests were performed to compare exposure treatments with solvent 
controls. Prior to analyses all data except survival responses was log 
transformed to achieve normality and variance homoscedasticity (Zar, 1996). 
Survival responses were assessed by Wilcoxon-Gehan tests. Tests were 
performed with the IBM SPSS Statistics software version 19. 
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3.3. Results and Discussion 
 
3.3.1. Contaminant levels in water 
In all tests performed measured (Mean±SD, n=4-10) SRRIs concentrations 
were close to nominal levels being for fluvoxamine 2.1±0.3, 7.5±0.4, 
26.5±3.4µg/L and for fluoxetine 8.7±0.5, 45.3±3.6, 76.1±4.9µg/L, respectively. 
For the sake of clarity, results are referred to nominal vales. 
 
3.3.2 Life-history responses 
Following exposure of adult females to fluvoxamine or fluoxetine the total 
number of offspring increased (ANOVA, F7, 57 =4.5, P<0.05) when compared to 
controls (Figure 3.2), with no significant changes in the offspring average size 
(ANOVA, F 7, 116 = 0.9, P>0.05). These results are in accordance with previous 
reports of increased offspring production by fluoxetine at concentrations similar 
to the ones used in this study (Flaherty and Dodson, 2005). Therefore, we 
conclude that this effect is a consistent consequence of the presence of SSRIs. 
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Figure 3.2. Effects of fluoxetine (10, 40, 80μg/L) and fluvoxamine (3, 7, 30μg/L) on offspring 
size and number in exposed adult females. Values are Mean±SE; N=10. Numbers after Fx 
and Fv indicate exposure levels. * Total offspring significant (P<0.05) differences from 
solvent control treatments following ANOVA and Dunnet’s post hoc tests. 
Chapter 3 
133 
 
Reducing the amount of food modulated the effects of SSRIs exposure on 
offspring size and number in D. magna. SSRIs effects were abolished at high-
food conditions (black symbols in Figure 3.3A), whereas at intermediate and low 
food rations (grey and white symbols in Figure 3.3A), SSRIs exposure effects 
on offspring number and size become more evident (Figure 3.3A, see ANOVA 
results in Table 3.1). In addition, females exposed to fluvoxamine reproduced 
earlier than control ones only at low and intermediate food rations (white and 
grey bars, Figure 3.3B, see also ANOVA results in Table 3.1). These results are 
consistent with the hypothesis that D. magna individuals exposed to SSRIs 
modified their perception of food ration levels switching life-history responses 
towards higher food rations, and that such changes were closely related to the 
pharmacological mode of action of SSRIs of increasing serotonin postsynaptic 
activity, and resulting in an increased offspring production and decreased 
offspring size and maturation age (see the experimental hypotheses depicted in 
Fig. 3.1, (Barata and Baird, 1998)).  
 
 
The pharmacological action of SSRIs inducing offspring production by 
increasing postsynaptic serotonin activities in D. magna was investigated by 
blocking serotonergic activity with the mammalian 5-HTs receptor antagonist, 
cyproheptadine. Cyproheptadine alone significantly inhibited total offspring 
production in a concentration related manner above 50µg/L (ANOVA, 
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Figure 3.3. Effects of fluoxetine (40μg/L) and fluvoxamine (7μg/L) on offspring size and 
number (A) and age at first reproduction (B) on D. magna individuals reared across food 
rations (1.6x105, 3.3x105, 6x105 cells mL-1 of C. vulgaris, respectively). Values are Mean±SE, 
N=9-10; * significant (P<0.05) differences from solvent control treatments following ANOVA 
and Dunnet’s post hoc tests 
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F5,50=17.6; P<0.05, Figure 3.4A). Exposures of adult females to 80µg/L of 
fluoxetine produced significantly (ANOVA, F6,60=5.0; P<0.05) more offspring 
than those in solvent controls but not when they were co-exposed to the same 
concentration of fluoxetine and 10 or 50µg/L cyproheptadine (Figure 3.4 B). 
Cyproheptadine by itself at 10 or 50µg/L did not affect reproduction, as females 
exposed to this antagonist alone had similar fecundity as those of solvent 
controls (Figure 3.4 B). These results support the hypothesis that SSRIs like 
fluoxetine act on D. magna reproduction increasing post-synaptic serotonin 
activity in its receptor 5-HT, a mechanism similar to its intended 
pharmacological effect in mammals.  
 
 
 
 
Trait Factor df F P 
 Food 2 17.1 <0.01 
Age 1 Treatment 3 12.7 <0.01 
 Treatment x Food 11 33.1 <0.01 
Total offspring 2 Food 2,94 365.6 0.00 
 Treatment 3,94 3.1 0.03 
 Treatment x Food 6, 94 2.3 0.04 
Offspring size 3 Cultch 1,158 101.7 <0.01 
 Food 2,158 8.5 0.00 
 Treatment 3,158 2.8 0.04 
 Treatment x Food 6, 158 2.8 0.01 
Body length 2 Food 2,98 293.7 0.00 
 Treatment 3,98 0.2 0.88 
 Treatment x Food 6, 98 1.0 0.43 
 
Table 3.1. .ANOVA results testing the effects of food ration levels and treatment on selected 
life history responses of D. magna individuals exposed to the studied SSRI at three food 
regimes. Offspring size analyses were performed on third and fourth clutch neonates. Only 
degrees of freedom (df), Fisher’s coefficient (F) and probability values (P) are depicted. 
1 Age at first reproduction was analysed by non-parametric Kruskal- Wallis tests; 
2
 effects on 
total offspring production and body length were tested by two way ANOVA; 
3
 Offspring size 
versus offspring number was analysed using ANCOVA analyses considering offspring number 
as a covariate. 
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Figure 3.4. Effects of Cyproheptadine (cy) alone (A) and of cyproheptadine (10, 50µg/L) 
co-administered with fluoxetine (Fx, 80µg/L (B) on offspring number. Values are 
mean±SE, N=10, * significant (P<0.05) differences from solvent control treatments 
following ANOVA and Dunnet’s post-Hoc tests. 
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Figure 3.5. Effects of cyproheptadine (cy) alone and of cyproheptadine (10, 50μg/L) co-
administered with fluoxetine (Fx, 80μg/L) on body length. Values are Mean±SE, N=10; * 
significant (P<0.05) differences from solvent control treatments following ANOVA and 
Dunnet’s post hoc tests. 
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Cyproheptadine has previously been shown to prevent serotonin from 
inducing spawning in bivalves (Fong et al., 2003) and ovary growth and oocyte 
maturation in the prawn Macrobrachium rosenbergii (Meeratana et al., 2006). 
Furthermore, our results also show that cyproheptadine acts as a true 5-HT 
antagonist because at high exposure levels (100 µg/L) it specifically inhibited 
reproduction (Figure 3.4A) without affecting growth (see also body length 
effects in Figure 3.5). The results of the present blocking experiments, thus, 
support the assumption that SSRIs are, in fact, blocking reuptake, increasing 
the availability of synaptic serotonin, and activating post-synaptic receptors. 
Thus, it is the release of serotonin that is inducing offspring production and 
therefore being blocked by cyproheptadine. Although synaptic serotonin levels 
or post-synaptic serotonin activity were not measured in the present study, 
there is evidence that serotonin as well as 11 other biogenic amines and their 
metabolites are present in D. magna tissues and their concentration are 
modulated during the daily cycle (Ehrenstrom and Berglind, 1988).  
 
3.3.3. Physiological effects 
Fed D. magna had significantly increased oxygen consumption rates compared 
with starved individuals (P<0.05; ANOVA; food effect F 1, 39= 51.5; Figure 3.6), a 
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Figure 3.6. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on adult oxygen 
consumption rates. White and black bars correspond to responses without and with food. 
Values are Mean±SE: N=6. Different letters indicate significant (P<0.05) differences among 
treatment groups following ANOVA and Tukey’s post hoc tests. 
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well-known characteristic of Daphnia physiology (Philippova and Postnov, 
1988).  
D. magna responded to SSRIs exposure by increasing oxygen consumption 
rates (P<0.05; SSRIs effect F3,39 =7.8), but SSRIs did so independently of food 
ration (not significant, P<0.05, interaction term; F3,39 = 0.9). D. magna 
individuals exposed to SSRIs did not have their feeding rates significantly 
affected (ANOVA, F3,30 =1.6; Figure 3.7).  
Whereas in absence of food, oxygen consumption rates in Daphnia provide 
good estimates of maintenance costs that include basal metabolism and 
swimming/ ventilation activities that are necessary to live, food ingestion is 
energetically expensive accounting for almost 40% of metabolic or respiration 
rates (Barber et al., 1994; Philippova and Postnov, 1988). Pollutants may 
increase maintenance costs by increasing detoxification mechanisms (demand 
side effects), but more often, when food is present, pollutants decrease 
metabolic rates inhibiting food intake (supply side effects) (Barata et al., 2004; 
Barber et al., 1994).  
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Figure 3.7. Effects of fluoxetine (80μg /L) and fluvoxamine (30μg /L) on proportional feeding 
rates relative to control treatments. Values are Mean±SE; N=10. 
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Our results suggest that SSRIs increase maintenance costs, either by 
increasing swimming/ventilation activity, detoxification and/or other 
physiological processes. One of such physiological processes could be the 
metabolic cost of having higher reproductive investment. We consider, however, 
that this factor cannot explain by itself the observed effects. Considering an 
averaged egg mass of 5 µg d.w. and an egg mass oxygen consumption rate of 
2.7µg O2*mg-1d.w.*h-1 (Glazier and Calow, 1992), the estimated increases of 
oxygen consumption rates associated to observed increases of fecundity of 5-
10 eggs per brood under SSRIs treatments were too low (0.13µg O2*h-1) to 
account for the observed 0.7-1.3µg O2*h-1 increase on oxygen consumption 
(Figure 3.6). Therefore, other physiological processes, like increasing 
swimming/ventilation activity and enhanced levels of catabolism (i.e. 
carbohydrate metabolism) should contribute significantly on the observed 20-
50% increase in oxygen consumption rates (De Lange et al., 2009; Huber and 
Delago, 1998; Kulkarni and Fingerman, 1992; McDonald et al., 2011; Santos et 
al., 2001; Sarojini et al., 1993). Analyses of putative energy reserves in de-
brooded D. magna females showed that SSRIs significantly decreased (P<0.05) 
carbohydrate levels (ANOVA, F 3, 12 = 11.0) but not those of lipids (F 3, 12 = 3.2) 
and proteins (F 3, 12 = 2.9, Figure 3.8). 
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Figure 3.8. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on lipid, carbohydrate 
and protein levels of exposed adults. Values are Mean±SE. N=4; * significant (P<0.05) 
differences from solvent control treatments following ANOVA and Dunnet’s post hoc tests.
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Figure 3.10. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on survival 
responses of adults under starvation and anoxia. 
Figure 3.9. Effects of fluoxetine (80μg/L) and fluvoxamine (30μg/L) on survival responses of 
adults under starvation. For clarity, longevity responses of adults pre-exposed to the studied 
SSRIs and starved in clean water (A) or in water plus SSRI (B) are separated. 
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Injection of serotonin and fluoxetine in several species of decapods 
increased glucose and hyperglycaemic hormonal levels in haemolymph (Santos 
et al., 2001). As crustacean hyperglycaemic hormones are present in central 
and peripheral nervous systems of D. magna (Zhang et al., 1997), these 
observations may be fully applicable to our results. A suitable model would be 
that SSRIs, by increasing synaptic serotonin levels, up-regulate hyperglycaemic 
hormones and hence increasing carbohydrate metabolism. 
Finally, survival responses under starving conditions of D. magna females 
pre-exposed to SSRIs was determined in water only and in water spiked with 
the studied SSRIs exposure levels under normoxic and low oxygen levels 
(1mg/L). Under normoxic conditions survival tests did not evidence significant 
(P<0.05) differences among treatments (Wilcoxon-Gehan tests=5.4; df=6; 
Figure3.9). This means that the observed increasing oxygen consumption rates 
and depleted carbohydrate reserves did not have measurable adult fitness 
costs in terms of tolerance to starving conditions. These unexpected results 
apparently contradict life-history theory that should predict lower survival of 
individuals having similar energy reserves but greater 20-50% oxygen 
consumption rates (Sibly and Calow, 1986). Indeed, using the energetic 
equivalent values reported for oxygen consumption (484kJ/mol O2), lipid 
(39500mJ/mg), protein (24000mJ/mg) and carbohydrates (17500mJ/mg) (De 
Coen and Janssen, 1997), and considering the data reported in Figures 3.6 and 
3.8, it was estimated that D. magna females starved and exposed to SSRIs 
should exhaust all their energetic reserves in 70 hours, whereas those of 
controls should last for 120 hours. Nevertheless, these predictions assume a 
constant oxygen consumption rate during starvation, and that oxygen 
consumption rates are directly related to aerobic metabolism in both SSRIs and 
control daphnids. Both assumptions may not be exactly correct, as D. magna 
can decrease its oxygen consumption rates during starvation (Glazier and 
Calow, 1992) and it may modulate aerobic and anaerobic metabolism to adapt 
to high and low oxygen conditions (Paul et al., 1998). A plausible hypothesis is 
that SSRIs may increase oxygen consumption rates by favouring aerobic 
metabolism at the expenses of the anaerobic one. As aerobic metabolism is 
energetically more efficient, daphnids exposed to SSRIs under starving 
conditions may use energy more efficiently than unexposed individuals, without 
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compromising survival. However, animals with higher oxygen consumption rate 
and low carbohydrate reserves should be more sensitive to anoxia, due to their 
dependence on aerobic metabolism.  
Figure 3.10 shows that exposure to SSRIs significantly reduced survival 
under low oxygen conditions (1 mg/L, Wilcoxon-Gehan tests = 22.7; df = 3; 
P<0.05). These results support the argument that SSRIs enhance aerobic 
metabolism, making the exposed individuals more susceptible to anoxia. In real 
field situations D. magna individuals often encounter low oxygen conditions and 
are adapted to live for certain periods under anoxia (Paul et al., 1998; Zeis et 
al., 2009). This means that in particular situations of low oxygen levels observed 
life-history and physiological effects of SSRIs on D. magna individuals may bear 
a fitness costs in terms of increasing mortality rates. 
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              +  L       ERETW KK +FLL+VIG+AVDLGNVWRFPYICY+NGGGAFL+PY +M +  
Human    67   TTTLVAELHQGERETWGKKVDFLLSVIGYAVDLGNVWRFPYICYQNGGGAFLLPYTIMAI  126 
 
D. pulex 119  FGGLPLFYMELALGQFHRSGCLTLWKRICPALKGVGYAICIIDFYMGMYYNTIIGWAVYY  178
              FGG+PLFYMELALGQ+HR+GC+++W++ICP  KG+GYAICII FY+  YYNTI+ WA+YY  
Human    127  FGGIPLFYMELALGQYHRNGCISIWRKICPIFKGIGYAICIIAFYIASYYNTIMAWALYY  186 
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D. pulex 236  DLGPIKWSLALCVFAVFVLVYFSLWKGVRSTGKAVWITAVAPYIVLIILLFRGASLPGAG  295 
              DLG I W LALC+  +F ++YFS+WKGV+++GK VW+TA  PYI+L +LL RGA+LPGA   
Human    247  DLGGISWQLALCIMLIFTVIYFSIWKGVKTSGKVVWVTATFPYIILSVLLVRGATLPGAW  306 
 
D. pulex 296  DGIRYFLTPQWSKLAETKVWTDAASQVFFSLGPGFGTLLALSSYNKFHNNCFYDALLTSS  355 
               G+ ++L P W KL ET VW DAA+Q+FFSLGPGFG LLA +SYNKF+NNC+ DAL+TS   
Human    307  RGVLFYLKPNWQKLLETGVWIDAAAQIFFSLGPGFGVLLAFASYNKFNNNCYQDALVTSV  366 
 
D. pulex 356  INLATSLLAGFVIFAVLGYMAEIRNVSIDQLGLE-GPGLVFVVYPEAIATMAGSTFWSMI  414 
              +N  TS ++GFVIF VLGYMAE+RN  + ++  + GP L+F+ Y EAIA M  STF+++I  
Human    367  VNCMTSFVSGFVIFTVLGYMAEMRNEDVSEVAKDAGPSLLFITYAEAIANMPASTFFAII  426 
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Human    427  FFLMLITLGLDSTFAGLEGVITAVLDEFPHVWAKRRERFVLAVVITCFFGSLVTLTFGGA  486 
 
D. pulex 475  YLVDLLNVYGPGIAILFLVFVEAMGVSWCYGTQRFSDDIESMLGFQPGPFWKITWAYVSP  534 
              Y+V LL  Y  G A+L +  +EA+ VSW YG  +F  D++ MLGF PG FW+I W  +SP  
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              R++K  TPE  ++  
Human    607  RIIKSITPETPTE  619  
Figure 3.11. Alignment of a putative Daphnia pulex SERT (DAPPUDRAFT_314292) and its 
closest human relative (ref|NP_001036.1, sodium-dependent serotonin transporter). Identical 
residues (51%) are represented in the central row, "+" signs correspond to conservative 
amino acid changes (69% of total homology). Numbers correspond to the amino acid position 
in both sequences. Analysis performed using the BLAST server at 
http://www.ncbi.nlm.nih.gov/blast 
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Our working hypothesis implies that SSRIs acts in Daphnia following a 
mechanism of action similar or identical to their intended pharmacological effect 
in humans, blocking serotonin reuptake and increasing serotonin post-synaptic 
activity (Wong et al., 1995). No bona fide SERT has not been characterized in 
Daphnia yet. However, an apparently complete sequence from the Daphnia 
pulex genome (DAPPUDRAFT_314292) encompasses a putative protein with 
51% identity and 69% homology to its closest human relative, a Na-dependent 
SERT (Figure 3.11).  
Whether or not this putative sequence corresponds to a functional SERT is 
unknown but its presence suggests that Daphnia genome codifies SERT 
proteins structurally similar to human SERTs, constituting therefore putative 
targets for SSRIs. Nevertheless, the physiological effect of SSRIs in human and 
Daphnia appears to differ. In humans, SSRIs re-establish serotonin levels and 
ameliorate depression and other neuronal disorders (Wong et al., 1995). In D. 
magna, they change the perception of food availability, switching life-history 
responses at limiting food rations. Under these conditions females exposed to 
SSRIs produced more but smaller offspring and matured earlier than non- 
exposed ones. Unexpectedly, no detrimental side effects of SSRIs on D. magna 
females were observed in aerobic conditions, as they showed similar survival 
rates under starving conditions than unexposed individuals, despite of their 
greater oxygen consumption rates and less carbohydrate reserves. 
Nevertheless, under anoxia conditions SSRIs exposed organisms died earlier 
than unexposed ones. These results indicate that SSRIs could increase aerobic 
catabolism in exposed females making them more efficient using their energetic 
reserves, yet less able to sustain aerobic respiration over time. D. magna, like 
many other species, modulates its aerobic and anaerobic catabolism to 
maximize its survival across anoxia and other stressful environments (Paul et 
al., 1998; Zeis et al., 2009). If SSRIs increases neuronal activity and 
carbohydrate metabolism in D. magna they may also increase aerobic 
metabolism making exposed organisms energetically more efficient but at 
expenses of consuming more oxygen. 
Being less tolerant to low oxygen levels may be ecologically and evolutionary 
critical in zoo-planktonic species like Daphnia that in lakes have a diel vertical 
migration to avoid fish predation, eating in shallow waters at night and migrating 
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to deep waters that usually have less oxygen during daylight (Cousyn et al., 
2001). Nevertheless, further research with more neurological disrupters and 
doses should be performed to confirm the effects reported in this study.  
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Abstract 
The molecular mechanisms explaining hormetic effects of Selective 
Serotonin Reuptake Inhibitors (SSRIs) and 4-nonylphenol in Daphnia magna 
reproduction were studied in juveniles and adults. Transcriptome analyses 
showed changes in mRNA levels for 1,796 genes in juveniles and 1,214 genes 
in adults (out of 15,000 total probes) exposed to two SSRIs (fluoxetine and 
fluvoxamine) or to 4-nonylphenol. Functional annotation of affected genes was 
improved by assuming the annotations of putatively homologous Drosophila 
genes. Self-Organizing Map analysis and Partial Least Square Regression 
coupled with selectivity ratio procedures analyses allowed to define groups of 
genes with specific responses to the different treatments. Differentially 
expressed genes were analysed for functional enrichment using Gene Ontology 
(GO) and Kyoto Encyclopaedia of Genes and Genomes databases (KEGG). 
Serotonin metabolism, neuronal developmental processes, and carbohydrates 
and lipid metabolism functional categories appeared as selectively affected by 
SSRI treatment, whereas 4-nonylphenol de-regulated genes from the 
carbohydrate metabolism and the ecdysone regulatory pathway. These 
changes in functional and metabolic pathways are consistent with previously 
reported SSRI and 4-nonylphenol hormetic effects in D. magna, including a 
decrease in reserve carbohydrates and an increase in respiratory metabolism. 
 
KEYWORDS: Daphnia magna, microarrays, mechanism of action, 4-
nonylphenol, SSRIs, fluoxetine, fluvoxamine 
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4.1. Introduction 
 
There is increasing evidence that the presence of many emerging pollutants 
in aquatic ecosystems may have detrimental effects on aquatic biota (Daughton 
and Ternes, 1999). In the last decade substantial research has been conducted 
evaluating toxic effects of pharmaceuticals and other emerging pollutants 
across non-vertebrate species (Fent et al., 2006; Pal et al., 2010). Among 
emerging pollutants, those that may act as putative endocrine disruptors in 
invertebrate species, for example altering moulting and reproductive processes, 
are of special concern (Barata et al., 2004). The industrial detergent 
degradation product 4-nonylphenol and the pharmaceutical group of Selective 
Serotonin Reuptake Inhibitors (SSRIs) had hormetic consistent effects (i.e. 
increased) on offspring production and/or juvenile developmental rates in D. 
magna at low concentrations (i.e. 3-15µg/l), inhibiting those responses at higher 
concentrations (i.e. 100-125µg/l) (Baldwin et al., 1997; Campos et al., 2012b; 
Hansen et al., 2008). Surveys in US have reported levels of 12-540ng/L of 
fluoxetine in surface waters and effluents (Kolpin et al., 2002) but total 
concentrations of SSRIs in aquatic systems were measured in the range of 
840ng/L (Vasskog et al., 2008) to 3.2μg/L (Metcalfe et al., 2010). 4-Nonylphenol 
levels in surface waters as high as 8μg/L has been reported in surface waters 
(Navarro et al., 2009). Therefore the above mentioned hormetic effects 
occurred at environmental relevant concentrations.  
SSRIs switch life-history responses towards higher food levels at limiting food 
conditions: juveniles develop faster reach maturity earlier and females produce 
more offspring (Campos et al., 2012a). Such hormetic effects, however, have a 
fitness cost: females exposed to SSRIs have enhanced glycogen and aerobic 
metabolism, which translates into a lower tolerance to starvation at low oxygen 
levels, a common situation in the field (Campos et al., 2012a). Exposure of D. 
magna adult females to low concentrations of 4-nonylphenol increases 
reproduction and decreases offspring size (Campos et al., 2012b; LeBlanc et 
al., 2000). These effects are maladaptive in D. magna, since smaller offspring 
take longer to grow, reach smaller adult size and produce less eggs at maturity 
(Hammers-Wirtz and Ratte, 2000). 
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The mechanisms of action of SSRIs studying phenotypic responses of D. 
magna exposed to SSRIs were analysed by studying effects on levels of lipids, 
carbohydrate, proteins, oxygen consumption rates, survival, and offspring 
production after exposure to SSRIs alone or with a serotonin antagonist 
(Campos et al., 2012a). The results from this analysis show that SSRIs act in a 
similar way in D. magna than in humans by increasing serotoninergic activity, 
but in doing so they alter physiological processes such as increase glycogen 
and aerobic metabolism. At high doses 4-nonylphenol causes embryo arrest in 
D. magna, an effect that according to LeBlanc et al., (2000) may be related to 
altered metabolism of endogenous steroids (such as ecdysone), resulting in 
perturbations in their provision to the newly produced eggs. 
The above mentioned studies support the view that 4-nonylphenol and SSRIs 
increase offspring production through different mechanisms of action (Campos 
et al., 2012a; Campos et al., 2012b). SSRIs affect life-history responses of both, 
juveniles and adults, having important metabolic effects that in adults result in 
increased carbohydrate and aerobic metabolism. Sublethal effects of 4-
nonylphenol have only been observed in adults and probably are related to 
altered metabolism of endogenous steroids like ecdysone (LeBlanc et al., 
2000).  
The water flea Daphnia magna is possibly the invertebrate system most used 
in toxicology and experimental ecology and together with its close relative D. 
pulex is used as a model for environmental genomics research (Piña and 
Barata, 2011). D. pulex genome has been fully sequenced and about 50% of its 
genome is annotated (Colbourne et al., 2011), thus that of its close relative D. 
magna, despite of being incomplete, may benefit from the former. Nevertheless, 
gene annotation available for the D. pulex genome was insufficient to aid 
functional analysis, thus additional annotation for functional enrichment and 
identification of gene networks and metabolic pathways can be performed using 
available bioinformatic tools such as Blast, Gene Ontology (GO) and Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (Asselman et al., 2012; Garcia-
Reyero et al., 2009; Poynton et al., 2012; Vandenbrouck et al., 2010).  
The main objective of this work is the study of molecular mechanisms 
explaining the hormetic effects observed in our two previous studies (Campos 
et al., 2012a; Campos et al., 2012b). This was accomplished using 
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transcriptional stress responses of D. magna juveniles and adults exposed to 
sublethal doses of 4-nonylphenol and the SSRIs fluoxetine and fluvoxamine. 
We aimed to identify gene pathways that characterize observed physiological 
and phenotypic response to these contaminants. To this effect, we used a 
custom microarray that has been successfully used to assess mechanisms of 
action of different pollutants in D. magna (Garcia-Reyero et al., 2012). 
Differentially transcribed genes were related to effects observed on offspring 
production of females chronically exposed to these pollutants using Partial 
Least Square (PLS) regression coupled with selectivity ratio (SR) procedures. 
Existing information from D. pulex and Drosophila melanogaster genomes was 
used to improve the currently poor annotation of D. magna genes and to 
facilitate the functional analyses of the observed transcriptomic changes.  
 
4.2. Experimental Section 
 
4.2.1. Chemicals 
4-nonylphenol (CAS No 104-40-5, PESTANAL® analytical grade standard, 
98.4% purity, Riedel-de-Haen, Germany); fluoxetine hydrochloride (CAS-No 
56296-78-7; analytical standard, purity 100%) Sigma-Aldricht, USA), and 
fluvoxamine maleate (CAS-No 61718-82-9, analytical standard, purity 100%) 
were purchased from Sigma-Aldrich (USA/Netherlands). All other chemicals 
were analytical grade and were obtained from Merck (Germany). 
 
4.2.2. Analytical Chemistry  
Methods and measured concentrations of the studied chemicals in adult 
reproduction tests were reported elsewhere (Campos et al., 2012b) and in all 
cases were within 90% of nominal values indicating that 
degradation/adsorption/uptake to experimental vessels/animals were negligible. 
 
4.2.3. Experimental animals  
All experiments were performed using a well-characterized single clone of D. 
magna (Clone F), maintained indefinitely as pure parthenogenetic cultures 
(Barata and Baird, 2000). Individual or bulk cultures of 10 animals/L were 
maintained in ASTM hard synthetic water as described in (Barata and Baird, 
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1998). Individual or bulk cultures were fed daily with Chorella vulgaris Beijerinck 
(5x105 cells/mL, respectively, corresponding to 1.8µg C/mL). C. vulgaris was 
grown axenically in Jaworski/Euglena gracilis 1: 1 medium (CCAP, 1989). The 
culture medium was changed every day, and neonates were removed within 
24h. Photoperiod was set to 14h light: 10h dark cycle and temperature at 
20±1ºC. 
 
4.2.4. Experimental design  
Juveniles and adult females from two distinct assay-experiments were 
considered for transcriptomic studies. Assays with adult females were 
conducted in a previous study (Campos et al., 2012b) and are briefly described 
in experiment 2. Selected exposure levels of the studied compounds include 
those treatments that in a previous study (Campos et al., 2012b) affected most 
reproduction responses: for SSRIs, 7µg/L of FV and 40µg/L of FX; for 4-
nonylphenol 20 and 60µg/L.  
Experiment 1: 72 h exposures of juveniles to the SSRIs: FV (7µg/L), FX 
(40µg/L) and the industrial detergent 4-nonylphenol (20, 60µg/L). Groups of 
twenty juveniles (less than 24h old) were exposed to selected exposure levels 
in 0.5L of ASTM hard water with food present (5x105 cells/mL of C. vulgaris) 
during two consecutive moults (about 3 days at 20oC and high food levels) 
(Nogueira et al., 2004b). Longer exposure periods were not performed as 
juveniles enter the adolescent instar where ovaries start to develop (Ebert, 
1994). Contaminants were dosed using acetone as a carrier (0.1ml/L). A carrier 
control of 0.1ml/L was also used to serve as a baseline comparison of 
transcriptomic responses. Treatments were quadruplicated. At the end of 
exposure the 20 juveniles of each treatment per replicate were collected, pooled 
in an eppendorf vial, flash- frozen in liquid N2 and preserved at -80ºC until RNA 
extraction. 
Experiment 2: Adult reproduction tests were performed to determine the 
effects of the chemicals of interest on transcriptomic responses and 
reproduction rates on adult stages (Campos et al., 2012a).Ten gravid females 
were separately exposed to the same concentrations of 4-nonylphenol (20, 
60µg/L), fluvoxamine (7µg/L) and fluoxetine (40µg/L) as described in 
experiment 1 using a food ration of 5x105 cells/mL of C. vulgaris. Likewise in 
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experiment 1 all contaminants were dosed in the carrier acetone (0.1mL/L) and 
a solvent control treatment of acetone (0.1mL/L) was also included for baseline 
comparison of transcriptomic responses. Experiments started with 8-9 day old 
gravid females, which were exposed during three consecutive broods to the 
studied chemicals (10-14 days). Cultures of 100 to 150 individuals (<24h old 
neonates) were initiated and maintained in bulk cultures as described above. 
Within 24h of deposition of the first clutch into the brood chamber, single 
females were removed and randomly assigned to each treatment. The first 
batch of neonates (hatching within the first 48-72h) was always discarded and 
not evaluated, as these animals were not exposed to the tested chemicals 
during their entire developmental period. Thus, only neonates from the second, 
third and fourth broods were counted for assessing effects on total offspring 
production. Just after releasing their fourth clutch into the brood pouch, eggs 
were gently flushed from the brood pouch and females were immediately flash- 
frozen in liquid N2 and preserved at -80ºC until RNA extraction. This protocol, 
by using only de-brooded females excludes the contribution of developing 
embryos on transcriptomic responses. Furthermore, the use of de-brooded 
adults in the first hours of their intermolt instar ensured measurement of 
transcriptomic responses of all the studied females at the beginning of the 
intermolt cycle, thus minimizing undesirable variation of gene transcription 
patters within females across the molt cycle (Piña and Barata, 2011).  
 
4.2.5. RNA extraction  
Total RNA was isolated from the samples using Trizol reagent® (Invitrogen, 
Carlsbad, USA) following the manufacturer’s protocol and quantified in a 
NanoDrop D-1000 Spectrophotometer (NanoDrop Technologies, Delaware, 
DE). RNA quality was checked in an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara CA). The samples that did not show degradation 
were used for microarray analysis.  
 
4.2.6. Microarrays  
Custom D. magna 15,000 probe microarrays (GLP13761) were purchased 
from Agilent (Palo Alto, CA, USA). A total of four replicates per treatment were 
used for both juveniles and adult exposures. One µg of total RNA was used for 
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all hybridizations, and cDNA synthesis, cRNA labelling, amplification, and 
hybridizations were performed following the manufacture’s kits and protocols 
(Quick Amp labelling kit; Agilent, Palo Alto, CA). The Agilent one-color 
Microarray Based Gene Expression Analysis v6.5 was used for microarray 
hybridizations according to the manufacturer’s recommendations. An Agilent 
high-resolution C microarray scanner was used to scan microarray images. 
Data were resolved from microarray images using Agilent Feature Extraction 
software v10.7. Raw microarray data from this study have been deposited at the 
Gene Expression Omnibus Web site (www.ncbi.nlm.nih.gov/geo/) with 
accession number GSE45053. 
 
 
  Primer sequence   
Genes forward Reverse Amplic
G3PDH  GACCATTACGCTGCTGAATACG CCTTTGCTGACGCCGATAGG 100
Acon AACTAACAACGGCACTGGCAC CTTCTCCGTTAGCGCCTTTG 81
Ddc AATGATTCCTGAAGCCGCC CCAGGCATAATGACGCGTT 81
Idh CTGTTTTCCGCGAACCTATCC GACGACCAATGACAATGGGC 81
ATPCL AACTTTGCGGCACATGAGCT CTTGTGCCGATGCCGAAC 81
Thiolase AGGCACACGCAATGTTTCC TTTGGCCGTGCTAACGATG 81
faa ACTGGAACCCCACCTGGAGT AACTTCGCATTCCACCACGT 81
 
4.2.7. Validation of Microarray results by qRT-PCR 
Microarray results were validated with real-time quantitative polymerase 
chain reaction (qPCR). We selected six significantly regulated genes from 
different pathways/gene families: lipids metabolism (thiolase), Krebs cycle 
(aconitase-acon, isocytrate dehydrogenase-idh, ATP citrate lyase-ATPCL), 
tryptophan metabolism (dopamine decarboxylase-Ddc) and nucleotide 
metabolism (fumarilacetoacetase-Faa). The gene G3PDH (glyceraldehyde 3-
phosphate dehydrogenase) was used as internal control. For each of these 
genes primers were designed with Primer Quest (IDT Technologies, Coralville, 
IA) and are listed in Table 4.1. Quantities of 1μg were retrotranscribed to cDNA 
using First Strand cDNA Synthesis Kit Roche® (Germany) and stored at -20ºC. 
Aliquotes of 10ng were used to quantify specific transcripts in Lightcycler® 480 
Real Time PCR System (Roche, Germany) using Lightcycler 480 SYBR Green I 
Master® (Roche, Germany). Relative abundance values of all genes were 
calculated from the second derivative of their respective amplification curve, Cp 
Table 4.1. Primer pairs designed from existing sequences used for amplification of selected 
Daphnia magna partial gene sequences.  
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values calculated by technical triplicates. Cp values of target genes were 
compared to the corresponding reference gene (Pfaffl, 2001). 
 
4.2.8. Gene Expression analysis  
Microarray data were analysed using GeneSpring GX v4.0 software (Agilent). 
Data were normalized using quantile normalization and baseline transformation 
to the median of all samples. Differentially transcribed genes of D. magna 
individuals exposed to 4-nonylphenol and SSRIs from that of carrier controls 
(hereafter named as controls) were analysed using one way ANOVA followed 
by Dunnett’s pos-hoc comparison tests and filtered based on expression levels 
(p<0.05; cut-off 1.5 fold change). A list of differentially transcribed genes with 
annotation for all the treatments can be found in Table 4.2 available at 
http://pubs.acs.org/doi/suppl/10.1021/es4012299 and included in 
supplementary electronic material). 
Transcriptomic patterns of differentially expressed genes of juveniles and 
adults were analysed using the Multi-Experiment viewer MeV4 software (Saeed 
et al., 2003), both by hierarchical clustering (sites) and Self Organizing Map 
(SOM) analysis (features), and the standard normalization protocol. 
Furthermore, the assays performed with single adult females (experiment 2), 
allowed to establish possible correlations between individual transcriptomic 
profiles and the observed effects of both SSRIs and 4-nonylphenol treatments 
on D. magna reproduction responses, and hence the identification of putative 
gene regulatory pathways affecting these reproduction responses. Partial Least 
Squares Regression (PLS) was used to investigate the correlations between 
transcriptome data (X-variables) and total offspring production (y variable) 
under both SSRIs and 4-nonylphenol treatments. Since both treatments 
affected fecundity similarly (increased offspring production) but likely through 
different molecular mechanisms, SSRIs and 4-nonylphenol treatments were 
analysed separately by PLS-SR. Genes contributing more to the prediction of 
the reproduction responses by the proposed PLS model were selected using 
the selectivity ratio (SR) (Rajalahti et al., 2009). This variable selection method 
minimizes the effect of uncorrelated X variance sources. Those genes (X-
variables) with SR values higher than the mean were considered to be the most 
relevant for explaining the Y responses related to treatments. Prior to data 
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analysis, X and Y variables were mean-centred to correct for their offset. The 
number of PLS-SR components was finally set at two, according to cross 
validation by the leaving-one-out prediction errors’ criteria (Wold et al., 2001). 
PLS-SR analyses were performed using the PLS Toolbox version 6.5, 
Eigenvector Research Inc. (Manson, WA) running under Matlab 7.4 computer 
environment, (MathWorks, Natick, Massachusetts)  
Genes included in the clusters identified by SOM and PLS-SR analyses were 
annotated using the recent update of the custom microarray, which incorporates 
D. pulex sequence annotations available at the Fleabase (Garcia-Reyero et al., 
2012). Further annotation was performed by identifying putative homologous 
Drosophila melanogaster genes using BLAST at Flybase server 
(http://flybase.org/blast/). Annotated genes were ascribed to functional Gene 
Ontology (GO terms) and to metabolic pathways using the AmiGO! Term 
Enrichment tool (http://www.geneontology.org/) and the Kyoto Encyclopaedia of 
Genes and Genomes (KEGG, http://www.genome.jp/kegg/kegg2.html) 
databases, respectively.  
 
4.3. Results 
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Figure 4.1. Total offspring production (Mean±SE, N=4) of the four selected females 
exposed to the studied SSRIs and 4-nonylphenol treatments. C, FV10, FX40, N20, N60 
are solvent control, fluvoxamine at 7µg/L, fluoxetine at 40µg/L, 4-nonylphenol at 20µg/L 
and 60µg/L, respectively. Asterisks indicate significant differences from solvent controls 
following ANOVA and Dunnett’s comparison tests 
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4.3.1. Phenotypic responses 
There was no mortality during juvenile exposures. Selected females for 
transcriptomic analyses produced significantly (P<0.01; F4,15=5.02) more 
offspring than controls in all treatments (Figure 4.1).  
 
4.3.2. Transcriptome analysis 
Transcriptome responses of juveniles and adults of experiments 1 and 2 
were analysed separately. A total of 1,796 and 1,214 genes were identified as 
differentially transcribed in at least one of the chemical treatments, in juveniles 
and adults, respectively. From the above-mentioned genes, only 221 were 
annotated (Table 4.2 available at 
http://pubs.acs.org/doi/suppl/10.1021/es4012299 and included in 
supplementary electronic material). 
Hierarchical clustering separated most biological replicates of SRRIs, 4-
nonylphenol and control treatments on both the juvenile and adult 
transcriptomic data set (Figure 4.2A and B). The SOM analysis performed on 
the differentially transcribed genes in juveniles and adults revealed six clusters 
of significantly de-regulated genes (Fig 4.3). For juveniles cluster 1 include 151 
significantly (P<0.01) up-regulated genes by both SRRI compounds (FX and 
FV). Clusters 2 and 3 included 210 and 456 FV down-regulated (P<0.01) 
unique genes, respectively. For adults, cluster 4 included 32 genes significantly 
(P<0.01) down-regulated by both SSRIs (FV and FX treatments), cluster 5 
included 86 genes significantly (P<0.01) down-regulated by 4-nonylphenol 
treatments (20, 60µg/L), whereas cluster 6 included 19 genes up-regulated by 
4-nonylphenol treatments (Fig 4.3). SOM graphs together with the de-regulated 
genes for each cluster are depicted in Figure 4.3 and Table 4.3. (Table 4.3 is 
available at http://pubs.acs.org/doi/suppl/10.1021/es4012299 and provided as 
supplementary electronic material).  
PLS analyses were performed separately for the different treatments 
considered (control and SSRIs) and (control and 4-nonylphenol treatments).  
In each data set the 1,214 de-regulated gene fragments were selected as 
predictors (X matrix of predictor variables) and the total offspring production of 
the exposed females was used as predicted variable (Y vector of predicted 
variables). The two components introduced in the PLS analysis explained 
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Figure 4.2. Heat map and hierarchical clustering (Pearson correlation) base on log2 ratios of 
the differentially transcribed genes in Daphnia magna adults (A) and juveniles (B) across the 
experimental replicates for the SSRIs (FV, FX) and nonylphenol (N20, N60) treatments. The 
for replicates are identify as A,B,C,D. Gene transcripts in red and green are up and down 
regulated and those in black unchanged. Colour scale spans from -2.5 to 2.5.  
A B 
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around 80% of the total Y variance (r2= 0.79) for the prediction of total offspring 
production of females treated either with SSRIs (Figure 4.4A) or with 4-
nonylphenol (Figure 4.4B). Following the established SR cut-off criteria, PLS 
analysis identified 272 and 331 genes differentially affected by SSRIs and 4-
nonylphenol, respectively (Figure 4.4). These predictor genes formed two 
differentiated groups: one in close proximity with SSRIs or 4-nonylphenol Y-
treatment including genes that co-varied positively with both treatments, and a 
second one close to control treatments and including genes inversely correlated 
with the two studied treatments. The final set of annotated genes differentially 
affected by SSRIs and 4-nonylphenol treatments (35 and 31 genes, 
respectively) are identified by numbers in Figure 4.4. Correlation plots between 
the log2 of fold change ratios of the selected annotated and non-annotated 
genes with the total offspring production are given in Table 4.4. 
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Figure 4.3. Self-Organizing Maps (SOM) of gene transcription responses of juveniles 
and adults across the experimental replicates for SSRIs (fluvoxamine, FV; fluoxetine, FX) 
and 4-nonylphenol (N20, N60) treatments. Results are depicted as Mean ± SD of log2-
ratios. Number of de-regulated genes are depicted between parenthesis. 
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SSRI's   4 nonylphenol   
Name Cod Correlation   Name Cod Correlation   
mt:ND1 35 -0.79 ** Got1 25 -0.82 ** 
Tom7 53 -0.76 ** cdc16 8 -0.76 ** 
Rfabg 40 -0.75 ** Acon 1 -0.76 ** 
CG7718 15 -0.7 * CG16986 10 -0.76 ** 
Spn2 46 -0.7 * Cht6 17 -0.76 ** 
cher 16 -0.7 * UGP 56 -0.72 ** 
san 43 -0.69 * CG33123 12 -0.71 ** 
Aph-4 4 -0.67 * CG3368 13 -0.7 * 
EndoA 19 -0.67 * Sr-CI 48 -0.69 * 
Papss 38 -0.64 * Oda 37 -0.69 * 
tok 52 -0.62 * AnnIX 3 -0.68 * 
GlyP 24 -0.59 * mRpS9 32 -0.67 * 
spen 45 -0.54 mt:ND1 34 -0.67 * 
jdp 28 -0.54 Btk29A 6 -0.67 * 
MstProx 33 -0.54 Papss 38 -0.63 * 
spok 47 -0.52 CG42337 14 -0.63 * 
Sr-CI 48 -0.51 Rfabg 40 -0.59 * 
Act57B 2 -0.51 san 43 -0.59 * 
Eps-15 20 -0.5 fbp 21 0.58 * 
Arf12F 5 -0.47 KdelR 29 0.58 * 
sns 44 -0.45 CG18155 11 0.66 * 
dy 18 0.49 Rab11 39 0.69 * 
ninaG 36 0.49 Sac1 42 0.7 * 
Try29F 55 0.55 RhoGAP1A 41 0.72 ** 
CadN 7 0.6 * flr 22 0.74 ** 
Sac1 42 0.62 * Hil 26 0.75 ** 
Tpc2 54 0.64 * βTub56D 59 0.76 ** 
yin 58 0.66 * Vha55 57 0.77 ** 
Gasp 23 0.67 * cenG1A 9 0.81 ** 
Mcm5 31 0.67 * Try29F 55 0.81 ** 
βTub56D 59 0.69 * Tg 50 0.84 ** 
128up-PA 60 0.71 * 
Rab11 39 0.76 ** 
Kr-h1 30 0.77 ** 
Idh 27 0.84 ** 
Table 4.4. Annotated and non-annotated genes selected in the PLS-SR analyses performed for 
SSRIs and 4-nonylphenol data. For annotated genes their name and associated cod number 
assigned in Fig 4.4 are reported. Only the probe name of non-annotated genes having significant 
(p<0.05) correlation coefficients of their relative expression with total offspring are depicted. * 
0.05<P<0.01; ** P<0.01, N=12.Full table in annex file. 
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Figure 4.4. PLS-SR summary of results for the two different sample treatments 
(Figure 1A, SSRIs; Figure 1B, 4-nonylphenol) using differential expressed genes as 
predictors (X) and total offspring production as response (Y). First and second PLS bi-
plots showing selected gene loadings (triangles) and offspring production scores 
(sample identification letters). Only genes with a selectivity ratio above the mean were 
considered. Annotated genes are indicated by numbers described in the Table 4.4. 
The four replicates are identified as A,B,C,D. 
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Results from RT-qPCR confirmed the fold change ratios of mRNA levels 
observed with the microarray, both in magnitude and direction, for the six 
selected genes (Figure 4.5) with a Pearson correlation coefficient of 0.83 
(P<0.01, N=33). 
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Figure 4.5. Confirmation of the array results with qPCR. Array and RT-qPCR results are 
represented as gene fold change ratios. Errors bars are standard errors of mean (SE, N=4).
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GO analyses were performed on annotated genes from SOM and PLS-SR 
clusters (Table 4.5, further details of GO terms and the name of involved genes 
are depicted in Table 4.6 that is available at 
http://pubs.acs.org/doi/suppl/10.1021/es4012299 and provided as 
supplementary electronic material). Juveniles appeared as selectively more 
affected by SSRIs treatments than adults, showing the highest amount of 
annotated genes grouped into GO term (P<0.05; 151 genes in total, Table 4.5).  
Adult SOM and PLS-SR clusters affected by SSRIs included 40 genes that 
could be adscribed to specific GO term (Table 4.5). 4-Nonylphenol only affected 
adult SOM and PLS-SR clusters, which included 38 genes with a specific GO 
term assignation (Table 4.5). The GO terms with the highest number of de-
regulated genes were related to three parental GO categories: developmental 
processes, structural constituents and binding (Table 4.5). Developmental 
processes were only affected by SSRIs. Other processes only affected by 
SSRIs were synaptic vesicle transport, localization and response to stimuli. 
Structural constituents, binding and catalytic activity related GO categories were 
shared by both SSRIs and 4-nonylphenol treatments although most of the de- 
regulated genes and sub-GO categories belonged to SSRIs treatments. The 
only unique GO category affected by 4-nonylphenol was lipid binding. 
Metabolic pathway analyses of de-regulated genes (>1.5 fold) in adult 
females exposed chronically to SSRIs and 4-nonylphenol indicated that 20 of 
these genes regulated metabolic pathways (Figure 4.6). More specifically, 
SRRIs and 4-nonylphenol de-regulated 12 and 7 genes from metabolism of 
carbohydrates and lipids and Krebs cycle, respectively. Further details of KEGG 
analyses are in Table 4.7.  
 
  
 
 
Table 4.5.  GO terms for the obtained six SOM and two PLS gene clusters for SSRI’s and 4-nonylphenol (N) treatments. SOM clusters of juveniles (JUV 1, 2, 
3) and of adults (ADT 4,5,6) and PLS ones for SSRIs and 4-nonylphenol are depicted in Fig 4.3, Fig 4.4. *0.05<P<0.01; **0.01<P<0.001; *** P<0.001. Further 
information of GO terms and annotated genes belonging to each group are in Table 4.6). Arrows indicate the direction of de-regulation.
 SOM -SSRI's  SOM - N  PLS 
  JUV1↑ JUV2↓ JUV3↓ ADT 4↓  ADT5↓ ADT6↑   SSRI↕ N↕ 
Total genes in group 27 42 82 7  6 4  33 28 
BIOLOGICAL PROCESSES                    
Developmental process                   
GO:0048856 anatomical structure development     12** 4**            
GO:0048513 organ development     39***          12***   
GO:0009888 tissue development   17*** 32***          7*   
Nervous system development                    
GO:0007399 nervous system development   11* 22***          10*   
GO:0048666 neuron development     12**          8**   
GO:0007411 axon guidance   10* 21***          5*   
Sensory organ development                    
GO:0001654 eye development                6*   
GO:0001751 compound eye photoreceptor cell differentiation     6*              
Morphogenesis                    
GO:0009653 anatomical structure morphogenesis     22***          11*   
GO:0046664 dorsal closure, amnioserosa morphology change                  2* 
synaptic vesicle transport                    
GO:0048488 synaptic vesicle endocytosis   2*            3*   
GO:0031629 synaptic vesicle fusion to presynaptic membrane     10***              
Structural constituints                    
GO:0003735 structural constituent of ribosome 17** 29*** 49***       4***      
GO:0005214 structural constituent of chitin-based cuticle             2*      
Localization                    
GO:0051179 localization     23***          15***   
Response to stimulus                    
GO:0040011 locomotion                8**   
GO:0006935 chemotaxis                6***   
MOLECULAR FUNCTIONS                    
GO:0003824 catalytic activity   21*** 47***            16*** 
GO:0005488 binding   15*** 20***          21*** 17** 
GO:0000166 nucleotide binding   24*** 56***     6*        
GO:0001882 nucleoside binding   12*** 20***              
GO:0008289 lipid binding                  6*** 
Chapter 4 
166 
 
 
 
 
Figure 4.6. KEGG diagram of metabolic pathways with the genes up and down regulated across 
SSRIs (in bold) and 4-nonylphenol (in grey) treatments in adult females. Arrows indicated de-
regulation direction relative to control treatments. Further details of genes are in Table 4.7. 
  
 
 
 
 
Fold change ratios 
Gene Name Probe FV7 FX40 N20 N60 
Acon Aconitase (EC:4.2.1.3) DM01751P1 1.19 up 2.13 up 1.55 up 1.37 up 
ATPCL ATP citrate lyase (EC:2.3.3.8 6.2.1.5) DM02886P2 1.4 down 2.71 down 2.09 down 1.56 down 
CDase Ceramidase (EC:3.5.1.23) DM01115P2 1.34 up 2.33 up 1.65 up 1.78 up 
GlcT-1 CG6437 gene product from transcript CG6437-RA (EC:2.4.1.80) DM00695P3 1.5 up 2.15 up 2.05 up 1.48 up 
Got1 Glutamate oxaloacetate transaminase 1 (EC:2.6.1.1) DM02714P3 1.76 down 2.16 down 2.47 down 1.95 down 
Papss PAPS synthetase (EC:2.7.1.25 2.7.7.4) DM00609P1 1.21 up 1.7 up 1.32 up 1.22 up 
UGP CG4347 gene product from transcript CG4347-RE (EC:2.7.7.9) DM02451P3 1.49 down 1.9 down 2.09 down 1.87 down 
Vha55 Vacuolar H[+]-ATPase 55kD B subunit (EC:3.6.3.14 3.6.3.6) DM01785P2 1.54 up 3.11 up 3.19 up 3.53 up 
awd abnormal wing discs (EC:2.7.4.6) DM02782P4 1.42 down 2.26 down 2 down 1.61 down 
fbp fructose-1,6-bisphosphatase (EC:3.1.3.11) DM01662P1 1.34 up 1.83 up 1.63 up 1.95 up 
GlyP Glycogen phosphorylase (EC:2.4.1.1) DM00386P3 3.22 down 1.8 down 1.93 down 1.74 down 
r rudimentary (EC:2.1.3.2 3.5.2.3 6.3.4.16 6.3.5.5) DM01003P2 1.13 down 1.9 down 2.22 down 1.68 down 
Aph-4 Alkaline phosphatase 4 (EC:3.1.3.1) DM02798P2 4.21 down 1.71 down 2.16 down 1.35 down 
Ddc Dopa decarboxylase (EC:4.1.1.28) DM02360P4 1.07 up 1.61 up 1.19 up 1.48 down 
Gdh Glutamate dehydrogenase (EC:1.4.1.2 1.4.1.3) DM04415P1 2.03 down 1.1 up 1.05 down 1.24 down 
Idh Isocitrate dehydrogenase (EC:1.1.1.42) DM01625P3 2.28 up 2.26 up 1.14 up 1.19 up 
Pfk Phosphofructokinase (EC:2.7.1.11) DM02942P2 1.18 up 2.31 down 1.36 down 1.07 up 
Thiolase CG4581 gene product from transcript CG4581-RA (EC:1.1.1.211 2.3.1.16) DM01778P1 1.55 up 2.49 up 1.07 up 1.29 up 
lace CG4162 gene product from transcript CG4162-RA (EC:2.3.1.50 2.6.-.-) DM02843P3 2.18 up 2.05 up 1.47 up 1.24 up 
 
Table 4.6. Genes with their mean fold change ratios that were included in the metabolic KEGG paths of Fig 4.6. FV7, FX40, N20 and N60 are fluvoxamine, 
fluoxetine and 4-nonylphenol at 7, 40, 20 and 60µg/L, respectively.  
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4.4. Discussion 
 
In this study we tested the hypothesis that low concentrations of SSRIs and 
4-nonylphenol affected offspring production and/or juvenile developmental rates 
though different mechanisms of action. Our hypothesis was tested by combining 
two developmental stages, juveniles and adults, exposed during two (3 days) 
and three (10 days) consecutive instars, respectively. Although in absolute 
terms juvenile exposures were much shorter than that of adults, both schemes 
included physiological equivalent periods (i.e. include 2-3 instars) (Nogueira et 
al., 2004a). Previous results also indicate that sublethal effects on juvenile 
developmental rates of SSRIs occurred at similar concentrations than those of 
adults (Campos et al., 2012a). Therefore, we consider that juvenile and adult 
stages were chronically exposed to equivalent concentrations and periods in 
our experiments.  
Hierarchical clustering clearly grouped replicated samples of SSRIs, 4-
nonylphenol and control by treatment in both juvenile and adult exposures, 
providing the first evidence that these contaminant families induced specific and 
unique transcriptional patterns. The number of de-regulated genes and 
significant GO terms obtained for juveniles exposed to all three chemicals was 
higher than that of adults, which supports the hypothesis that short term 
exposures may be more suited to assess differentially altered transcriptomic 
responses. This was particularly evident for the SOM clusters obtained for 
adults that only involved 17 annotated genes whereas those of juveniles 
included 151 ones (Table 4.5). Alternatively, the number of de-regulated genes 
could be a direct consequence of previously reported phenotypic effects. 
Previous work indicated that at the studied exposure levels FV affected juvenile 
developmental rates whereas FX and 4-nonylphenol did not (Campos et al., 
2012b). This is consistent with the apparent stronger effect of FV on the 
juveniles’ transcriptome, both in terms of number of de-regulated genes and of 
the number of significantly enriched GO terms (Fig 4.2A and B). Reproduction 
was similarly affected by the three chemicals at all exposure levels, and so was 
the number of annotated genes and enriched GO terms defined by both SOM 
and PLS-SR analyses (7,10 genes in SOM clusters for SSRIs and 4-
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nonylphenol, respectively; 35 and 32 genes selected by PLS-SR for SSRIs and 
4-nonylphenol, respectively; Table 4.5).  
Relating molecular responses to phenotypic effects is crucial in 
environmental risk assessment. A promising approach is the adverse outcome 
pathway (AOP) framework, which is a conceptual construct that portrays 
existing knowledge concerning the linkage between a direct molecular initiating 
event and an adverse outcome at a biological level of organization relevant to 
risk assessment (Ankley et al., 2010). The application of AOP has been 
restricted to model organisms (i.e. few fish species) (Ankley et al., 2009; 
Tanneberger et al., 2013; Yozzo et al., 2013). In a previous study (Campos et 
al., 2012b) we showed that 4-nonylphenol increased offspring production but 
decreased at the same time offspring size. According to several studies being 
smaller at birth bears a fitness disadvantage since smaller neonates are more 
sensitive to environmental stress, and have lower fitness than bigger ones 
(Barata et al., 2001; Hammers-Wirtz and Ratte, 2000). SSRIs also increased 
offspring production with apparently no effects on offspring size but such effects 
were related with increasing oxygen demand and being less tolerant to low 
oxygen levels (Campos et al., 2012a).Thus in the two studied chemical groups 
(4-nonylphenol and SSRIs), adverse effects were directly or indirectly 
associated with increasing reproduction at the selected exposure levels. In the 
present study the combination of further annotation establishing gene 
homologies with known genomes like D. melanogaster improved the functional 
enrichment of de-regulated D. magna gene sequences and hence it was 
possible to obtain reliable gene pathways using GO and KEGG. Furthermore, 
the use of multivariate methods like PLS and SR to identify de-regulated genes 
related with observed phenotypic effects in chronic exposures performed with 
adult females identified 111 annotated genes related to effects observed in 
reproduction. More standard clustering methods like SOM only allowed to 
identify 17 de-regulated genes in adult females. PLS methods are already being 
used to relate gene transcription patterns with toxicological effects (Dom et al., 
2012). The combination of PLS with SR, however, offers the possibility to select 
de-regulated genes highly correlated with phenotypic responses (see Table 
4.4).Juvenile SOM clusters included several differentially expressed genes 
involved in developmental processes after SSRIs exposure, which can be linked 
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to the reported increased juvenile developmental rates (Campos et al., 2012b). 
The SSRIs exposures also de-regulated ribosomal structural constituents, 
which could be linked to protein biosynthesis or cell proliferation. (Dom et al., 
2012) reported the up-regulation of ribosomal constituents related genes in D. 
magna exposed to polar narcotics as intent to overcome toxicant stress and /or 
to restore the damage elicited by exposure to those narcotics. Neuronal 
pathways, including synaptic vesicle transport, establishment and maintenance 
of localization, and response to stimuli were GO functional terms down-
regulated in both juvenile and adults. The down regulation of neuronal pathways 
may be associated to an adaptive gene response to the presence of neuronal 
active compounds, as a similar response has been observed for the neurotoxic 
insecticide methomyl (Pereira et al., 2010).  
Three genes involved in the ecdysone regulatory pathway that controls 
morphogenesis and integrin expression during Drosophila metamorphosis 
(D'Avino and Thummel, 2000) appeared specifically down-regulated by 4-
nonylphenol treatment: papss (3'-phosphoadenosine 5'-phosphosulfate 
synthetase), got1 (Glutamate oxaloacetate transaminase), and btk29A (Bruton's 
tyrosine kinase). This is consistent with the hypothesis that 4-nonylphenol can 
affect D. magna by disrupting ecdysone metabolism (LeBlanc et al., 2000). 
However, the number of affected genes related to this pathway was too low to 
be considered significantly enriched by the AmiGO! algorithm. Further research 
on ecdysone metabolism-related genes in Daphnia is thus required to prove or 
refute this hypothesis. 
Common pathways de-regulated by both, SSRIs and 4-nonylphenol, involved 
enzymes that regulate morphogenesis and tissue differentiation probably 
involved in molting and reproduction, which are essential processes for growth 
and energy supply (e.g. cuticle formation, ribosomes, catabolism, transport and 
binding of essential macromolecules). Similar de-regulated pathways were 
found to be altered in D. magna individuals exposed to narcotic chemicals, 
pesticides, ammunitions constituents, silver nanoparticles, metals and 
temperature changes (De Schamphelaere et al., 2008; Dom et al., 2012; 
Garcia-Reyero et al., 2012; Pereira et al., 2010; Vandenbrouck et al., 2011) 
(Garcia-Reyero et al., 2009; Poynton et al., 2012; Poynton et al., 2007; Poynton 
et al., 2008; Soetaert et al., 2006; Soetaert et al., 2007). The simplest 
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explanation to this finding of similar responses to disparate substances is that 
these pathways are related to general stress responses and not to the observed 
specific hormetic responses on juvenile developmental rates and female 
reproduction.  
De-regulated metabolic pathways in D. magna adults chronically exposed to 
the studied chemicals were further analysed using KEGG to identify altered 
metabolic pathways linked to reported effects on energy and carbohydrate 
metabolism. Both SSRIs and 4-nonylphenol de-regulated similarly key genes 
such as glyp (glycogen phosphorylase) and ugp (UTP:glucose-1-phosphate), 
both involved in starch and sucrose metabolism, mainly in the transformation of 
glycogen to glucose (Heckmann et al., 2008). Although both chemical families 
up-regulated fbp (fructose-1,6-bisphosphatase), only SSRIs down-regulated pfk 
(phospho-fructo kinase), which is involved in control of glucose homeostasis by 
allowing to switch from glycolysis to gluconeogenesis (Rider et al., 2004) and is 
a key gene in the regulation from aerobic to anaerobic metabolism. In a 
previous study we found that exposure to SSRIs decreases carbohydrate levels 
in adult D. magna females (Campos et al., 2012a) , thus down-regulation of pfk 
may be an adaptive response to maintain minimum levels of glucose and may 
be linked to reported effects of SSRIs on oxygen consumption rates (Campos et 
al., 2012a). There are also evidences that serotonin, whose regulation is the 
pharmacological target of SSRIs, may be involved in the regulation of pfk. In 
human cells, serotonin increases pfk by binding to the 5-HT(2A) receptor, 
causing the tyrosine residue of pfk to be phosphorylated via phospholipase C. 
Because pfk regulates glycolytic flux, serotonin plays a regulatory role in 
glycolysis (Coelho et al., 2012).  
SSRIs and 4-nonylphenol treatments de-regulated acon (aconitase) and 
ATPCl (ATP citrate lyase), respectively. Additionally, SSRIs specifically up-
regulated idh (isocitrate dehydrogenase). Thus SSRIs and 4-nonylphenol de-
regulated genes involved in 6 and 4 out of 10 reactions of the Krebs cycle, 
respectively. These effects could potentially affect oxygen consumption rates 
and the consumption of carbohydrates to produce energy. SSRIs indeed 
increased oxygen consumption rates and decreased levels of carbohydrates in 
D. magna (Campos et al., 2012a). 4-nonylphenol is known to increase mRNA 
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levels of D. magna haemoglobin (Ha and Choi, 2009), which may indicate also 
increasing rates of oxygen consumption.  
The beta-oxidation pathway was affected exclusively by SSRIs up-regulating 
thiolase, which is a key control gene of lipids metabolism and biosynthesis (Liu 
et al., 2008). 4-nonylphenol and SSRIs up-regulated 2 and 3 genes, 
respectively, from the sphingolipid biogenesis pathway (cDASE, Glct-1, lace) 
that are involved in the biogenesis of ceramide, glycosphingolipids and 
sphingosines. Recently, sphingolipid metabolites, such as ceramide and 
sphingosine-1-phosphate, have been shown to be important mediators in the 
signalling cascades involved in apoptosis, proliferation, stress responses, 
necrosis, inflammation, autophagy, senescence, and differentiation (Hannun 
and Obeid, 2002) . 
SSRIs up-regulated specifically dopa-decarboxylase (Ddc) that catalyses the 
conversion of 5-hydroxytryptophan to serotonin in response to several 
endogenous or exogenous signals, and has already been shown to be involved 
in insect cuticle maturation, neuronal regulation, pigmentation patterning and 
innate immunity (Hodgetts and O'Keefe, 2006). Up-regulation of Ddc in rats 
exposed to SSRIs has been suggested as a response to the blocking of the re-
uptake mechanisms, which leads to low levels of serotonin inside the terminal 
neuron axon (Choi et al., 2012). 
The expression pattern of key genes from significantly enriched pathways 
such as lipids metabolism (thiolase), Krebs cycle (Acon, idh and ATPCL), 
tryptophan metabolism (Ddc) and nucleotide metabolism (Faa) was validated by 
qPCR, confirming the microarray results. 
In summary SSRIs and 4-nonylphenol de-regulated different gene pathways 
in D. magna that in most cases could be related to reported phenotypic effects. 
SSRIs de-regulated more genes than 4-nonylphenol specially in juvenile stages, 
which support the hypothesis that these compounds act as neuronal disruptors 
in Daphnia (Campos et al., 2012a). SSRIs specifically de-regulated one of their 
targeted pathways, serotonin metabolism, and key genes from the carbohydrate 
and Krebs cycle metabolism. 4-nonylphenol specifically targeted genes related 
to ecdysone, carbohydrate and Krebs cycle in adults. Taken together, the 
observed changes in the energy-related pathways are consistent with a 
decrease on reserve carbohydrates and an increase on respiratory metabolism, 
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in line with our previous observations on the effects of SSRIs in D. magna 
(Campos et al., 2012a).  
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Abstract 
The extent to which different forms of nanoparticles of titanium dioxide (nano-
TiO2) aggregated with microalgae, decreased food levels and hence impaired 
growth, reproduction and fitness of Daphnia magna individuals were studied. 
Treatments included three different types of nano-TiO2 differing in their coating 
or crystalline structure but of similar primary size (20nm) plus a micron-sized 
bulk material, two exposure levels (1, 10mg/L) and two food ration levels of the 
microalgae Chlorella vulgaris that included a non limiting (1.5µg C/mL) and a 
limiting one (0.3µg C/mL). Effects were assessed using standardized chronic 
tests and assays that maximized food depletion in the water column under 
semi-static and resuspension conditions. Results indicated that the high ion 
levels in culture medium lead to the aggregation of nanoparticles followed by 
particle destabilization. Nanoparticle aggregates interacted with the algae cells, 
forming clusters. Large TiO2-algae agglomerates settled readily dramatically 
depleting the concentration of available food for D. magna. At limiting food 
rations food depletion by nanoparticle aggregation had dramatic effects on 
reproduction and fitness of exposed D. magna at 1mg/L irrespectively of the 
particle form. At high food rations, effects were only observed for one of the 
nano-TiO2, P-25, at high exposure levels (10mg/L) under both semi-static and 
particle re-suspension conditions, which suggest that P-25 effects were 
mediated by clogging the gut and hence diminishing food acquisition. These 
results indicate that nano-TiO2 may affect the transfer of energy throughout the 
planktonic aquatic food webs increasing the settlement of edible particles from 
the water column.  
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5.1. Introduction 
 
The study of the ecotoxicity of manufactured nanomaterials (NM) to aquatic 
organisms has a relative recent history when compared with that of other toxic 
substances (Baun et al., 2008a). Several reviews claim that new toxicity 
procedures should be used to evaluate NM toxicity due to their unique 
characteristics of size being below 100nm and their inherent toxicity (Baun et 
al., 2008a; Handy et al., 2012a; Handy et al., 2008a; Handy et al., 2008b). At 
present, most studies have been focused in determining the bio-availability of 
NM to aquatic organisms and their direct toxicity to cells, aquatic invertebrates 
and fish (Baun et al., 2008a). Fewer ones, however, have addressed indirect 
effects that NM may have in aquatic biota such as in water column invertebrates 
due to their aggregation properties in aqueous solutions (Li et al., 2011), that 
can lead to interactions with microscopic (phytoplankton, zooplankton) food 
particles. There is reported evidence that NM like those of titanium dioxide 
(nano-TiO2), fullerenes (C60), or single walled carbon nanotubes (SWCNT) 
aggregate to microalgae, copepods and Daphnia cell surfaces or carapaces, 
impairing their growth or swimming behaviour (Baun et al., 2008a; Baun et al., 
2008b; Li et al., 2011; Metzler et al., 2011; Oberdörster et al., 2006; Templeton 
et al., 2006). Zooplanktonic grazers such as cladocerans and copepods eat 
mainly edible particles (i.e. microalgae, bacteria, ciliates) from the water column 
and hence are very sensitive to changes in food concentration levels. This is 
especially so in cladoceran species such as Daphnia magna whose growth and 
reproduction is very sensitive to changes in food levels (Barata and Baird, 
1998). Therefore, it is crucial to assess to which extent NM can make edible 
microalgae to sediment faster by forming aggregates with them thereby 
diminishing food levels for planktonic grazers. Such effects may have profound 
consequences in the aquatic food web since it will reduce energy transfer from 
grazers to predators (Baird and Burton, 2001). There are several studies 
reporting that clay particles of sizes in the low µm range remove microalgae 
from the water column, a phenomenon that is dependent on the concentration 
and the size of clays and microalgae and the ionic strength of water (Han and 
Kim, 2001). NM such as those of nano-TiO2 may act like clay particles making 
microalgae to sediment faster (Li et al., 2011). According to Han and Kim (2001) 
Chapter 5 
183 
the closer the clay particle size is to the microalgae size the greater the 
potential to aggregate with them and make them to settle. There is reported 
information that nano-TiO2 aggregates in water reach sizes of few µm in waters 
with relatively high ionic strength (Sillanpää et al., 2011). Thus it is feasible to 
hypothesize that no or moderately toxic NM like nano-TiO2 may affect growth 
and reproduction of grazers by decreasing food levels. Li et al., (2011) found 
that nano-TiO2 and nano-Al2O3 decreased the concentration of algae in the 
water column and consequently impaired growth and reproduction of the 
cladoceran Ceriodaphnia dubia. The biological toxicity of NM is closely related 
with many physicochemical characteristics such as size, surface area, surface 
modification, and radical formation. Size is a well known important factor 
determining nano-TiO2 toxicity to aquatic organisms since penetration is eased 
with decreasing particle size and bioavailability is increased, so that more 
particles can be deposited inside the cell (Kim et al., 2010; Lovern and Klaper, 
2006; Metzler et al., 2011). The phase composition of nanoscale titanium 
particles is also known to affect toxicity under UV light with anatase TiO2 being 
100 times more toxic to human fibroblast or lung epithelial cells that an 
equivalent sample of rutile (Sayes et al., 2006). There is, however, few if any 
study that have compared the aquatic toxicity of nano-TiO2 having different 
phase composition to aquatic species. It is difficult, however, to distinguish 
experimentally if effects of NM on growth and reproduction are due to direct 
toxicity, to a lower availability of algae as food, to decreased food intake due to 
ingestion of NM that are not edible or due to the contribution of all factors. 
Nevertheless, there is still substantial controversy on the mode of toxic action of 
NM to aquatic organisms due to problems, for example, to establish exposure 
pathways (Handy et al., 2012b). Most nanotoxicity studies followed conventional 
protocols designed to test dissolved chemical species that may not be totally 
applicable to nanoparticles (Handy et al., 2012b). For example in the semi-static 
testing conditions of the Organization for Economic Cooperation and 
Development protocols (OECD, 1981), NM are likely to aggregate with 
themselves and with algae, increasing algae sedimentation rates and hence 
diminishing food levels for grazers such as D. magna that eat algae from the 
water column. In relation to this, test vessel volumes usually used to conduct 
chronic tests with cladoceran species are quite small (30–150ml), having small 
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water columns (3–6cm) and hence may also minimize algae sedimentation 
effects. The above mentioned limitations, however, can be avoided by 
performing tests with larger vessels holding larger water columns under semi-
static and continue water column resuspension conditions. Here we aim to 
evaluate the extent to which different forms of nano-TiO2 aggregate with 
microalgae, decreasing food levels and consequently growth and reproduction 
of D. magna individuals. To accomplish our objective we performed different 
experiments using three different types of nano-TiO2 differing in their coating or 
crystalline structure but of similar primary size (20ηm) plus a micron-sized bulk 
material, two nano-TiO2 exposure levels (1, 10mg/L) and different food ration 
levels of the microalgae Chlorella vulgaris that included non limiting (1.5µg 
C/mL) and limiting food conditions (<1µg C/mL) (Barata and Baird, 1998). 
Effects were assessed using three different types of assays. Assays included 
chronic reproduction 21-day tests using semi-static conditions that followed 
OECD protocols (OECD, 1981) and tests performed in 1L bottles with a water 
column height of 16cm. The latter included two exposure scenarios: semi-static 
and re-suspension of algae. Particle size and aggregation measurements of 
nano-TiO2 were conducted using scanning and transmission electron 
microscopy (SEM and TEM, respectively), dynamic light scattering (DLS) and 
particle counter procedures. Algae concentration measurements were based on 
chlorophyll a and effects on D. magna were determined from growth and 
reproduction performance measurements. 
 
5.2. Material and methods 
 
5.2.1. Nanoparticles 
Two of the used nano-TiO2 has been supplied by the repository of the 
European Commission (EC) Joint Research Centre at Ispra, Italy. In order to 
facilitate the collection of data and the comparison with other studies performed 
with same nano-TiO2, the codes used in this work are those of the repository. 
NM-103 and NM-104 are TiO2 of rutile modification, with a TiO2 total content of 
89%, a primary crystal size according to Scherrer of 20nm (the Scherrer formula 
is used in X-ray diffraction to correlate the size of solid nanoparticles with the 
broadening of a peak in a diffraction pattern, (Scherrer, 1918) and a specific 
Chapter 5 
185 
surface area according to BET of 60m2/g (Brunauer–Emmet–Teller method, 
(Brunauer et al., 1938). According to the received information NM-103 exhibits 
hydrophobic properties while NM-104 is hydrophilic. Both nanomaterials are 
used as UV screening agents in sunscreen products and NM- 104 has received 
an organic treatment with glycerin. The other NM used in this work was P-25 
(Evonik Degussa, Germany). It is a TiO2 of anatase–rutile modification (78% 
anatase, 14% rutile and 8% amorphous phase, according to (Ohtani et al., 
2010) ). The manufacturer reports 99.5% purity and a specific surface area 
according to BET of 50±15m2/g. A primary size of 21nm has been reported 
(Sigma–Aldrich, http://www.sigmaaldrich.com/). Finally a microTiO2 was used 
as reference: Tiona AT-1 (Cristal Global, MD). The manufacturer reports that 
the crystal form is anatase, with 98.5% TiO2 content and with untreated surface. 
Initial stock solutions of particle suspension of 1 g/l were dispersed with the aid 
of an ultrasonic bath during 30minutes in MilliQ water and left for 24h in 
agitation in darkness prior to be used to prepare test solutions. 
 
5.2.2. Particle characterization 
 
5.2.2.1. Pristine particles 
Properties of particles were characterized for primary particle size and 
aggregates (or secondary particle size distribution). TEM pictures of the 
different particles were taken. Particle samples were prepared by 
ultrasonication (5–10min) with an ultrasonic bath Elmasonic S40 (Elma, 
Germany) at maximum energy output to eliminate aggregates and ensuring the 
possibility to image single particles. A few drops of suspension were allowed to 
evaporate in a copper grid at room temperature and examined under a JEOL 
transmission electron microscope, model 2000FX (JEOL, Ltd., Japan) operating 
at 200 kV. 
 
5.2.2.2. Particles in suspension 
Particles were dispersed in ASTM hard synthetic water, pH 7.8 (ASTM, 1980) 
following the above mentioned methods and left to settle for 24h, then the 
aggregate size of nanoparticles in the water column was determined with 
dynamic light scattering (DLS) using a Zeta-Sizer Nano ZS (Malvern 
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Instruments Ltd., Malvern, UK). ASTM hard water without particles was used as 
a control. Before measuring the samples the instrument temperature was set at 
20ºC. Three independent measurements were taken with 4 readings per 
measurement, each reading consisting of six runs of 10s duration. The mean 
hydrodynamic size was calculated from the histogram of size distribution 
frequency for each nanoparticle. The polydispersity index (Pdi) that informs 
about the width of the size distribution was also included. Nanoparticle 
concentrations in water were also measured indirectly using absorbance 
measurements at 348nm calibrated against a standard of 8 points. 
 
5.2.3. Culture conditions 
 
A single clone F of D. magna, which has been the subject of many 
investigations (Barata and Baird, 2000), was used. Individual cultures of 10 
animals/L were maintained in ASTM hard synthetic water with the addition of a 
standard organic extract (Baird et al., 1989a). Individual cultures were fed daily 
with C. vulgaris Beijerinck (5×105 cells/mL). Algae were cultured in Woods Hole 
MBL medium (Nichols, 1973) with constant aeration, collected in the 
exponential phase and re-suspended in ASTM hard water (ASTM, 1980). Algal 
cell concentration was calculated using a particle counter Coulter Multisizer 
(Beckman Coulter, CA). The culture medium was changed every other day, and 
neonates were removed within 24 h. Photoperiod was set to 14h light: 10h dark 
cycle and temperature at 20±1ºC. Light was provided with neon fluorescent 
lamps that according to the manufacturer have low UVA emissions 
(<10µW/cm2), which are roughly 300-fold lower than the typical maximum 
(clear-sky, mid-day, mid-summer) intensity in temperate regions such as Duluth 
(USA) and Paris (France) (Ma et al., 2012).  
 
5.2.4. Experimental design 
 
5.2.4.1. Algae assays 
Effects of the four studied particle suspensions (NM-103, NM- 104, P25, 
Tiona) on the formation of particle–algae aggregates and its effect on algae 
sedimentation rates were tested at two concentrations (1 and 10mg/L) and at 
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low and high food ration levels of C. vulgaris (1×105 and 5×105 cells/mL) with an 
equivalent carbon content of 0.3 and 1.5µg C/mL, respectively, that correspond 
to limiting and non-limiting food levels to D. magna, respectively (Barata and 
Baird, 1998). To determine carbon content, three replicate algae samples of 
known volume and concentration were freeze dried, weighed on a microbalance 
and their C:N:H content measured in a Thermo Electron Flash 1112 elemental 
analyser (Thermo Scientific, UK). Particle test suspensions were prepared from 
appropriated dilutions of stocks and were dispersed with ultrasonication for 
30min in ASTM hard water and kept in continuous agitation. Experiments were 
conducted in 1.2L bottles filled with 1L of ASTM with the required algae and 
particle suspensions and then left to settle for 24h prior to sampling. Algae 
concentrations in those treatments with nanoparticles cannot be assessed using 
particle counter methods due to particle reading interference and hence were 
determined from chlorophyll a measurements. Water samples (100mL) were 
carefully taken from the mid-point of the water column (approximately 7.5cm 
from the bottom) with the aid of a glass pipette. Water samples were first filtered 
using fibre-glass filters (Whatman GF/F 0.2µm, Whatman, UK) and then 
chlorophyll was extracted with acetone overnight following established methods 
(USEPA, 1997). Extracts were then measured at 664, 647, 630 and 750nm by 
spectrometry (DU720 Beckman Coulter, CA). The concentration of chlorophyll a 
was calculated using the trichromatic equations of Jeffrey and Humphrey (1975) 
and converted to cell counts using a calibration curve of 8 data points. Final 
results were then expressed in µC of algae/mL. Measurement of the size of 
algae aggregates with nanoparticles were visualized with the aid of a Hitachi S-
3500N (Hitachi High Tecnologies Corporation, Japan) scanning electron 
microscope (SEM) and measured using a particle counter Coulter Multisizer 
(Beckman Coulter, CA) in three independent experiments. To visualize algae 
aggregated with particles in the SEM, 1–5mL of algae sample was filtered in a 
Nucleopore filter (Whatman), 0.8µm pore size, and fixed in glutaraldehyde at 
3% prepared in ASTM hard water during 1h. After that the sample was washed 
for 20min in ASTM and dehydrated using ethanol serial dilutions. Filters were 
air dried, glued to SEM stubs with colloidal silver and sputter-coated with gold–
palladium. The samples were examined with a Hitachi S-3500N SEM operating 
at 5kV. To measure the metallic composite of the aggregates an X-ray 
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microanalysis, Quantax 400 energy dispersive spectrometer Si (Li) detector 
(Bruker AXS, Germany), was used attached to the SEM and working at 15kV.  
 
5.2.4.2. D. magna reproduction tests 
Effects of the four studied particle suspensions (NM-103, NM-104, P-25, 
Tiona) on D. magna growth and reproduction were tested at two concentrations 
(1 and 10mg/L) and at low and high food ration levels of C. vulgaris (0.3 and 
1.5µg C/mL, respectively). Particle test suspensions were prepared similar than 
in the algae assays. Four different assays were performed: 
Experiment 1: included a 21-day reproduction test following established 
OECD (1981) protocols. Neonates (<24 h old) were exposed individually until 
their fourth brood (approximately 21–23 days at 20ºC) to the studied particle 
concentrations across low and high food ration levels in 100ml of ASTM hard 
water, in 120mL screw top glass jars (6cm water column), with the addition of a 
standard organic extract (Barata and Baird, 1998). Exposure solutions with 
algae were changed every day and were replicated ten times. In experiments 2 
and 3, neonates (<24h old) were exposed until their first brood (approximately 
9–11 days at 20ºC) to the studied particle concentrations and algae treatments 
(low and high food ration levels) in groups of 10 individuals cultured in 1L of 
ASTM hard water, in 1.2L screw top glass bottles hold-ing a water column of 16 
cm, also with the addition of a standard organic extract (Baird et al., 1989b). 
Experiment 2: cultures were maintained like in the experiment 1 in semi-
static conditions. The medium was renewed every 24h.  
Experiment 3: cultures were maintained in a rotatory wheel at 2rpm to allow 
continuous re-suspension of algae and particles until medium replacement 
every 24h. 
Experiment 4 was performed like experiment 2 but with algae alone that was 
dosed at food ration levels matching the food levels not removed by 
sedimentation with the studied nano-TiO2 at 1 and 10mg/L. These food ration 
regimes correspond roughly to half and 1/5 of the levels initially used at high 
food (0.75, 0.3µg C/ml, respectively) and to half and ¼ the levels initially used at 
low food (0.15, 0.075µg C/ml, respectively). The high food ration level used in 
experiments 1–3 (1.5µg C/mL) was also included as a reference treatment. 
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Measured responses included individual survival, age, body size and clutch 
size at first reproduction, cumulative reproduction (only for experiment 1) and 
population growth rates. Body length was taken from the head to the base of 
the spine using the ImageJ software (http://rsb.info.nih.gov/ij/) and a Nikon 
stereo-scopic microscope (SMZ 150, Nikon, Spain). Population growth rates 
were determined as the intrinsic rate of increase (r), which was computed 
iteratively from the Lotka equation (Eq. 5.1) using the measured age, specific 
survival and fecundity rates: 
1
0
e 

 ml xx
x
rx
      (eq. 5.1) 
where lx is the proportion of the females surviving to age x (days) which was set 
to 1 since no mortality occurred during assays; mx is the number of juveniles 
produced per surviving female between the ages x and x+1. The age at birth 
was set to 0. The 95% confidence intervals were estimated by the jackknife 
method (Meyer et al., 1986). 
 
5.2.5. Data analyses 
Due to experimental constrains it was not feasible to perform all experiments 
at once, neither was it possible to test particle suspension effects at both food 
levels simultaneously. Accordingly, each experiment and food ration was 
analyzed separately by one way ANOVA to exclude confounding effects of 
inter-trial/experiment variation (Barata and Baird, 1998). When significant 
(P<0.05) treatment effects occurred, post-hoc Tukey’s or Dunnet’s tests were 
performed to compare treatments. Prior to analyses all data except age at first 
reproduction were log transformed to improve normality and variance 
homoscedasticity (Zar, 1999). Effects of treatment on age at first reproduction 
were analyzed by non-parametric Kruskal–Wallis test. Analyses of r were based 
on jackknife pseudovalues (Meyer et al., 1986). Tests were conducted with the 
aid of the statistical package IBM SPSS v19. 
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5.3. Results 
 
5.3.1. Particle characterization 
Primary particle size determined by transmission electron microscope (TEM) 
confirmed the sizes reported by manufacturers (i.e. approximately 20nm for 
NM-103, NM-104, P-25 and approximately of 200nm for Tiona). DLS 
measurements are reported in Table 5.1 and indicate in most cases aggregate 
sizes greater than 1µm and bigger at 10mg/L than at 1mg/L. Polydispersity 
indexes were also higher than 0.5 in 6 out of 8 particles*dose combinations, 
which denoted the existence of polydispersity. 
After 24h nanoparticle concentration level estimates decreased from 6.5% to 
39% of nominal values at 1mg/L and about 70% at 10mg/L (Table 5.1). 
 
5.3.2. Algae–particle aggregates 
The tested nano-TiO2 and the micron-sized reference material aggregated to 
algae as shown in Figure 5.1-5.4. A SEM image of those aggregates is depicted 
in Figure 5.1 showing that at high food rations, aggregates to algae were larger 
at 10mg/L than at 1mg/L. Measurement of the metallic composition of 
aggregates by X-ray microanalysis confirmed that they were of titanium. The 
size of algae–particle aggregates determined by means of a Coulter Multisizer 
showed that in most cases nano- and micron-sized TiO2 formed significantly 
(P<0.05, based on ANOVA) larger aggregates with algae than algae alone 
(Figure 5.2).  
The hydrophobic nano-TiO2 NM-103 formed larger aggregates with algae 
cells at high food ration conditions and high exposure levels (10mg/L, Figure 
  NM103   NM104   P-25   Tiona  
1 mg/L N Mean SD  Mean SD  Mean SD  Mean SD 
Hydrodynamic size (nm) 12 255.1 42.9  312.1 26.0  412.8 167.5  722.6 518.4 
Pdi 12 0.36 0.03  0.80 0.04  0.89 0.14  0.98 0.28 
Concentration 24 h (mg/l) 4 0.81 0.08  0.93 0.1  0.8 0.06  0.61 0.06 
             
10 mg/L             
Hydrodynamic size(nm) 12 1076.6 33.4  699.0 9.8  1354.9 35.8  1502.2 61.9 
Pdi 12 0.66 0.03  0.91 0.05  0.45 0.01  0.63 0.02 
Concentration 24 h (mg/l) 4 2.80 0.30  3.12 0.21  2.70 0.28  2.33 0.31 
Table 5.1. Nano-Tio2 and micron sized particle characterization by dinamic light scattering 
(DLS) and particle concentration estimated from absorbance measurements at 348nm. 
Pdi, Polydispersity index. Results are depicted as mean±SD
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5.2D), whereas P-25 did so at low food levels and low exposure suspensions 
(Figure 5.2A).The micron-sized Tiona formed the smallest aggregates with 
algae. Nevertheless it is important to note that such aggregate measurements 
are likely to be under-estimate by the Coulter Multisizer since it counts and 
measures particles assuming a spherical shape, which was not the case as 
shown in Figure 5.1. Further information on the frequency distribution of algae–
particle aggregates in volumetric % is in Figure 5.3.  
Algae sedimentation results expressed as food levels (µg C/ml of the algae 
C. vulgaris) remaining in the water column after 24h are depicted in Figure 5.4. 
Again the results obtained evidenced that the tested TiO2–particle suspensions 
decreased significantly (P<0.05, based on one way ANOVA) algae 
concentrations in water at low and high food ration levels. Such effects were 
greater at 10mg/L than at 1mg/L. Nano-TiO2 suspensions of 1mg/L decreased 
algae levels about 2-fold while those at 10mg/L did so 4 and 9-fold, depending 
on the food ration level. Effects on depletion of algae concentration levels were 
greater under exposure to the tested nanoparticles than to the micron-sized 
reference material Tiona. There were also significant (P<0.05) differences 
among the tested nanoparticles with the hydrophilic coated one (NM-104) and 
P-25 having the greatest effects. Within each food level Pearson correlation 
coefficients of particle–algae aggregate size and sedimentation rates were 
negative and significant (P<0.05; N=9; −0.71 and −0.64 at low and high food 
levels, respectively), which means that the larger the algae–particle aggregate 
the lower the food level remaining in the water column (for further information, 
those relationships are depicted in Figure 5.5). 
  A B 
Figure 5.1. SEM Images of algae cells in the presence of 1 mg/L (A) and 10 mg/L (B) of P25-
TiO2 at high food levels. 
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Figure 5.2 Mean algae and particle-algae aggregate sizes of the studied nano and mricron-
sized TiO2 particles at low (A, B) and high (C, D) food ration levels. White, grey and black 
symbols correspond to 0, 1 and 10mg/L of particle suspension, respectively. Within each 
food level and particle suspension concentration different letters indicate significant (P<0.05) 
differences following ANOVA and Tukey’s test. Each assay was replicated three times. 
Errors are SE. 
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Figure 5.5. Relationships between algae-particle aggregate size and algae sedimentation 
rates (expressed as concentration of algae remaining in the water column after 24h) at 
low and high food ration levels. Error bars are SE (N=9). White, grey and black symbols 
correspond to algae only, 1 and 10mg/l of particle suspensions, respectively. 
Figure 5.4 Algae concentrations measured as µg C/mL remaining in the test medium after 
24h across the tested particle suspensions at low (A) and high (B) food ration levels. 
Straight and dotted lines indicate non-limiting and limiting food levels, respectively, a and 
the location of the initial algae concentration levels. White, grey and black symbols 
correspond to 0, 1 and 10mg/L of particle suspension, respectively. Within each particle 
suspension level different Arabic (1mg/L) or Greek (10mg/L) letters indicate significant 
differences following ANOVA and Tukey’s test. Each experiment was replicated three 
times. Errors are SE. 
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5.3.3. D. magna responses 
In the conventional chronic reproduction test the tested particle suspension 
affected significantly (P<0.05) most of the studied traits (Table 5.2). Post-hoc 
Dunnet’s multiple comparison tests, however, indicated that most detrimental 
effects relative to control treatments occurred at low food levels in animals 
exposed to NM-103 and P-25 at 10 mg/L (Figure 5.6). Significant (P < 0.05) 
effects on body length were observed for NM-103, NM-104 and P-25: at first 
clutch females exposed to 1 and 10mg/l of P-25 at high food ration levels were 
bigger and smaller than controls, respectively; at low food ration levels the size 
of females at first clutch exposed to 10mg/l of MN-103 and that of 21-day old 
females exposed to 1mg/l MN-104 and to 10mg/l P-25 were bigger than 
controls (Figure 5.6). Effects on population growth rates (r), which is a fitness 
measurement that integrates effects on survival, developmental and 
reproduction rates denoted significant effects of NM-103 only at 10mg/L at low 
food ration levels.The use of new experimental designs allowed an increase in 
the sensitivity of observed effects of the studied nanoparticles. In the semi-static 
test (Figure. 5.7, left panel of graphs) where animals were exposed in bottles of 
1L, significant (P<0.05) detrimental effects on age at first reproduction, clutch 
size, body length and r were observed at high food ration levels and 10mg/L of 
P-25. At low food ration levels significant (P<0.05) detrimental effects relative
Table 5.2, ANOVA results on D. magna traits for the three assays performed with the four 
particle suspensions (NM103, NM104, P-25, Tiona) dosed at two concentrations (1, 10mg/L) 
across two food ration levels (low and high). Results from a forth experiment comparing D. 
magna life-history performance across five different ration levels are also included Only 
degrees of freedom (df), Fisher’s coefficient (F), Chi-square (2) and significant levels are 
depicted. ns P≥0.05; *0.01<P<0.05, **P<0.01. Traits are: age at first reproduction (Age), 
clutch size at first reproduction ( Fec 1st), body length at maturity (Size mat) fitness (r ),body 
length at the end of 21 d test (Size end), and total fecundity in 21 d tests (Fec Tot). 
 Ag  Fec 1st Size mat r  Size end Fec Tot 
 df 2 df F df F df F df F df F 
1. Chronic Exp             
High 8 2.3 8,6 3.6** 8,6 5.8** 8,7 2.2* 8,5 1.7 8,6 4.0**
Low 8 23.8* 8,6 4.9** 8,6 2.8** 8,7 6.3** 8,6 6.0* 8,6 11.4*
Designed experiments            
2.Semi-static Low 8 19.6* 8,6 12.5** 8,6 4.6** 8,6 12.8**     
2.Semi-static High 8 25.8* 8,6 4.4** 8,6 2.7* 8,6 19.9**     
3.Re-suspension 8 9.30 8,7 7.9** 8,7 1.4 8,7 10.0**     
3.Re-suspension 8 24.5* 8,6 4.8** 8,6 1.7 8,6 14.9**     
4. Ration Food level 4 50.6* 4,5 104.9* 4,5 83.2* 4,5 180.9*      
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Figure 5.6. Life-history responses of D. magna individuals exposed to the studied particle 
suspensions at low (L) and high (H) food ration levels in a 21 d chronic test. White, grey and 
black bars correspond to 0, 1 and 10mg/L of particle suspension, respective respectively. 
Within each food level * indicates significant (P<0.05) differences from control treatments 
following ANOVA and Dunnett’s test. Errors are SE (N=10).
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to controls on clutch size and r were observed even at 1mg/L in all the tested 
nano-TiO2 (Figure. 5.7). Effects of Tiona occurred only at low food ration levels 
and high exposure levels (10 mg/L) (Figure. 5.7). Comparison of observed life-
history effects of D. magna individuals exposed to the studied particle 
suspensions with those obtained at food ration levels matching what was not 
removed by sedimentation showed the following: in the experiment performed 
at high food ration levels, observed fitness (r) effects at 10mg/L of P-25 were 
not significantly (P<0.05 based on ANOVA tests) different from those obtained 
at L/2 (Figure 5.7), which roughly corresponds to food depletion values 
measured in Figure 5.4B. In the experiment performed at low food ration level, 
life-history effects observed at 1 and 10mg/L of nano-TiO2 suspensions were 
similar to effects measured at food levels matching those not sedimented 
according to Figure 5.4A (L/2, L/4, Figure 5.7).The re-suspension experiment 
conducted under similar conditions as the semi-static test but allowing particles 
and algae to re-suspend continuously provided similar results at high food ration 
levels but effects at low food ration ones were only observed at 10 mg/L (Figure 
5.7 right panel graphs). 
 
 
 
Correlation analyses were restricted to population growth rate since it is a 
better measure of fitness than the other studied traits. Interestingly, at low food 
ration levels population growth rates were correlated significantly (P<0.05; 
N=10) with particle–algae aggregate size and with algae concentration levels 
remaining after 24h (i.e. sedimentation rates) in the semi-static test, with sedi-  
Table 5.3. Pearson correlation coefficients between particle-algae aggregation size, 
sedimentation rates measured as algae concentration levels remaining in the water column 
after 24h and r-values in the chronic, semi-static and re-suspension assays at low and high 
food ration levels. *0.01<P<0.05; **0.01<, N=10 
 r-chronic r-semi-static r –re-suspension 
Low Food     
Aggregate size -0.13 -0.77* -0.44 
Sedimentation 0.40 0.87** 0.68* 
High food    
Aggregate size -0.36 -0.22 -0.80** 
Sedimentation 0.35 0.39 0.52 
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Table 5.4. Life-history responses of D. magna cultured at different food ration levels matching 
those remaining in the water column at 24 h following nanoparticle treatments. High and low 
food ration levels have also been included for comparison purposes 
Food ration   Age (days) Clutch (number) Length (mm) r (days-1) 
µgC/ml N Mean SE Mean SE Mean SE Mean SE 
L/4 10 22.21 0.92 1.26 0.13 2.1 0.02 0.006 0.005 
L/2 10 16.14 0.26 2.89 0.22 2.22 0.03 0.065 0.006 
L 10 13.1 0.16 4.4 0.63 2.36 0.03 0.11 0.013 
H/2 10 11.46 0.26 10.13 0.45 2.7 0.02 0.204 0.009 
H 10 10.2 0 11.8 0.38 2.69 0.02 0.243 0.004 
 
mentation rates in the re-suspension test and with none of these variables in the 
chronic test (Table 5.3). At high food levels population growth rates were 
correlated significantly (P < 0.05; N = 10) with particle–algae aggregate size in 
the re-suspension test (Table 5.3). Further information on the relationships 
between fitness (r responses) and algae–particle aggregate size or 
sedimentation rates are depicted in Figure. 5.8. 
 
5.4. Discussion 
 
The particle size distribution determined by laser scattering analysis showed 
that nano-TiO2 was consistently agglomerated in test suspensions (1 and 
10mg/L). The agglomerate size and polydispersity index were also 
concentration-dependent with the higher TiO2 concentrations showing greater 
agglomerate size. Particle–TiO2 concentration estimates using absorbance 
measurements showed that by the end of 24h, particle sedimentation caused 
loss of particle–TiO2 suspensions of 21 and 72% from initial levels of 1 and 
10mg/L, respectively. The observed aggregation effects across nano-TiO2 
concentrations are in agreement with other descriptions of nano-TiO2 behaviour 
in high ionic strength media (Sillanpää et al., 2011). Therefore, the culture 
medium with high ion levels leads to the aggregation of nanoparticles followed 
by particle destabilization. Nanoparticle aggregates interacted with the algae 
cells, forming clusters as shown in Figures 5.1, 5.2, 5.3. Large TiO2 –algae 
agglomerates settled readily dramatically depleting the concentration of food for 
D. magna. Results of Figure 5.4 indicated that at low food ration levels, algae 
food concentrations were reduced by about 2 and 4-fold in the presence of 1  
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Figure 5.8. Significant (P<0.05, Table 5.3) relationships between algae-particle aggregate 
size or algae sedimentation rates (expressed as concentration of algae remaining in the 
water column after 24 h) and fitness (r-responses) across food ration levels and 
experiments. Error bars are SE (N = 9). White, grey and black symbols corresponds to algae 
only, 1 and 10 mg/L of particle suspensions, respectively. 
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and 10mg/L of nano-TiO2, respectively. At high food ration levels food 
reductions by nanoparticle suspensions were greater being about 2 and 9-fold 
for 1 and 10mg/L of nano-TiO2, respectively. These results agree with reported 
aggregation effects of nano-TiO2 in algal cells and subsequent algae 
sedimentation (Li et al., 2011; Metzler et al., 2011). 
Life-history theory and empirical data indicate that Daphnia prioritize 
resource allocation to maintenance, growth and reproduction, thus under limited 
food conditions reproduction will be affected first, then growth and ultimately 
maintenance and hence survival (Glazier, 1992). The high food ration levels 
used in the present study and those recommended by he OECD are not limiting 
(1–1.5µg C/mL, (Barata and Baird, 1998), but those remaining in the water 
column after nanoparticle sedimentation including that used for the low food 
ration level (0.3µg C/mL) became limiting. Accordingly, except for the micron-
sized Tiona particle suspensions of 1mg/L at high food ration levels, the studied 
particle suspensions impaired reproduction and fitness (measured as r) in D. 
magna in the semi-static test performed with larger bottles (Figure 5.7 left panel 
graphs). At limiting low food ration levels (i.e. low food experiment) the studied 
particle suspension by decreasing food concentrations remaining in the water 
column dramatically impaired D. magna reproduction and fitness even at 1mg/L 
of particle suspensions. Indeed, observed life-history effects were similar than 
measured in individuals cultured across food ration levels matching those not 
sedimented and remaining in the water column (i.e. food experiment). At high 
food ration levels, life-history effects of nano-TiO2 were only evident for P-25 at 
10mg/L, thus, contradicting food depletion effects reported in Figure 5.4 that 
predicted limiting food conditions and hence detrimental effects on life-history 
responses at 1 and 10mg/L for all nano-TiO2 . Therefore at low food ration 
levels nanoparticles acted mainly by reducing food availability. The lack of 
match observed at high food ration levels between expected and observed 
effects due to food depletion are likely related to the fact that D. magna 
individuals are able to move across the water column (Ringelberg, 1999; Young 
and Getty, 1987) and hence could feed on sedimented nanoparticle–algae 
aggregates from the bottom of the test vessels. The higher proportion of 
nanoparticles versus algae or/and the use of very limiting food conditions 
(Barata and Baird, 1998) may explain why at low food ration D. magna 
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individuals were truly starving even if grazing on sedimented algae–particle 
aggregates. 
Life-history effects observed in the re-suspension experiment allowed us to 
indirectly test effects of the studied nano-TiO2 in food ingestion and assimilation 
rates since tests were conducted under continuous re-suspension of algae and 
nanoparticles, thus minimizing the effect of food and nanoparticle depletion from 
the water column. Results depicted in Figure 5.7 in the re-suspension 
experiment and under high food ration levels (right panel graphs) showed that 
only the nano-TiO2 P-25 at 10mg/L impaired growth, reproduction and fitness (r) 
similarly to that in the semi-static test (Figure 5.7 left panel graphs). These 
results indicate that at high food ration levels the P-25 may affect the feeding 
process decreasing food intake and hence growth and reproduction. In the re-
suspension experiment performed at low food ration levels, nano-TiO2 affected 
reproduction and fitness (r) only at high exposure levels of 10mg/L. There is 
reported evidence that P-25 nanoparticles at high doses (50mg/L) clog the gut 
of C. dubia and diminished its energy intake (Li et al., 2011). Our data, thus, 
indicate that the studied particle suspension at high exposure levels of 10mg/L 
and under limiting food conditions affected food acquisition and hence fitness 
probably by clogging the digestive tract. The exception was the nano-TiO2 P-25 
that affected fitness responses negatively at low and high food ration levels. 
Interestingly the nano-TiO2 P-25 was the only studied nanoparticle having a 
phase composition dominated by anatase, which is phototoxic under UV light 
(Sayes et al., 2006). Thus, despite of using artificial light with low UV emission 
(<10W/cm2 of UVA), photocatalytic oxidative stress effects of nano-TiO2 P-25 
cannot be ruled out (Colvin, 2003; Klaine et al., 2008). Note, however, that the 
UV-A intensity in the present study was about 170-fold lower than in those that 
reported nano-TiO2 photo-toxicity in D. magna (Ma et al., 2012). 
Results obtained at low food levels in semi-static experiments together with 
the high correlation values observed between fitness (r) responses and the size 
of particle–algae aggregates or sedimentation rates (see Table 5.3) indicate 
that measured effects on growth, reproduction and fitness are likely to be 
related to depletion of food. Despite that the studied nano-TiO2 can also affect 
growth and reproduction by clogging the gut, this phenomenon was measured 
under re-suspension conditions and at high exposure levels of 10mg/L. At high 
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food ration levels, however, our experimental design failed to predict life-history 
effects of the studied nano-TiO2. The more plausible explanation was that our 
nanoparticle food depletion hypothesis was tested assuming that D. magna 
individuals do not move in the water column and hence cannot graze from the 
bottom of the experimental bottles, which it is not the case for most 
zooplanktonic organisms (Ringelberg, 1999). 
There is still substantial controversy on the mode of toxic action of 
nanoparticles to aquatic organisms due to problems, for example, to establish 
exposure routes (Handy et al., 2012b). Most nanotoxicity studies follow 
conventional protocols designed to test dissolved compounds instead of toxic 
particle suspensions (Handy et al., 2012b). For example in the semi-static 
testing conditions of OECD protocols (OECD, 1981), nanoparticles are likely to 
aggregate with themselves and with algae, increasing algae sedimentation 
rates and hence diminishing food levels for grazers and ecotoxicological model 
organisms such as D. magna, C. dubia or the planktonic copepod Acartia sp. 
that graze algae from the water column (Barata and Baird, 2000; Barata et al., 
2012; Barata et al., 2002). In relation to this, test vessel volumes usually used to 
conduct chronic tests with planktonic grazers are quite small, hold small water 
columns, hence minimizing algae sedimentation effects. The above mentioned 
limitations, however, can be improved using larger enclosures holding larger 
water columns under semi-static conditions. Here we present data clearly 
showing that at limiting food conditions the use of larger enclosures allowed to 
assess food depletion effects on the studied zooplanktonic species D. magna 
that were not detected in the standardized reproduction D. magna tests of the 
OECD (Figures. 5.6 and 5.7). Indeed, in the OECD reproduction test depicted in 
Figure 5.6 effects of the studied nano-TiO2 on fitness (r) were only observed at 
low food ration levels for NM-103 at 10mg/L, whereas in our semi-static test 
effects on r were observed in 7 out of the 12 treatments of nano-TiO2 and algae 
(Figure 5.7). These results agree with those of (Seitz et al., 2012) that using 
similar food conditions and small volumes (50 ml) found no effects of P-25 on D. 
magna reproduction at ≤ 2 mg/L. Therefore our data clearly support the need to 
implement new test design for assaying nanoparticle toxicity in aquatic biota. 
In summary despite that many studies have already addressed the toxicity of 
nano-TiO2 in D. magna and other planktonic species, few of them have reported 
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clear evidences that nano-TiO2 aggregate to algae, diminish food levels and 
hence dramatically affect reproduction and fitness of zooplanktonic species.(Li 
et al., 2011) studying the effects of two types of metallic nanoparticles (TiO2 and 
Al2O3 ) in growth and reproduction of the cladoceran C. dubia showed that 
these two nanoparticles aggregated to algae, depleted food levels and impaired 
growth and reproduction of the studied cladoceran species but at 
concentrations greater than 10mg/L. In this present study we showed that 
nanoparticle concentration and food level are important parameters to be 
considered and that there was a clear relationship between particle–algae 
aggregate size, food depletion rates and effects on fitness. This present study, 
however, was conducted under relatively high concentrations of nano-TiO2 
(≥1mg/L), which are greater than those predicted to be found in the environment 
(Gottschalk et al., 2009). Nevertheless, particle–cell aggregation is expected to 
increase with exposure time in waters with high ionic strength, thus in field 
conditions even low concentration levels of nano-TiO2 may aggregate to algae 
making them to settle, a process that occur in other nanoparticle types (Hoecke 
et al., 2009; Li et al., 2011). Depletion of food levels from the water column may 
have dramatic consequences to the planktonic aquatic food web (Baird and 
Burton, 2001). Thus, future efforts should be focused in studying such effects 
using realistic nanoparticle suspensions, longer periods and probably larger 
experimental enclosures. 
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Abstract 
Chemosensitization, which is reduction of tolerance of organisms against 
toxicants by inactivation of cellular multixenobiotic resistance mechanisms 
(MXR), could provide a mechanistic explanation of cases where combined 
effects of a mixture of compounds are stronger than the added effects of the 
isolated constituents. We cloned partial cDNA sequences of four MXR related 
ABC transporter genes in the water flea Daphnia magna and found constitutive 
expression of the respective transcripts in D. magna eggs, embryos, neonates 
and juveniles. Increased levels of transcripts of two out of the four newly 
sequences genes were detected in juveniles exposed to known inducers 
(mercury and pentachlorophenol). MXR associated efflux activity was monitored 
using the fluorescent substrate dyes rhodamine 123, rhodamine B and Calcein-
AM combined with specific MXR transporter inhibitors (chemosensitizers). 
Specific inhibitors of ABCB1 and/or ABCC transport activities (reversin 205, 
MK571 and cyclosporine A) resulted in a concentration dependent inhibition of 
the transport of fluorescence dye reporters in D. magna juveniles. Furthermore, 
all the studied inducers (mercury, pentachlorophenol, dacthal) decreased dye 
accumulation in pre-exposed juveniles, which were interpreted as induction of 
transporter activity. Mitoxantrone and chlorambucil, putatively toxic ABCB1 and 
ABCC substrates, respectively, were applied singly and in combination with the 
specific chemosensitizers to study the tolerance role of ABCB and ABCC efflux 
transporters. In five out of the eight binary combinations between the studied 
chemosensitizers and toxic substrates joint toxicities were greater than 
additivity. These results evidenced the existence of the genes and of the 
associated efflux activities of ABC transporters in juvenile stages of D. magna 
and indicate that MXR mechanisms may play a significant role in the species' 
tolerance to environmental contaminants. 
Keywords: Daphnia, mixture toxicity, phospho-glycoprotein, multidrug 
resistant protein. 
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6.1. Introduction 
 
The cellular multixenobiotic resistance (MXR) system in aquatic organisms 
represents a broad-scale defence mechanism protecting cells and organisms 
against environmental toxicants dissolved in the water (Kurelec, 1992). MXR is 
mediated by membrane-based transport proteins from the ATP binding cassette 
(ABC) protein family, which recognize a wide variety of chemical structures as 
substrates, pumping them out of the cell in an energy dependent, ATP-driven 
process thus keeping their levels in cells low. Cellular MXR efflux activities in 
various aquatic invertebrate species were so far associated with homologs of 
mammalian ABCB1 and ABCC proteins (Bard, 2000; Epel et al., 2008a). 
There are two aspects regarding MXR of aquatic organisms that are highly 
important for assessments of ecotoxicological effects of chemicals: 
1) Organisms with potent MXR defence are less sensitive to the toxic 
impact of compounds that act as transporter substrates, because comparatively 
few of those molecules reach their site of toxic action (Bard, 2000; Epel et al., 
2008b). In comparison, non-substrates will appear more bioactive because 
relatively more of those molecules are bioavailable. Consequently, bioassay-
based assessments of the ecotoxic potentials of chemicals will therefore be 
biased: compounds that are substrates of MXR transporters of the test species 
used will appear less hazardous than non-substrates, even though they may 
have similar bioactive potentials when internal concentrations and number of 
molecules reaching their target site are corresponding. 
2) Compounds can act as inhibitors of MXR transporters, causing increased 
sensitivity of organisms towards other, toxic compounds that, as substrates, are 
usually kept out of the organism. This so called chemosensitizing effect is a 
possible mechanism behind synergistic effects of compound mixtures (Kurelec, 
1997). 
The water flea Daphnia magna is a widely used eco-toxicological model 
species for an aquatic invertebrate (Barata et al., 2002a), but there is so far no 
evidence in the literature for activity of MXR transporters in daphnids. However, 
for reasons outlined above information to which degree MXR can affect the 
bioactive potential of compounds would be important to take into account. 
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Sixty four ABC transporters were annotated based on genomic sequences of 
another Daphnia species, D. pulex, the only crustacean genome so far 
sequenced (Colbourne et al., 2011). ABC transporter orthologs from all so far 
characterized subfamilies, ABCA – ABCBH, were identified in the D. pulex 
genome. From the ABCB and the ABCC subfamilies, sequences of homologs of 
MXR related ABC transporters ABCB1 or P-glycoprotein with two homologs in 
D. pulex and of ABCC1 to 5 or MRP1 to 5 (multidrug resistance-associated 
proteins) were identified (Sturm et al., 2009). 
There are no published studies yet providing experimental evidence that 
functional properties of these Daphnia ABCB and ABCC transporters are 
indeed MXR related. However, considering that MXR related functions are 
conserved properties of ABCB1 and ABCC homologs across aquatic animal 
species (Bard, 2000; Epel et al., 2008a) a similar function may also be assumed 
for the Daphnia homologs (Sturm et al., 2009). ABCB1- and ABCC-like efflux 
activities in daphnids should therefore become visible with substrate/inhibitor 
compounds generally used as probes for MXR transporter activity (Epel et al., 
2008a). 
This study aimed to determine the role of ABC transporter based efflux 
activity in D. magna as toxic defence against chemicals in the water applying 
the following approaches: 
1) Sequences of putative MXR transporters were identified in the D. pulex 
genome, but it has so far not been shown that those genes are indeed active, 
i.e., transcribed. Using polymerase chain reaction (PCR) techniques constitutive 
expression of transcript levels of those genes from the ABCB and ABCC 
subfamilies were determined in different life stages of D. magna and changes in 
transcript levels were quantified in animals upon exposure to known chemical 
inducers of ABC transporter expression.  
2) For determining whether MXR transporters are active in D. magna, dye 
efflux assays were performed using fluorescent substrate dyes in combination 
with specific inhibitor compounds known to interact with MXR transporters in 
other organisms. Active efflux of those compounds, and thus of MXR 
transporter activity, is indicated by increased accumulation of dye in the 
organism with inhibitors present. Dye efflux activity can thus be used as a 
measure of transporter protein levels: With more protein present, less dye will 
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accumulate in the cells. Hence, in addition to untreated animals with constitutive 
transporter protein expression levels, dye efflux assays were also performed 
with animals previously exposed to known inducers of ABC transporters to 
investigate changes of protein expression. 
3) The activity of MXR transporters was further determined by performing 
toxicity assays with toxic transporter substrates and inhibitors. The experiments 
were based on the assumption that, if MXR transporters are active in daphnids, 
the combination of substrates and inhibitors would cause larger toxic effects 
than would be anticipated from the effects of compounds when applied singly. 
Toxic effects were analysed using the independent action (IA) and 
concentration addition (CA) concepts for dissimilar and similar acting 
compounds, respectively (Altenburger et al., 2003). 
 
6.2. Material and Methods 
 
6.2.1. Chemicals 
Cyclosporine A (CsA), Reversin 205 (REV205), MK571, mitoxantrone, 
chlorambucil, rhodamine B (RhB), rhodamine 123 (Rh123), calcein AM (Ca-
AM), Calcein disodium salt, mercury chloride (HgCl2), dacthal (1, 5µM ) and 
pentachlorophenol (PCP) were purchased from Sigma-Aldrich (Steinheim, 
Germany). Acetone, DMSO, (analytical grade), methanol, acetonitrile 
(SupraSolv grade) and HPLC water (LiChrosolv grade) were supplied by Merck 
(Darmstadt, Germany). Ammonium formate ≥99% were purchased from Sigma-
Aldrich (St. Louis, USA) and formic acid were supplied by Merck (Darmstadt, 
Germany). 
 
6.2.2. Experimental animals  
Daphnia magna, clone B obtained from Bayer CropScience, Mannheim, 
Germany, was used for all experiments. Individual cultures of 10 animals/L were 
maintained in ASTM hard synthetic water (ASTM, 1980) with the addition of a 
standard organic extract (Baird et al., 1989). Individual cultures were fed daily 
with Chorella vulgaris Beijerinck (5x105 cells/mL). The culture medium was 
changed every other day, and neonates were removed within 24 h. Photoperiod 
was set to 14h light: 10h dark cycle and temperature at 20±1oC. 
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6.2.3. Identification of partial abcb1 and abcc coding sequences from D. 
magna 
In order to obtain partial coding sequences (cds) of D. magna ABC 
transporters, reverse transcription polymerase chain reaction (RT-PCR) was 
performed with primers designed based on regions encoding the highly 
conserved nucleotide binding domains (NBD) in abcb and abcc genes of D. 
pulex (Sturm et al., 2009). Primers (Table 6.1) were designed based on 
genomic sequences encoding the predicted proteins Dappu-347264 (NCBI 
accession number EFX85237; ABCB1 homologue), Dappu-347281 (NCBI acc. 
no. EFX72783; ABCC1-3 (MRP1-3) homologue), Dappu-347288 (NCBI acc. no. 
EFX68457; ABCC4 (MRP4) homologue), and Dappu-347292 (NCBI acc. no. 
EFX72656; ABCC5 (MRP5) homologue). 
PCR was performed using a MiniCyclerTM (MJ Research) with cDNA from 
total RNA isolated from D. magna juveniles as described below. PCR conditions 
were 95ºC for 5min, followed by 35 cycles at 95ºC for 30sec, 55ºC for 60sec 
and 72ºC for 30sec each, and a final step at 72ºC for 10min. The PCR product 
was cloned into vector pTZ57R/T from the InsTAcloneTM PCR Cloning Kit 
(Fermentas) and propagated using X Blue competent cells. Sequencing of 
cloned DNA was performed on a 3730 DNA Analyzer (Applied Biosystems). 
Homology of the amino acid sequences predicted from obtained partial abcb1, 
abcc1-3, abcc 4, abcc5 transporter cds with ABC transporter sequences from 
other organisms was confirmed using NCBI (National Center for Biotechnology 
Information, Bethesda, MD, US) by blastn and blastx and the sequence was 
deposited on GenBank (accession no.KC122929, KC122922- KC122924 for D. 
magna abcb1, abcc-3, abcc4, abcc5, respectively). Alignments were performed 
with respective sequences of a range of Abcb/ABCB and Abcc/ABCC amino 
acid sequences from various organisms using ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) and percent identities were 
determined. Homologies of the obtained ABC gene sequences were further 
analyzed using phylogenetic trees with the first 100 hits of BLASTP 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) removing predicted and unidentified 
                                            
1 Our nomenclature for gene/protein names is: abcc/Abcc for Daphnia and ABCC/ABCC for 
human 
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sequences. Phylogenetic trees were made using JSTREE 
(http://lh3lh3.users.sourceforge.net/jstree.shtml).  
 
 
Genes Forward Reverse Amplicon  
PCR primers   
ABCB CGTCGCCTTGGTCGGCACTTC CAGCCTGTGGGCGACAATGATGGTG 502 
ABCC1-3  CAGAGGGTGGCGAGAATTTA GGCGCGTATTCTTTGATTTC 259 
ABCC4 AGGAACCTGTCGAATTGCTG ATTGAAGCTGGTGGGTGACT 453 
ABCC5 ACGTCAAAATGCGCTACAGA TCAGTACGGACGGTTTGTCA 165 
Real time qPCR primers  
ABCB GTATCCAGTGCGGAAGTGGC ACAGCGTATCGCTATTGCCC 100 
ABCC1-3  TAGCTCGCGCTCTACTGAGAA GATCGTCGGTCTCCAGATCG 100 
ABCC4 CCCGATCCCTTTACGTCGAT GGTGGCGTCCTACATGAGTGT 100 
ABCC5 CAGTCCAGTCATCGAGAACGG TGACGCAACAGAGCTCGG 100 
GAPDH GACCATTACGCTGCTGAATACG CCTTTGCTGACGCCGATAGG 100 
-actin TTATGAAGGTTACGCCCTGCC GCTGTAACCGCGTTCAGTCAA 100 
18S CGCGAATGGCTCAATAAATCA CAGTCGAGGCTCGAGTGCA 100 
 
6.2.4. RNA extraction and qPCR analysis 
Abundances of D. magna abcb, abcc1-3,abcc4 and abcc5 transcripts were 
determined in just released eggs (stage 1 eggs), embryos (stage VI) (Threlkeld, 
1979), newly released neonates (<12h) and 4 day old juveniles. Eggs and 
embryos were obtained from de-brooding females by gently flushing water to 
the brood chamber (Glazier, 1992). For RNA extraction 20 eggs, 20 embryos, 
10 neonates and 5 juveniles were pooled to obtain sufficient RNA. Total RNA 
was isolated from D. magna tissues using Trizol reagent® (InvitrogenTM). The 
RNA concentration was measured by spectrophotometric absorption in a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Delaware, 
DE) and the quality was checked with an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara CA). Quantities from 1 µg to 100 ng of DNAse II-
treated RNA (Ambion®) were retro-transcribed to cDNA using the First Strand 
cDNA Synthesis Kit (Roche Applied Science®) and stored at -20ºC. The 
amounts of cDNA used for quantitative real-time PCR (qPCR) corresponded to 
10 ng of the original RNA preparation. qPCR was performed with a LightCycler® 
480 Real-Time PCR System using LightCycler® 480 SYBR Green I Master 
Table 6.1. Primer pairs designed from D. pulex used for amplification of Daphnia magna ABCB 
and ABCC subfamilies partial sequences. Primers used to amplify reference D. magna genes 
are also included.  
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(Roche Applied Science®). qPCR primers (Table 6.1) were designed with 
Primer Express software. Sequences of amplicons were confirmed by 
sequencing using an Applied Biosystems 3730 DNA Analyzer (Applied 
Biosystems) and by comparing them to the corresponding references in 
GenBank using NCBI BLAST (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).  
Relative mRNA abundance values were calculated from the second 
derivative maximum of their respective amplification curve (Cp, values from 
triplicate assays). RNA abundances of putative reference genes -actin and 
g3pdh (mRNA) and of 18S (rRNA) (Heckmann et al., 2006) were quantified and 
tested for stability in the three RNA sources used in this work, eggs, embryos 
and juveniles. Table 2 shows average Cp values and their standard deviations 
from all samples tested in this work (each sample tested in triplicate). The 
minimal variation of Cp values was found for 18S rRNA, which showed SD 
values below 1 Cp units in all samples; therefore, this gene was selected as 
reference gene.  
Cp values obtained for the target genes (TG) were compared to the 
corresponding values of 18S to obtain ∆Cp values (∆Cp = Cp ref- CpTG). PCR 
efficiency values for reference and target genes were calculated as described 
by Pfaffl (2001a) and assumed to be close to 100% from these calculations. 
qPCRs were performed with RNA extracts from nine replicates with three runs 
per sample. Mean mRNA abundances and standard deviations were calculated 
for each gene from the mean values of each sample.  
 
6.3.5. Dye efflux assays 
MXR transporter activities were determined in 4-day old juveniles using dye 
accumulation assays. The assays are based on the property of certain 
fluorescent dyes to act as substrates of ABC efflux transporters. The dyes are 
kept out of cells if efflux transporters are active and increasingly accumulate 
inside the cells if transporter activities are disrupted by transporter inhibiting 
chemicals (Homolya et al., 1993; Neyfakh, 1988). As proxies for efflux activity in 
daphnids we used two rhodamine dyes, RhB and Rh123, and Ca-AM. Ca-AM is 
not fluorescent but forms fluorescent Calcein once it reaches the cytosol where 
it is cleaved by cellular esterases. All dyes are known to be transported by 
mammalian ABCB1 and ABCC transporters (Daoud et al., 2000; Essodaïgui et 
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al., 1998; Holló et al., 1994; Homolya et al., 1993; Neyfakh, 1988; Yeheskely-
Hayon et al., 2009a). Low fluorescence levels of cells/tissues indicate high 
efflux transporter activity and enhanced fluorescence occurs with low efflux 
activity. For disrupting ABCB1 and ABCC type efflux activities in tissues from 
different live stages of D. magna we used the model inhibitors of mammalian 
ABCB1 and ABCC transporters, REV205 (Sharom et al., 1999a) and MK571 
(Gekeler et al., 1995), respectively, and the inhibitor of both transporters CsA 
(Qadir et al., 2005) .  
We noticed that the ABC transporter inhibitors we used had a toxic effect on 
D. magna that, independently from transporter inhibition, changed accumulation 
of fluorescent dyes in the animals by affecting their filtering activity. 
Accumulation of fluorescent dyes in vital animals that mainly occurred in the gut 
of D. magna (Fig 6.1) strongly depended on the filtering activity of the animals. 
Thus, we observed that dye uptake was reduced by 60 % when filtering activity 
was blocked (Fig 6.2 ). 
Figure 6.1. Fluorescent microscopy images of D. magna juveniles exposed to Rh123 (A,D), 
RhB (B, E), Ca-AM (C,F). Images were taken after 1.5h for in vivo (A-C) and 2h for ex-vivo (D-
F) incubation periods with 5 µM RhB, 2.5 µM Rh123 or 0.5 µM Ca-AM. Images of a juvenile 
individual taken with the bright file is also included (G).  
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Figure 6.2. Effect of transported MXR inhibitors on the accumulation of Rh123 (pmol/individual) 
and proportional filtering rates in D. magna juveniles. Symbols and error bars are Mean ± SD 
(n=10). 
 
In order to clearly determine inhibitor effects on ABC transporter related 
efflux activity in D. magna, animals were immobilized immediately prior to dye 
efflux assays by pinching their hearts with a needle and thus stopping filtering 
activities in all animals used in the experiment. Cells and tissues in these 
animals were still vital and dye efflux activity was intact. This “ex-vivo” 
experimental procedure where vital tissue instead of intact animals is used for 
recording MXR transporter activity can be seen as similar as other approaches 
where freshly dissected bivalve gills were used instead of whole organisms 
(Cornwall et al., 1995; Faria et al., 2011a; Luckenbach and Epel, 2005b). 
Immobilized D. magna juveniles (4 days old) were exposed individually for 1h 
to 2.5, 1.5 and 0.5µM of Rh123, RhB and Ca-AM (stock dissolved in DMSO), 
respectively, in 110mL of ASTM hard water. In parallel to controls with dye only 
and solvent controls with dye and solvent, treatments with 1-10µM of model 
inhibitors CsA, MK571 and REV205, and the transporter substrates 
chlorambucil (20, 200µM) and mitoxantrone (2, 10µM) were run. All controls 
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and treatments were replicated 10 times. After the exposure period animals 
were transferred to 100mL clean ASTM hard water for 5min to allow depuration 
of excess dye, and the accumulated dye was extracted from tissue by 
sonication of animals in 1mL of ASTM water. Fluorescence measurements were 
performed in a microplate fluorescence reader (Synergy 2, BioTek, USA) using 
excitation/emission wavelengths of 480/530nm for Rh123 and Ca-AM and 
530/590nm for RhB. Measurements of each replicate were run in triplicates and 
were corrected for background fluorescence levels of ASTM water. 
Fluorescence values were then converted to concentration units using a 
calibration curve based on 8 data points from different concentrations of calcein 
disodium salt (fluorescent dye), or Rh123 or RhB. Accumulated dye is reported 
as pmol/individual.  
 
6.3.6. Gene and dye efflux induction experiments 
D. magna juveniles (4d old) were pre-exposed to two sublethal 
concentrations of inorganic mercury dosed as HgCl2 (Hg, 1,10nM) and the 
pesticides dacthal (1, 5µM ) and pentachlorophenol (PCP; 2,8µM). The tested 
concentrations were selected from preliminary acute responses. These three 
contaminants at the tested concentration range are known to induce ABC 
transporter transcripts, proteins and related efflux activities in mussel gills and 
fish cell lines (Della Torre et al., 2012; Eufemia and Epel, 2000; Navarro et al., 
2012b; Tutundjian and Minier, 2007b). Experiments were set up with groups of 
five individuals in 400mL of ASTM hard water with chemical added in the 
treatments and without chemical in the controls. Dacthal and pentachlophenol 
were dosed using acetone (<0.1mL/L) as a carrier and hence appropriate 
solvent controls were also used. After pre- exposures either transporter efflux 
activities in the animals were determined with dye efflux assays or transporter 
transcript levels were quantified with qPCR.  
 
6.3.7 Toxicity assays 
Acute toxicity assays were performed with the toxic ABCB1 substrate 
mitoxantrone (Taylor et al., 1991a), the toxic ABCC1 substrate chlorambucil (Su 
et al., 1998a), the ABCB1 inhibitor REV205, the ABCC inhibitor MK571, the 
ABCB1/ABCC inhibitor CsA and with combinations of toxic transporter 
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substrates and inhibitors. The toxicity assays with D. magna were performed 
following established guidelines (OECD, 1981). For preparing stock solutions, 
CsA and chlorambucil were dissolved in acetone, REV205 was dissolved in 
DMSO and MK571 and mitoxantrone were dissolved in milliQ water. 
Appropriate amounts on the chemical stocks were then added to ASTM hard 
water to prepare test solutions. The same amount of carrier (acetone or DMSO, 
0.1mL/L) were added to a solvent control and to the rest of test solutions to 
account for any carrier effect on survival and an additional control (ASTM water 
only) treatment were used. No mortality, monitored as immobile individuals, was 
observed in either carrier controls or non-manipulated controls. 
In a first set of experiments, toxicities of single compounds were determined 
with 6 to 8 concentrations in duplicates. Based on the concentration-effect 
curves derived from these data concentrations applied in binary mixtures of 
toxic substrates and inhibitors were defined and predictions of the combined 
toxic effects were made. In a second set of experiments, toxicities of binary 
mixtures of the toxic substrate compounds mitoxantrone and chlorambucil were 
determined, each combined either with inhibitor REV205, MK571 or CsA. We 
hypothesized that pairings of substrate and inhibitor compounds that interact 
with the same efflux transporter type (ABCB1-type efflux: mitoxantrone with 
REV205 or CsA; ABCC-type efflux: chlorambucil with MK571 or CsA) had joint 
toxic effects that were greater than additive because interference of inhibitors of 
a specific transporter type will result in increased uptake and toxic effect of the 
respective toxic substrate. Further, as the compounds that we used as inhibitors 
are in some cases also transporter substrates as was shown for CsA, a 
substrate of ABCB1 (Saeki et al., 1993), greater than additive toxic effects may 
also be expected for pairings of inhibitors targeting the same transporter type 
(ABCB1-type efflux: REV205 with CsA; ABCC-type efflux: MK571 with CsA) but 
not for the pairing of the inhibitors REV205 and MK571 targeting different 
transporter types. Additive joint toxicity was expected for pairings of both toxic 
substrate compounds (mitoxantrone, chlorambucil) and of the ABC transporter 
inhibitors REV205 and MK571. Toxicities of the mixtures were determined using 
the ray design that is based on constant mixture ratios deduced e.g. from LC50 
values (Altenburger et al., 2003). The ray design enables to determine whether 
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toxicities of mixtures follow the “concentration addition (CA)” or “independent 
action (IA)” concepts. 
 
6.3.8. Determination of the stability of test chemicals in aqueous test 
solutions 
The stability of mitoxantrone, chlorambucil, CsA, MK751, and REV205 in 
ASTM hard water over the duration of the toxicity tests was investigated by 
measuring their concentrations in freshly made aqueous test solutions (time 0) 
and after 24 and 48 h . Two concentrations of each compound were tested that 
corresponded to low and high exposure levels in the toxicity tests (0.5-10mg/L) 
(Table 6.2). Experiments were conducted under the same conditions as toxicity 
assays. Dissolved levels of the studied compounds were determined by direct 
sample injection using an AcQuity Ultra Performance Liquid Chromatography 
(UPLC) system equipped with a quaternary pump and connected to a triple 
quadrupole MS/MS system (Waters, USA). Data was acquired and processed 
using MassLynx 4.1 software package. A ZORBAX Eclipse XDB-C18 Narrow-
Bore column 2.1 x 150mm, 5µm from Agilent Technologies (Santa Clara, USA) 
was used. The mobile phase consisted of solvent A 5mM ammonium formate in 
water and solvent B 5mM ammonium formate in methanol. The initial mobile 
phase composition was 70% A and 30% B (5min), to 70% B in 3min and held 
for 10min, and to 100% B in 3min. These conditions were held for 4min and 
then the initial conditions were regained in 5min with an equilibration time of 
2min. The flow rate was set at 0.3mL*min-1. To optimize ionization and to 
establish mass spectral features, individual standards were first analysed by 
Flow Injection Analysis (FIA) in UPLC-MS in positive ESI mode, except for CsA 
that was analysed in negative ESI mode. Full-scan data acquisition was 
performed scanning from m/z 100 to 600 in profile mode, using a scan time of 
2s with a step size of 0.1u and a pause between each scan of 2ms. Optimized 
parameters were source temperature (from 125 to 150ºC), cone voltage (from 5 
to 50V) and collision energy (from 5 to 50eV).  
 
6.3.9. Data analyses and modelling responses 
One way ANOVA analyses of relative mRNA expression was performed 
using ∆Cp values, as this parameter followed normal distribution and the 
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variances were homocedastic, as assessed by the Kolmogorov–Smirnov, 
Shapiro Wilk and Barlett’s tests. To facilitate the interpretation of results these 
values were expressed as mRNA copies of target gene per 106 copies of the 
reference gene mRNA. 
Transporter efflux activity was evaluated comparing the levels of 
fluorescence in absence and presence of inhibitors across treatments using one 
way ANOVA. Lowest Effect Concentration values (LOEC) were estimated with 
post-hoc Dunnet’s test. When required data was log transformed to improve 
ANOVA assumptions of normality and variance homocedasticity. Statistics tests 
were performed using the SPSS 17 (SPSS Inc., 2002) package.  
 
6.3.9.1. Modelling single and mixture effects 
Transporter efflux activity and IC50 values were evaluated by fitting data to 
the classical Hill four parameter dose–response model (eq. 6.1)  
)1.6.eq(
x
IC1
min)(maxminR Hill
50 


  
where R is the response, min and max represents minimum and maximum of 
the response, Hill is the shape parameter, IC50 is the concentration of 
chemosensitizers that corresponds to 50% of the maximal effect.  
The concentration–response relationships of the individual substances were 
biometrically modelled by using a best-fit approach (Scholze et al., 2001) and 
eq 6. 2 which is a simplification of eq. 6.1:  
)2.6.eq(
)x/LC(1
100)inh(%E p
50
  
with E = effect in %; p = slope; LC = lethal effect concentration; 
x=concentration (µM). 
On the basis of the concentration–response functions of individual 
compounds, predictions of concentration addition were calculated for mixtures 
containing binary combinations in a definite ratio (based on LC50). A total 
concentration of the mixture, at which a certain effect is generated, can be 
calculated using concentration addition according to eq. 6.3 
)3.6.eq(
LCx
pLCx
1
n
1i
i
i
mix

 


   
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In this equation LCxmix is the total concentration of the mixture provoking x% 
lethal effect; LCxi is the concentration of component i provoking the x% lethal 
effect, when applied singly; and pi denotes the fraction of component I in the 
mixture. The calculation of total mixture concentrations for various effect levels 
lead to a complete iteration of an expected concentration–effect relationship. 
The prediction concept independent action allows explicit calculation of 
combined effects according to eq. 6. 4 
  )4.6.eq()c(L11)c(L n
1i
imix 

  
The lethal effect at the total concentration of the mixture, L(cmix), is based on 
the lethal effects of the components which they generate at concentration x at 
which they are present in the mixture (L(ci)). If the latter is expressed as a 
fraction (pi) of the total mixture concentration, it holds eq. 6.5: 
  )5.6.eq()cp(L11)c(L n
1i
miximix 

  
This allows calculation of an effect expected according to the concept of 
independent action for any concentration of the mixture. 
 
6.4. Results and Discussion 
 
6.4.1. Stability of test chemicals in aqueous test solutions 
Concentrations of REV205, MK571 and CsA in unmodified form were stable 
in ASTM hard water over 48h as measured concentrations at 0, 24 and 48h 
were close to nominal ones (Table 6.2). REV205 was confirmed with a fragment 
ion at m/z 699, formed by the loss of ester moiety. MK571 was confirmed with 
the fragment ions at m/z 409 and m/z 382, and CsA was confirmed with 
fragment ions at m/z 513 [C25H47N6O5]+ and m/z 113 [C7H13O]+ (Table 6.2). 
Mitoxantrone was rapidly degraded, the parental compound was absent even in 
freshly prepared aqueous solutions. The two identified transformation products 
were TP1 at m/z 268 and TP2 at m/z 282, both confirmed with the fragment ion 
at m/z 214. TP1 at m/z 268 corresponds to [C4H10NO]+. TP2 identified at m/z 
282 corresponds to the loss of N-ethylethanolamina [C4H10NO]+ and N-
methylethanolamina [C3H8NO]+. These two TPs that were stable during the 
48h period of the experiment in sum corresponded to almost 100% of initial 
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nominal concentrations (Table 6. 2). Chlorambucil quickly degraded in aqueous 
solutions. The parental compound, monitored at m/z 304, was detected only in 
the freshly prepared solutions, albeit at a level 81 % below the nominal 
concentration in the high concentration solution. The transformation product of 
chlorambucil [C14H18NOCl2]+ was identified at m/z 286, corresponding to the 
loss of the hydroxyl group.. It accounted for 95% and 85 %, respectively, of the 
nominal concentrations in the freshly prepared solutions, but was absent after 
24 and 48 h (Table 6.2).Our results agree with other studies showing that the 
mitoxantrone and chlorambucil parental compounds rapidly degraded to 
transformation products in aqueous solutions (Löf et al., 1997; Lohmann and 
Karst, 2007; Negreira et al., 2013). There are no reports on toxicities of 
transformation products of those cytostatic drugs (Kosjek and Heath, 2011). 
Nevertheless, further toxicological studies conducted in our lab (data not 
shown) were performed using water initially fortified with toxic doses of 
mitoxantrone and chlorambucil and subsequently left aging during 4 days 
(Gómez-Canela et al., in press). The results of those experiments showed that 
D. magna toxicity of aqueous solutions of mitoxantrone were stable for 96 
hours, whereas those of chlorambucil decreased exponentially during the first 
24h. This means that mitoxantrone toxicity or that of its transformation products 
was stable over the studied period but that of chlorambucil did not decreasing to 
marginal levels within the first 24h.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compound    Time 0 h Time 24 h Time 48 h 
 
Protonated 
molecule 
[M+H]+ 
Fragment 
ions 
Nominal 
(mg/L) 
Mean 
(mg/L) 
SD 
Mean 
(mg/L)  
SD 
Mean 
(mg/L) 
SD 
Mitoxantrone 445 214 
2 BDL -- BDL -- BDL -- 
10 BDL -- BDL -- BDL -- 
Mitoxantrone TP1 268 214 
2 1.91 0.02 1.90 0.02 1.90 0.02 
10 7.26 0.09 6.98 0.18 7.12 0.15 
Mitoxantrone TP2 282 214 
2 0.09 0.02 0.10 0.01 0.10 0.01 
10 2.74 0.09 3.02 0.18 2.88 0.15 
Chlorambucil 304 181 
2 BDL -- BDL -- BDL -- 
10 1.52 0.27 BDL -- BDL -- 
Chlorambucil TP1 286 181 
2 1.90 0.01 BDL -- BDL -- 
10 8.48 0.27 0.54 0.08 BDL -- 
Reversin 205 799 699 
0.5 0.40 0.04 0.41 0.08 0.36 0.08 
5 3.81 0.17 3.44 0.23 4.18 0.42 
MK571 515 409/382 
1 1.03 0.06 1.19 0.05 1.15 0.05 
5 5.22 0.29 5.13 0.08 5.12 0.21 
CsA 1201 [M-H]- 113/513 
0.5 0.54 0.15 0.51 0.11 0.42 0.09 
5 4.95 0.32 4.70 0.49 4.00 0.87 
Table 6.2. Nominal and measured concentration levels (mg/L) of the studied compounds in ASTM hard water in freshly prepared (time 0) and old test 
solutions (24-48 h). Protonated molecule of mitoxantrone was not detected and instead its transformation products TP1 and TP2 were analysed. 
Chlorambucil analyses include protonated molecule and transformation product 1 (TP1). BDL, below detection limit.
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6.4.2. Identification and expression of partial ABCB, ABCC cds 
RT-PCR with primers directed against abc transporters predicted from the D. 
pulex genome (Sturm et al., 2009) resulted in D. magna sequences that were 
identified as partial abcb, abcc1/3, abcc4 and abcc5 cds (Fig 6.3). 
The structure of full transporter ABC proteins, such as ABCB and ABCC, 
comprises 3/4 subunits, each with one or two trans-membrane domain and two 
nucleotide binding domains (NBD) (Sturm et al., 2009). The NBDs contain 
typical and highly conserved motifs, such as Walker A, Walker B and ABC 
signatures (Ambudkar et al., 2006). For these reason this was the target region 
of the gene selected for sequencing. We cloned five partial sequences, ranging 
from 200 to 540bp cDNA sequence from D. magna (NCBI access. numbers 
KC172920, KC172922- KC172924 for ABCB1, ABCC1-3, ABCC4, ABCC5, 
respectively). Alignments of the obtained D. magna partial ABC amino acid 
sequence with respective NBD sequences from D. pulex ABCB, ABCC1-3, 
ABCC4 and ABCC5 showed a 94%, 99%, 98% and 91% identity, respectively, 
indicating that the identified sequence encodes partial NBD’s of a D. magna 
ABC transporters (Figure 6.3). Obtained sequences encompassed NBD 
fragments as determined with the Conserved Domain Database (CDD) 
(Marchler-Bauer et al., 2011) including ABC signature and Walker B motif 
(Figure 6.3).  
NCBI BLAST of the D. magna amino acid sequences further confirmed their 
identities as different ABC transporter homologs. This is illustrated by the 
phylogenetic trees based on alignments of the respective D. magna amino acid 
sequences with sequences appearing within the first 100 hits of a NCBI BLAST 
search (Fig.6.4). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3A. Alignment of the putative partial ABCB1, ABCC1-3-like sequences from D. magna with ABC nucleotide binding domains (NBD) of several 
organisms. Amino acid positions of the comparison ABC sequence stretches that align with the D. magna ABC sequences are indicated. The conserved 
motifs ABC signature and Walker B domain are highlighted in light and dark grey respectively. From all the ABC sequences only amino acids diverging from 
the D. magna ABC sequences are given. Protein codes as those of NCBI. 
 
 Daphnia magna ABCB1 KC172920  ident  501VALVGTSGCGKSTCVQLLQRFYDPIEGSVSIDGNELRDLHLGWLREQMGVVGQEPVLFGTSIGENICYGRDGVSQEEMERAAKEANAHDFIQRLPRKYDTLVGERGAQLSGGQKQRIA 148 Daphnia pulex  EFX85237  94%  481..............I.........L....T.......N.N.....D...M........................K...............................G........... 598 
Branchiostoma floridae XP_002608794  74%  314...C.S.......T...I......TK.M.TL..HDI.S.NIQ...QNI...S......A.T.A...S...A..T...I.K...........K...K..N................... 431 
Crassostrea gigas  EKC23020  75%  283.....S.......II.........E..E.AL..RNIKN.NTK...Q.I...S...I..A.T.A...R..KEAI..Q.I.A...M.......MNF.K..E.........M......... 400 
Rattus norvegicus AAI07561  76%  421.....N.......T......L......E.....QDI.TINVRY...II...S......A.T.A...R...EN.TMD.I.K.V.....Y...MK..H.FN................... 538 
Rattus norvegicus  AAK83023  75%  415.....N.......T......L......E.....QDI.TINVRY...II...S......A.T.A...R...EN.TMD.I.K.V.....Y...MK..H.F.................... 532 
Sus scrofa AAW02918  76%  155.....N.......T...M..L...T..V.....QDI.TINVRY...II...S......A.T.A...R...EN.TM..I.K.V.....Y...MK..N.F.................... 272 
Rattus norvegicus  AAS91649  76%  415.....N.......T......L......E.....QDI.TINVRY...II...S......A.T.A...R...EN.TMD.I.K.V.....Y...MK..H.F.................... 532 
Rattus norvegicus NP_596892  76%  415.....N.......T......L......E.....QDI.TINVRY...II...S......A.T.A...R...EN.TMD.I.K.V.....Y...MK..H.F.................... 532 
Rattus norvegicus  P43245  76%  422.....N.......T......L......E.....QDI.TINVRY...II...S......A.T.A...R...EN.TMD.I.K.V.....Y...MK..H.F.................... 539 
Heterocephalus glaber EHB12084  76%  372.....N.......T...I..L...T..V.....QDI.T.NVRY...II...S......A.T.A...R...EN.TM..I.K.V.....Y...MK..H.F.................... 489 
Daphnia magna ABCB  KC172920  identit  147  IARALVRQPKILLLDEATSALDTQSESVVQKALDKARQGRTTIIVAHRL 1 
Daphnia pulex  EFX85237  94%  599  ..........................A...................... 647 
Branchiostoma floridae XP_002608794  74%  432 .......N...............E..AT..E............VI.... 480
Crassostrea gigas  EKC23020  75%  401  ......KD...............D......E......A....VV..... 449 
Rattus norvegicus  AAI07561  76%  539  .......N...............E..A...A......E.....VI.... 587 
Rattus norvegicus  AAK83023  75%  533  .......N...............E..A...A......E.....VI.... 581 
Sus scrofa  AAW02918  76%  273  .......N...............E..A...V......E.....VI.... 321 
Rattus norvegicus  AAS91649  76%  533  .......N...............E..A...A......E.....VI.... 581 
Rattus norvegicus  NP_596892  76%  533  .......N...............E..A...A......E.....VI.... 581 
Rattus norvegicus  P43245  76%  540  .......N...............E..A...A......E.....VI.... 588 
Heterocephalus glaber  EHB12084  76%  490  .......N...............E..A...V......E.....VI.... 538 
   D. magna ABCC 1‐3 KC172922  identit 3EGGENLSVGQRQLICLARALLRKTQVLILDEATAAVDLETDDLIQATIRKEFKEGTVITIAHRLNTILDSNRVMVLDKGEIKEYA 173[Daphnia pulex EFX72783  99%  1440........................K............................................................ 1496
Rattus norvegicus CAA65258  81%  1.............V..........KI.V.................S...TQ.EDS..L.........M.YT..I.......R. 57
Pongo abelii XP_002826206  80%  117.............V..........KI.V.................S...TQ.EDC..L.........M.YT..I.......Q..G 173
Culex quinquefasciatus XP_001862061  86%  333........................K....................R...T...DC..L.........M..DK.I.....Q.T… 389
Rhipicephalus microplus AEI91125  76%  55.....I.......V.........SRI...........M...........R..ADC.I.........V..YD.I....R.Q.V.F 111
Cricetulus griseus EGV92991  80%  40.............V..........KI.V.................S...TQ.EDC..L.........M.YT..I......VR. 96
Macaca mulatta AFE71101  80%  178.............V..........KI.V.................S...TQ.EDC..L.........M.YT..I.......Q..G 234
Apis mellifera XP_001123016  82%  176.......I................K.........S..........Q...Q...DC.IL............D.II...N.R.V.. 232
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3B. Alignment of the putative partial ABCC4, ABCC5-like sequences from D. magna with ABC nucleotide binding domains (NBD) of several 
organisms. Amino acid positions of the comparison ABC sequence stretches that align with the D.magna ABC sequences are indicated. The conserved motifs 
ABC signature and Walker B domain are highlighted in light and dark grey respectively. From all the ABC sequences only amino acids diverging from the D. 
magna ABC sequences are given. Percentage identity is also depicted. Protein codes as those of NCBI. 
 
   
D. magna ABCC 4 KC172923  ident  201ALDKDFSLFPNGDQTAVGERGVSLSGGQKARVNLARSLYVDADIYLMDDPLSAVDTHVGRHLFDKAINGYLRDKIRVLVTHQLQ 380
Daphnia pulex  EFX68457  98%  521...............T.....................................................F.............. 580
Acromyrmex echinatior EGI58005  75%  569.KR....L.Y..K.I............R..I....AV.A...............A...K.M..ECV.K...G.T.I....... 627
Drosophila virilis XP_002056519  74%  547..ER..E.L.Y..K.I.....A.........IS...AV.RK.....L.................QCMR.....N.VL....... 606
Drosophila pseudoobscura XP_002137937  71%  520..ER..Q.L.Y..K.I.....A.........IS...AV.RR.....L.................QCMH....SELVI....... 579
Drosophila persimilis XP_002019432  71%  520..ER..Q.L.Y..K.I.....A.........IS...AV.RR.....L.................QCMH....SELVI....... 579
Drosophila grimshawi XP_001994164  73%  545..ER..E.L.Y..K.I.....A.........IS...AV.RK.....L.................QCMR.F..ED.V........ 604
Drosophila sechellia XP_002031608  71%  524..ER..E.L.F..K.I.....A.........IS...AV.RR.....L.................QCMR....SELVI....... 583
Tribolium castaneum EFA04298  73%  546..VR..Q.L.D....I...K.A......R..I....AV.KN.....L............KQ....C.T.F.A...VI....... 605
Drosophila mojavensis XP_002000613  74%  545..ER..E.L.Y..K.I.....A.........IS...AV.RK.....L.................QCMR.....N.VL....... 604
Daphnia magna ABCC5 KC172924  identit  3 LYTDEAIWEAIERTNMKDKIKALPDKLDSPVIENGENFSVGERQLLCMARALLRHSKVRM 182
Daphnia pulex EFX72656  91%  1275 .........V.............Q....L.T.........................I 1331
Daphnia pulex EFX72657  86%  1263 .D.DV...........E......GQ...A...........................I 1319
Daphnia pulex EFX63846  86%  1124 .D.DV.....G.....E......G....A...........................I 1180
Monosiga brevicollis  XP_001748233  69%  241 V.A..Q..T.L..AH.R.A.RR..E...A..V...N..................N.RI 298 
Ciona intestinalis XP_002124642  73%  253 .S..E..K.L...H..PT.SE.....ETE.V...................I.....II. 311
Nematostella vectensis  XP_001623747  68%  1196 .S..EL.K.L..SHL..MVSN..L..EA..V.............I...........IL. 1254 
Saccoglossus kowalevskii XP_002739851  68%  282 ...AEL.N.L.K.C..PN..D..EQ.ET..V.............M........N..I 338
Saccoglossus kowalevskii XP_002730480  68%  982 ...QEL..SL.K.Y..ST.SN.DNQ.E.................I........N..IL. 1040
Danio rerio  XP_696904  72%  1228 .K..EL.L.L.K.Y...T.SK..E..Q...V.............M........N..I 1284
Branchiostoma floridae XP_002610101  68%  1097 .S.NQL.Q.L..SY...R.S..EKQ.EA................I........N..I 1153
  
 
Figure 6.4A. Phylogenetic tree including the D. magna ABCB1 sequences with the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual phylogenetic position of the sequence in the tree. Clustering only considered the protein 
region equivalent to the one sequenced in the D. magna abcb1 gene identify as “p glycoprotein partial Daphnia magna”.  
  
  
 
 
Figure 6.4B. Phylogenetic tree including the D. magna ABCC1-3 sequences with the first 100 identified sequence hits. Gene definitions are from the 
GenBank original description, without considering their adequacy to the actual phylogenetic position of the sequence in the tree. Clustering only considered 
the protein region equivalent to the one sequenced in the D. magna abcc1-3 gene identify as “putative multidrug protein 1-3 partial Daphnia magna”.  
  
 
 
Figure 6.4C. Phylogenetic tree including the D. magna ABCC4 sequences with the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual phylogenetic position of the sequence in the tree. Clustering only considered the protein 
region equivalent to the one sequenced in the D. magna abcc4 gene identify as “putative multidrug protein 4 partial Daphnia magna”.  
 
 
 
 
 
 
  
Figure 6.4D. Phylogenetic tree including the D. magna ABCC5 sequences with the first 100 identified sequence hits. Gene definitions are from the GenBank 
original description, without considering their adequacy to the actual phylogenetic position of the sequence in the tree. Clustering only considered the protein 
region equivalent to the one sequenced in the D. magna abcc5 gene identify as “putative multidrug protein 5 partial Daphnia magna”.  
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The aim of this part of the study was to determine whether putatively MXR 
associated genes are transcribed at all in D. magna and our data indicate that 
this is the case. Since our sequence data were obtained from RNA, these data 
show that these ABC transporter genes that highly correspond with predicted 
gene sequences from D. pulex (Sturm et al., 2009) are active genes that are 
indeed transcribed in D. magna. 
Further, although other physiological functions of the transporter proteins 
need to be considered transcription activity of abcb and abcc genes that in other 
organisms are associated with MXR function can be seen as indication that 
MXR efflux activity based on the respective transporter proteins may be found 
in D. magna. 
The sequences we obtained with PCR are from one representative of each 
homologue of mammalian ABCB1, ABCC1/ABCC3, ABCC4 and ABCC5. 
Among ABCB full transporters one other gene beside the one of which we 
obtained partial cds from D. magna and which in D. pulex encodes for protein 
Dappu-347264 was predicted from D. pulex genomic sequences, which 
encodes for Dappu-347265. Both D. pulex proteins, as also the D. magna 
sequence, cannot be clearly associated with any mammalian ABCB full 
transporter ortholog (Sturm et al., 2009); Fig. 2); the D. magna gene is therefore 
called here abcb. We were not able to amplify transcript corresponding to the 
Dappu-347265 encoding sequence and this gene may therefore not be 
transcribed in D. magna. Within the ABCC sub-family the abcc1/3 sequence of 
D. magna could not be associated with mammalian ABCC1 or ABCC3. There 
are similarities in functional properties of mammalian ABCC1 and ABCC3. Both 
proteins are multidrug resistance associated proteins conferring cellular efflux of 
conjugated compounds (Deeley and Cole, 2006) and a likewise function may 
also be assumed for the, on sequence level, comparatively similar D. magna 
Abcc1/3. 
There are no Abcc transporters in D. pulex that could be associated with 
ABCC2, another mammalian multidrug resistance associated protein, but one 
representative similar to mammalian ABCC4 and three ABCC5 like isoforms 
(Sturm et al., 2009). The Abcc5 sequence that we identified in D. magna 
Chapter 6 
235 
 
corresponds to the isoform encoding for the EFX72656 protein in D. pulex (Fig 
6.3B). 
Abcb and abcc1/3 transcript abundances in different live stages of D. magna 
as determined by qPCR were relatively low in eggs and embryos and increased 
in neonates and juveniles, whereas abcc4 and abcc5 transcripts were 
constantly at comparatively high levels in all life stages (Fig. 6.5A). Across 
transporters, transcript levels were lowest for abcb in eggs and juveniles with 
levels 10- to 15-fold below abcb levels in the older stages. Abcc1/3 levels that 
were also comparatibely low in eggs and embryos were about five-fold higher 
than abcb transcript levels in those stages. Compared to the other life stages 
examined transcript levels of all transporters were highest in juveniles. The 
different abcb and abcc1/3 transcript levels in different D. magna life stages 
resemble expression patterns of corresponding homologs in other aquatic 
invertebrate species. In mussels mRNA levels and transporter activity of 
abcb1/Abcb1 or/and of abcc/Abcc transporters are absent in eggs but they 
increase dramatically in the one day trocophora larvae (Faria et al., 2011b; 
McFadzen et al., 2000; Navarro et al., 2011; Navarro et al., 2012b). Function of 
those ABC transporters in early life stages of aquatic invertebrates has been 
associated with protection against potentially toxic chemicals dissolved in the 
water as development takes place outside of a parental organism and in direct 
contact with the environment (Faria et al., 2011b; Hamdoun et al., 2004; 
McFadzen et al., 2000; Navarro et al., 2012b; Roepke et al., 2006; Toomey et 
al., 1996). Although Daphnia eggs and embryos develop inside a maternal 
brood pouch they are also in direct contact with the water and with dissolved 
chemicals therein. Therefore, it may be assumed that ABC transporters likewise 
serve as defence against xeno-toxicants from the outside. Further, transporters 
from the ABCC subfamily may flux out metabolites from cells, another pivotal 
function for development of embryos (Shipp and Hamdoun, 2012).
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Figure 6.5. Relative levels of putative abcb, abcc1/3, abcc4, abcc5 transporters depicted as 
relative mRNA abundance of 18S ribosomal (Mean±SE, n=5-9) in D. magna eggs, embryos, 
newborn neonates, and juveniles of 4 days (A); and in juveniles of 4 days pre-exposed for 24h 
to model inducers. Different low case letters in graph A or symbols in graph B indicate 
significantly (P<0.05) different sets of data after ANOVA and Tukey's or Dunnett’s posthoc tests, 
respectively. In graph B mercury (Hg) results have been contrasted with those of control, 
whereas those of dacthal and pentachlorophenol (PCP) with solvent controls.  
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Exposure of D. magna juveniles to sub-lethal concentrations of inorganic Hg 
(1, 10nM), dacthal (1, 5µM) and pentachlorophenol (5µM), which have been 
shown to induce expression of MXR transporters in the past in mussels 
(Eufemia and Epel, 2000; Navarro et al., 2012b), had only little effects on 
transporter transcript levels (Fig 6.5B). Abcb transcript levels were significantly 
elevated only in the pentacholophenol treatment group and transcript levels of 
abcc4 were significantly above controls in the 10 nM Hg treatment (P<0.05, 
based on ANOVA and Dunnett’s tests). These data thus show that mRNA 
expression of abcb and abcc4 transporter genes can be induced by chemical 
stress. Although it needs to be considered that the applied compounds do not 
have the same transcription inducing effects of transporter genes in D. magna 
as in other species and/or that the abcc1/3 and abcc5 transporter genes are not 
chemically inducible it is also conceivable that the applied concentrations of the 
test compounds were not sufficient to induce transporter transcription. This may 
be the case for dacthal that had a D. magna 48h-LC50>150µM but not of 
mercury and pentachlorophenol since the tested concentrations were just two 
fold lower than the obtained 48h-LC50s (20nM Hg, 16µM PCP; results obtained 
from preliminary experiments). Nevertheless, selected concentrations of 
inducers were within the range used in previous studies (Eufemia and Epel, 
2000; Navarro et al., 2012b)  
 
6.4.3. Dye efflux assays  
Ex-vivo assays showed that both ABCB1, ABCC specific and unspecific 
inhibitors of MXR transporters (REV203, MK571 and CsA, respectively) were 
able to inhibit transporter activity leading to the accumulation of trace dyes in 
the organisms in a concentration-dependent manner (Fig. 6.6). The high 
variability observed, however, across replicates prevented the estimation of 
significant (P<0.05) IC50 in most occasions using regression approaches 
(Table 6.3). 
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Figure 6.6. Effect of transported MXR inhibitors on the accumulation of Ca-AM, (measured as 
calcein) (left), Rh123 (middle) and RhB (right graph pannel) (pmol/individual) in D. magna 
juveniles. Symbols are single measurements. Data were fitted to the four parameter dose-
response Hill model of eq. 6.1. Solvent controls (C) are also included.  
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Table 6.3. Inhibition concentration (IC50) values based on nominal concentrations and its 
standard error (SE), maximal accumulation (Max, fold increase) of Ca-AM, Rh123 and RhB with 
the model inhibitors used. The lowest significant (P<0.05) concentration effect in dye 
accumulation levels relative to controls (LOEC) is also depicted . N, sample size, r2, r square. 
ns, P≥ 0.05: * 0.01<P<0.01; ***P<0.001  
 
Substrate Parameter Model Inhibitor  
  REV205 MK571 CsA 
Ca-AM Max  2.2 2.2  1.9 
 IC50 (µM) 0.3 (ns) 1.5(0.6) 2.7 (ns) 
 LOEC (µM) 1 1 2 
 r2 0.34 ** 0.64 *** 0.50 *** 
 N 48 60 68 
     
Rh123 Max  1.4 1.5 1.8 
 IC50 (µM) 3.4 (ns) 0.9 (ns) 6.2 (ns) 
 LOEC (µM) 5 1 5 
 r2 0.26 ** 0.51 *** 0.57*** 
 N 38 59 70 
     
RhB Max  1.6 1.9 1.4 
 IC50 (µM) 1.5 (ns) 4.6 (0.7) 3.1 (1.1) 
 LOEC (µM) 5 5 5 
 r2 0.36 *** 0.60 *** 0.42 *** 
 N 39 58 60 
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Nevertheless, ANOVA results depicted as estimated LOEC indicated that in 
all the transporter inhibition assays there was a significant (P<0.05) increase of 
accumulated dye relative to controls. These results provided the first indication 
of the activity of ABC transporter activity in D. magna.  
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Figure 6.7. Effect of putative transported MXR inducers on the accumulation (Mean±SE, 
N=10) of Ca-AM, (measured as Calcein), Rh123 and RhB in D. magna juveniles after 24h of 
exposure. Respective control (C) or solvent control (SC) treatments are also depicted. 
*significant (P<0.05) differences from controls or solvent controls after ANOVA and Dunnet’s 
post-hoc tests 
 
 
The use of ex-vivo assays may have underestimated transporter activity, 
increasing experimental noise since prevented dyes to be accumulated in the 
gut, which was the organ having greater levels of fluorescence and probably of 
transporter activity (images of dye target organs are depicted in Fig 6.1). 
Nevertheless, in most treatments mean IC50s varied across dyes and 
transporter inhibitors. For Ca-AM, REV205 had a greater specificity (lower IC50, 
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Table 6.3) than MK571 but an equivalent inhibition potential (similar maximal 
fold increase in accumulated dye; Table 6.3). For the dye Rh123, MK571 
showed greater specificity than REV205 and CsA (lower IC50, Table 6.3). For 
the dye RhB, REV203 had a greater specificity (i.e., lower IC50 value) than 
MK571 and CsA accumulating dye. It has been reported that RhB is a specific 
ABCB1 substrate, whereas Rh123 and Ca-AM may also be substrates for 
ABCC1 and ABCC2 as well (Daoud et al., 2000; Essodaïgui et al., 1998; Eytan 
et al., 1997; Hollo et al., 1994; Holló et al., 1996; Yeheskely-Hayon et al., 
2009b). Furthermore, REV205 and MK571 are not fully specific inhibitors of 
ABCB1 and ABCC, respectively, since at higher µM concentrations show a 
significant cross-inhibitory activity (Haimeur et al., 2004; Sharom et al., 1999b; 
Zaja et al., 2008). These findings from mammalian/vertebrate models were 
confirmed in our experiments in D. magna as inhibitors of ABCC transporters in 
mammalian systems (CsA and MK571) also led to an increase in the 
accumulation of Ca-AM and Rh123 in D. magna juveniles. It is noticeable that 
REV205, but not CsA, (both putative ABCB1 inhibitors) changed their inhibitory 
properties depending on the substrate, showing the greatest affinity for Ca-AM 
followed by RhB. MK571 (a ABCC inhibitor) had the greatest potential to inhibit 
efflux transporter activity of Ca-AM and the lowest to do so for RhB, which 
agrees with expectations since Ca-AM is considered a more specific substrate 
of ABCC than RhB (Essodaïgui et al., 1998; Yeheskely-Hayon et al., 2009b). 
Maximal level of inhibition across MXR substrate dyes and inhibitors (1.4-2.8) 
were in the lower range of those reported in mussel gills (2-7 fold), zebra 
mussel embryos or fish cell lines (7-23 fold) (Luckenbach et al., 2008; 
Luckenbach and Epel, 2005a; Smital et al., 2004) (Faria et al., 2011b; Zaja et 
al., 2008). 
Pre-exposure of D. magna juveniles to inorganic mercury, dachtal and 
pentachlorophenol, decreased significantly (P<0.05) the accumulation of the 
studied dyes in most occasions (Fig 6.7). In only two treatments there were no 
significant (P<0.05) dye accumulation changes relative to controls. These 
treatments included accumulation of Ca-AM and RhB of juveniles pre-exposed 
to dachtal and mercury, respectively. Lower accumulation levels of dye can be 
interpreted as greater MXR type transporter activity. There is reported evidence 
that the chlorinated aromatic pesticides dacthal and pentachlorophenol induce 
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abcb1/Abcb1 gene/ protein expression and related efflux of RhB and Ca-AM in 
the mussels Mytilus californianus and Dreissena polymorpha (Eufemia and 
Epel, 2000; Navarro et al., 2012a; Tutundjian and Minier, 2007a). Mercury 
induced expression of mammalian ABCC1 (Kim et al., 2005) and increased 
abcc gene expression and Abcc transporter activity in zebra mussel (Navarro et 
al., 2012a). Ca-AM is known to be specific substrate of ABCB1 and ABCC 
transporters and RhB and Rh123 a better substrate for ABCB1 and ABCC 
transporters, respectively (Daoud et al., 2000; Essodaïgui et al., 1998; Eytan et 
al., 1997; Hollo et al., 1994; Holló et al., 1996; Yeheskely-Hayon et al., 2009b). 
Results obtained for RhB, then, agree with expectation since only dachtal and 
pentachlorophenol decreased the accumulation of the dye in pre-exposed 
juveniles. All three inducers decreased the accumulation of Rh123 having 
mercury the strongest effects. This may indicate that in D. magna dachtal and 
pentachlorophenol also induced Abcc type transporters or that D. magna Abcb 
like transporters were not as specific as mammalian ones for rhodamine dyes, 
thus showing also high affinity for transporting RhB. The second argument 
seems to be the most feasible provided the observed lack of specificity of Abcb 
and Abcc type efflux activity across the studied dyes (Fig 6.6). The lack of effect 
of dachtal decreasing the fluorescence levels of Ca-AM but not of RhB and 
Rh123 may be also related to secondary side effects related with the hydrolysis 
of Ca-AM by cellular esterases.  
The results obtained from induction experiments (Fig 6.5B and Fig 6.6) could 
be summarized as follows: Under exposure to mercury, increased levels of 
mRNA of abcc4 (Fig 6.5 B) were related with low rates of accumulation of Ca-
AM and of Rh123 but not of RhB (Fig 6.7), which may indicate that mercury is 
inducing functional abcc4 like transporters. In fish cell lines and zebra mussel 
gills mercury induces mRNA levels of abcc1-4 transporters and their related 
transporter activity (Della Torre et al., 2012; Navarro et al., 2012b). Dacthal 
induction results were not conclusive since this pesticide decreased the 
accumulation of RhB but not of Ca-AM, despite that both compounds are 
substrates of ABCB1 transporters; decreased the accumulation of a putative 
ABCC transporter (Rh123) and did not affect transcription levels of the studied 
abc genes. In zebra mussel embryos and adult gills dacthal was also not a 
specific inducers of Abcb1 transporters since it also induced abcc genes and 
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the putative transporter activity (Navarro et al., 2012b). This means that dacthal 
may be detoxify by other MXR transporters than the ones sequenced in the 
present study, which is likely to occur provided the high diversity of abc 
transporters found in the genome of D. pulex (Sturm et al., 2009). Results for 
pentachlorophenol also agree with those obtained in M. californianus (Eufemia 
and Epel, 2000) since this compound increased mRNA transcripts of abcb1 and 
also the associated transporter activity of RhB and Ca-AM.  
In summary induction experiments provided further evidence that the 
sequenced abcb1 and abcc4 D. magna genes, that were homologous to those 
of D. pulex (Sturm et al., 2009) are likely to be ABCB1 and ABCC transporters, 
whereas the functionality of the remaining gene sequences is still unknown.  
 
6.4.4. Toxicity responses 
Toxicity concentration-response curves for all tested chemicals in D. magna 
juveniles at 24 and 4 h are shown in Fig. 6.8. In the case of CsA, its maximum 
water solubility levels (100µM) corresponded to the LC30 value at 24h. As 
expected, toxicity (LC50, Table 6.4) increased with exposure time being the 
greatest effect observed for CsA and mitoxantrone. It is important to note that 
toxicity of chlorambucil hardly increased with exposure time, probably because 
it’s relatively low stability in ASTM water. Estimated regression parameters of 
eq. 2 showed a good model fit (r2≥0.78; Table 6.4) of all single concentration-
response curves.  
 
Table 6. 4. Regression parameters according to eq. 2 of fitted models to single exposures of the 
studied chemicals. All regressions were significant (P<0.001). N, sample size, r2, r square. LC50 
are based on nominal concentrations. 
Compound Exposure time (h) LC50 (µM) 95% CI (µM) p r2 N 
Chlorambucil 24 102 95.2 108.8 5.3 0.87 50 
48 77.4 75.4 79.4 15.9 0.93 50 
Mitoxantrone 24 45.7 37.7 53.7 2.3 0.84 24 
48 11.6 9.5 13.7 2.4 0.94 24 
REV205 24 35.7 32.6 38.8 2.2 0.94 29 
48 15.1 13.9 16.3 3 0.97 29 
MK571 24 89 86.4 91.6 6.6 0.91 40 
48 80.3 75.3 85.4 5.7 0.78 40 
CsA 24 160.1 115.9 204.3 1.6 0.79 43 
  48 24.6 20.4 28.8 2 0.88 43 
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Figure 6.8. Percentage of immobile D. magna juveniles after 24 and 48h of single exposure to 
the studied compounds. Each symbol corresponds to a single replicate. Responses have been 
fitted to the Hill regression model of eq. 2 (see text). Horizontal axis is depicted in log scale. 
Open and black triangles or doted and strike lines correspond to 24 and 48h exposures, 
respectively. Triangles are single observations 
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The mode of action of the studied chemicals is unknown in D. magna but 
those of cytostatic drugs are well known in mammalian cells and used to treat 
cancer. Chlorambucil is an anti-neoplasic agent used to treat lymphocyte 
leukaemia that belongs to the group of alkylating agents (Barnouin et al., 1998). 
The human multidrug resistance protein (ABCC1) confers resistance of cells to 
chlorambucil (Barnouin et al., 1998). Mitoxantrone, a ABCB1 substrate, belongs 
to the series of anthraquinones and stop tumour growth by cross-linking 
guanine bases in DNA double-helix strands - directly attacking DNA (Kizek et 
al., 2012; Shen et al., 2009). There is also evidence that CsA is an inhibitor of 
different cytochrome P450 Cyp enzymes in humans, and MK571 is a 
leukotriene receptor agonist (Lin and Lu, 1998; Mellor et al., 2001; Moochhala 
and Renton, 1986). Considering that it is likely that the five studied compounds 
act through different mechanisms, we should expect a priori joint additive 
effects to be predicted by the IA concept. Nevertheless, the alternative 
argument that the tested chemicals could act by the same mechanisms of 
action cannot be discarded. Therefore, the observed joint effects were 
confronted with effects predicted by IA and CA concepts.  
From the 19 binary mixtures and exposure period combinations from which it 
was possible to obtain defined concentration-response joint effects (Fig. 6.9), 
those involving the studied cytostatic compounds and the model inhibitors 
MK571 and CsA and CsA and MK571 (9 mixtures) showed toxic effects greater 
than additivity according to both IA and CA concepts (Table 6.5). Synergism in 
terms of fold changes in toxicity relative to reference additive models (i.e. IA) 
was as high as 7.4 fold for the binary mixture of mitoxantrone and CsA. Binary 
combinations involving the studied model inhibitors and chlorambucil showed 
greater synergistic effects at 24 than at 48 h probably since chlorambucil 
disappeared from water shortly after exposure. Consequently, 
chemosensitization effects of the studied MXR inhibitors impairing the efflux of 
this drug were greatest during the first hours of exposure. Alternatively, 
synergistic effects of CsA were greater at 48 h than at 24 h. We consider that 
this retarded effect of CsA may be related to its high molecular weight and 
hence to its lower bio-availability to D. magna juveniles. Binary combinations of 
cytostatic drugs with REV205 only showed moderate levels of enhance toxicity 
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(1.5 fold) relative to IA predictions for chlorambucil at 24 h being antagonistic or 
additive in the remaining seven studied pair combinations. These results 
disagree with expectations since chlorambucil is known to be effluxed out by 
ABCC transporters in mammalian cells and REV205 is a known ABCB1 
inhibitor. Similarly greater than additive toxic effects may also be expected for 
pairings of inhibitors targeting the same transporter type (REV205 with CsA). 
Nevertheless, it is important to consider that in in vivo assays REV205 showed 
a great potential to inhibit filtering rates of D. magna juveniles decreasing the 
uptake of Rh123 that was used as a surrogate substrate of MXR transporters 
(see Fig S4, Supplementary Information). Thus, it is likely that REV205 
prevented both the uptake and the release of the studied drugs or inhibitors. 
This means that the inhibitory effect of REV205 on MXR transporters, which 
would increase internal cell concentrations of cytostatic drugs or CsA, may have 
been overcome by the inhibition of filtering rates and the consequent reduction 
of drug uptake. Join toxicity of binary combinations of cytostatic drugs or 
between inhibitors targeting different transporters (REV205 and MK751) should 
be expected to be additive and accurately predicted by the IA concept. Results 
reported in Fig 6.9 and those depicted in Table 6.5 agree with expectations. 
Joint synergic effects greater than IA and CA predictions have been seldom 
reported in mixture toxicity evaluations conducted with individuals (Altenburger 
et al., 2003). This means that our success in getting synergic effects (5 out of 8 
binary combinations) is uncommon and support the statement that 
chemosensitization increased the joint toxicity of chemical mixtures to a greater 
extent than predicted by IA and CA concepts probably by favouring the 
accumulation of cytostatic drugs or inhibitors as it was shown indirectly in the 
dye efflux assays. Obviously mixture toxicity results are not conclusive and 
cannot discard alternative mechanisms of action that may enhance toxicity 
more than expected. For example CsA, which is also known to inhibit P450 
enzymes in humans (Moochhala and Renton, 1986) may also inhibited them in 
D. magna resulting in a reducing metabolism of cyclostatics. In our study CsA 
was the chemosensitizer showing greater synergic effects when co-exposed 
with the studied cytostatics, an effect that could be explained due to the fact that 
CsA inhibits the two transporter subfamilies (ABCB, ABCC) or due to the joint  
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Figure 6.9. Percentage of immobile D. magna juveniles after 24 and 48h of exposures to 
equitoxic binary mixtures of mitoxantrone and chlorambucil with REV205, MK571 and CsA. 
Each symbol corresponds to a single replicate. Concentration – responses curves predicted by 
the CA (black lines) and IA (grey lines) concepts are also depicted. Fitted Hill curves (eq. 6.2) to 
observed joint effects are depicted as short dashed lines. Horizontal axis is depicted in log 
scale. Within each binary combination left and right graphs or open and black triangles 
correspond to 24 and 48h exposures, respectively.  
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Table 6. 5. Summary of mixture assays showing estimated median lethal concentration effects 
referred to nominal concentrations; LC50s (95% CI) of observed joint responses according to 
the model of eq 2 and those derived from the IA and CA concepts (eqs 3,5). Fold changes of 
median lethal effects due to antagonism (clear grey) and synergism (dark grey) are also shown. 
White coloured cells means that joint effects did not deviate from additivity since 95% CI overlap 
with mean predictive values according to either IA and CA.  
 
        LC50   Fold change 
    Time LC50 (95% CL) IA CA IA CA 
Mitoxantrone REV205 24 63.9 (60.5-67.3) 55.6 40.7 1.1 1.6 
48 23.0(21.1-24.9) 18.2 13 1.3 1.8 
MK571 24 70.1 (58.9-81.3) 93.7 84.9 1.3 1.2 
48 42.9 (39.9-45.9) 82.2 61.9 1.9 1.4 
CsA 48 2.4 (2.2-2.6) 17.8 14.6 7.4 6.1 
Chlorambucil REV205 24 70.9 (60.1-81.8) 107.8 68.9 1.5 1 
48 39.7 (36.2-43.2) 33.1 26.9 1.2 1.5 
MK571 24 68.4 (64.0-72.8) 164.8 95.6 2.4 1.4 
48 64.0(57.6-70.4) 139.5 78.8 2.2 1.2 
CsA 24 94.6 (86.6-102.6) 123.8 109.7 1.3 1.2 
48 26.6 (19.8-33.4) 89.7 55 3.4 2.1 
Mitoxantrone Chlorambucil 24 112.3 (105.1-119.5) 113.4 87.4 1 1.3 
48 46.5 (43.9-49.2) 47.7 38.3 1 1.2 
CsA REV205 24 68.4 (55.6-81.2) 79.7 67 1.2 1 
48 28.0 (24.9-31.2) 26.7 19.6 1 1.4 
MK571 24 87.1 (84.3-90.0) 113.3 97.8 1.3 1.2 
48 34.0 (30.2-37.8) 78.1 51.8 2.3 1.5 
REV205 MK571 24 114.4 (101.3-127.5) 102.4 70.4 1.1 1.6 
    48 81.1 (72.3-89.8) 74.1 46.5 1.1 1.5 
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Figure 6.10. Effect of chlorambucil and mitoxantrone on the accumulation (Mean±SE, N=10) of 
Ca-AM, (measured as Calcein), Rh123 and RhB in D. magna juveniles. Any of the treatments 
affected significantly (P<0.05, based on ANOVA) the accumulation of the studied dyes. 
 
effects of chemosensitization and metabolism impairment. Other mechanisms 
of actions such as inhibitory effects on MXR transporters of the studied 
cytostatic drugs was discarded provided that those substances did not affected 
dye accumulation (Fig 6.10) and the joint toxicity of their binary mixture was 
additive (Fig 6.9, Table 6.5). Furthermore, alternative toxic mechanisms of 
action of the studied competitive inhibitors REV205 and MK571 were also 
unlikely to occur since the joint toxicity of their binary mixture was also additive 
(Fig 6.9, Table 6.5). 
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6.5. Conclusions 
 
In summary our results provide the first evidence for the involvement of the 
MXR defensive system in toxicological responses of D. magna juveniles 
exposed to mixtures of known chemosensitizers and MXR toxic substrates as 
follows: 
(1) We showed that D. magna had gene sequences homologous to 
previously characterized D. pulex abcb1, abcc transporters and that these 
genes were differentially transcribed across developmental stages showing the 
greater mRNA levels in fully developed juveniles.  
(2) Dye efflux assays indicated that accumulated of fluorescence MXR 
substrates of ABCB and ABCC pumps increased in a concentration related 
manner in D. magna juveniles co-exposed to model ABCB and ABCC inhibitors. 
These results provide evidence that ABCB and ABCC type transporter activity 
exist in D. magna. 
(3) Induction experiments indicate that at least two of the sequenced genes 
abcb1 and abcc4 were MXT transporters since their transcripts and putative dye 
efflux activity were induced by pentachlorophenol and mercury, respectively. 
(4) Mixture toxicity assays tested the hypothesis that the studied 
chemosensitizers will inhibit the efflux of the tested toxic cyclostatics also known 
to be substrates of ABCB and ABCC transporters, increasing cytostatic internal 
cell concentration and hence toxic effects in whole D. magna individuals. 
Reported results indicate more than additive joint effects for most of the binary 
combinations involving a MXR model inhibitor and a cytostatic, which support 
our hypothesis.  
These results provide a physiological basis to explain synergism in mixture 
toxicity evaluations. Such synergistic effects, albeit rarely assessed in natural 
systems, are unpredictable and hence may have dramatic consequences in 
environmental risk assessment of chemical mixtures. D. magna acute tests are 
one of the most used toxic assays in aquatic toxicology. Thus the proposed 
experimental framework may be used to screen for potential chemosensitizers 
that may have more than additive effects when co-occurring with other 
pollutants.  
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7.1. General discussion  
 
In the last decades, the scientific community has focused on the evaluation of 
the toxicity of persistent and widely distributed chemical pollutants (Daughton 
and Ternes, 1999). Special regulations have been issued for those considered 
as particularly noxious for the environment, with the ultimate target of their 
abolishment whenever possible, or, at least, a severe reduction on their 
production and use (Barceló, 2003). The recent development of new and more 
powerful analytical methods have allowed the detection of new forms of 
contamination previously considered of no environmental relevance (Barceló, 
2003). The study of these so-called emergent pollutants/effects is included in 
the priority research guidelines of many environmental- and health-regulation 
bodies, such as the World Health Organization (WHO), the USA Environmental 
Protection Agency (EPA) or the European Commission (EC). One of the 
properties of emerging pollutants is their low acute toxicity but their potential 
sub-lethal effects and toxicological mode of action is unknown or only known in 
humans (Fent et al., 2006). Furthermore, many emerging pollutants have a 
common Mode of Action across species but their final effects may vary 
dramatically across them. For these reasons their environmental diagnosis 
requires the development of new assessment tools and mostly new conceptual 
toxicological approaches.  
Emerging pollutants effects can be very diverse. An important effect can be 
the impairment of physiological responses of live organisms through changes of 
several molecular mechanisms. Important ones include nuclear receptors, 
metabolism, oxidative stress and chemosensitization effects (Bolong et al., 
2009; Epel, 1998; Farré et al., 2008). Emerging chemicals may also act 
specifically in some key developmental processes, as proliferation, apoptosis, 
or differentiation, as well as to impair some specific responses of adult stages 
such as growth and reproduction and behavioural responses related to the 
ecological fitness (swimming, foraging, escaping reactions) (Farré et al., 2008) 
but also changing the environment itself.  
Emerging effects may also be measured beyond individuals at the population 
and community levels using laboratory and field assays. Environmental features 
such as exposure to pollutant mixtures and changes in the food supply are likely 
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to increase due to global change (chemicals usage increase and/or climate 
change). Thus these particular aspects need to be addressed in future 
investigations. Besides toxicological studies, new advances in physiology have 
underline the importance of impairment of the neuro-endocrine system of 
aquatic organisms and the importance of natural factors such as food supply.  
 
In this thesis I have focused in three different types of emerging effects that 
have seldom been considered until now. In chapters two, three and four I 
presented data showing that environmentally relevant levels of SSRIs and 4-
nonylphenol are able to increase offspring production in D. magna in a non-
adaptive way. 4-Nonylphenol increase offspring production but reduced 
offspring size irrespectively of food ration levels. This means that females 
exposed to 4-nonylphenol will produce maladaptive juveniles (i.e. juveniles will 
be smaller than the optimal size for that environment). According to life-history 
theory (Sibly and Calow, 1986) D. magna females adjust the size of their 
offspring to maximize its success rate under a particular natural environment, 
namely the food availability conditions. The effects of 4-nonylphenol can be 
viewed as maladaptive in the sense that mothers will produce smaller offspring 
that their evolutionary optimal size for a given food and maternal environment 
(Barata and Baird, 1998). There is also studies showing that smaller offsprings 
are also more sensitive to changes, environmental and chemical (Naylor et al., 
1992) 
Detrimental effects of SSRIs were not obvious in chapter 2 since juveniles 
exposed to SSRIs matured earlier and produce more offspring of apparently 
similar size than unexposed individuals. Reproducing earlier and producing 
more offspring of the same quality means that those females will have a higher 
fitness (intrinsic rate of growth of the population) (Campos et al., 2012b). 
According to the principle of energy allocation, every change in life-history 
carries, as backdrop, a negative effect (Sibly and Calow, 1986). In my exposure 
scenario, I was able to observe an increase in the reproductive output of both 
SSRI and 4-nonylphenol, but there was only a negative trade-off (smaller 
offspring) in the 4-nonylphenol exposure. This observation apparently 
contradicted life-history theory on fitness costs. Because of this, I proceeded to 
study interactive effects of SSRIs and food ration levels. Growth and 
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reproduction in Daphnia is tightly tuned across food ration levels such that 
female adults adjust their per offspring reproductive investment to maximize 
offspring fitness across food environments as follows: at high food ration levels 
adult females produce more but smaller offspring and the opposite trend occurs 
at low food levels (Barata and Baird, 1998). Daphnia juveniles also grow faster 
at high food levels and consequently matured earlier that at low food ration 
levels (Barata and Baird, 1998). D. magna life history responses across food 
ration levels and SSRs indicated that the latter compounds changed the 
Daphnia perception of food availability switching this perception towards higher 
food ration levels. That is, at limiting food ration levels Daphnia individuals 
exposed to SSRIs matured earlier and produce more but smaller offspring than 
non-exposed individuals. This switch per se is maladaptive since non optimal 
per offspring reproductive investment will translate into lower offspring fitness. 
Nevertheless, it was still intriguing to understand how animals exposed to 
SSRIs were able to invest more resources into growth and reproduction without 
any costs for example on survival. To solve this query in chapter 3 I studied the 
mode of action of SSRIs assessing if they acted like in humans altering the 
serotoninergic signalling pathways as well as if SSRIs had any physiological 
costs (Campos et al., 2012a). Observed increases in total offspring production 
under SSRIs did not occur when animals were also co-exposed to the serotonin 
receptor antagonist (cyproheptadine), thus indicating that SSRIs in Daphnia had 
a similar target than in humans (increased serotonin activity). Feeding, 
respirometry and biochemical assays indicated that Daphnia individuals 
exposed to SSRIs, despite of eating the same amount of food, consumed more 
oxygen irrespectively of food and also had lower carbohydrate reserves than 
non-exposed animals. These results may indicate that SSRIs enhanced aerobic 
catabolism.  In natural environment Daphnia populations performs a diel vertical 
migration cycle (Ebert, 2005) feeding on algae at surface level at night and 
resting in deep waters during the day. This cycle is an evolutive outcome to 
cope with fish predation but requires tolerance to the low oxygen levels of deep 
waters. Daphnia species are adapted to the migration across the water column, 
switching from aerobic to anaerobic metabolism, and hence making them able 
to tolerate low oxygen conditions of the hypolimnion during daylight. I 
hypothesise that SSRIs just switched Daphnia metabolism to be more aerobic, 
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which is much more energetically efficient than the anaerobic one. Being more 
efficient, allowed organisms exposed to SSRIs to grow faster and reproduce 
more than non-exposed one. Nevertheless, having an aerobic metabolism and 
low carbohydrate reserves can be costly under low oxygen levels. Survival 
assays performed under low oxygen levels confirmed the previous arguments 
since exposed animals to SSRIs survived less than non-exposed ones. This last 
result is ecologically maladaptive since SSRIs will decreased the tolerance of 
Daphnia populations to anoxia and hence will select out genotypes that migrate 
less (Ebert, 2005). In chapter 4, I studied transcriptomic responses of Daphnia 
individuals exposed to 4-nonylphenol and SSRIs to try to unravel the molecular 
mechanisms of action of these compounds enhancing offspring production or 
increasing growth rates (just for SSRIs). In this study by relating differentially 
de-regulated gene signalling pathways with phenotypic effects it was possible to 
establish the molecular mode of action of the studied compounds. To do so, the 
study benefit from using the so far most advanced and complete custom made 
D. magna microarray (Garcia-Reyero et al., 2012), and  Partial Least Square 
analyses coupled with Selectivity Ratio (PLS-SR) (Dom et al., 2011), which 
allowed us to related gene expression patterns with phenotypic effects. The 
results of chapter 4 indicated that SSRIs were affecting the serotonin signalling 
pathway in a similar way as in humans but resulting in different outcomes. 
SSRIs de-regulate the neuroendocrine signalling pathway of serotonin but also 
changed the gene signalling pathways responsible for the regulation of 
developmental processes, structural constituents and morphogenesis. De-
regulation of genes involved in localization, nervous system development and 
synaptic vesicle transport were also present. In this study I tried also to use new 
tools, which had the potential to allow a better insight into the molecular effects 
and how the de-regulated genes relate to each other and which physiological 
responses are affected by. For that I use KEGG (Kyoto Encyclopedia of Genes 
and Genomes), an unavailable tool in D. magna, but quite well developed in 
Drosophila melanogaster, and can be a good proxi to what might be happening 
in Daphnia. When looking to the metabolic pathway maps of Drosophila and 
using our D. magna genes, I was able to observe that most of the de-regulated 
metabolic genes affected by SSRIs belonged to specific regulatory pathways 
linked with the target pathway of serotonin metabolism, carbohydrate 
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metabolism and Krebs cycle (Campos et al., 2013a). This supports our working 
hypothesis that SSRIs can act as neuronal disruptors in D. magna. Conversely, 
4-nonylphenol altered few transcriptomic signalling pathways. Most of the de-
regulated genes by 4-nonylphenol were related to ecdysone, which agree with 
previous findings (LeBlanc et al., 2000), but were also related with carbohydrate 
metabolism and Krebs cycle (Campos et al., 2013a). Unfortunately, I did not 
measure the energy reserves, neither oxygen consumption of 4-nonylphenol 
exposed animals, so I cannot fully explain the genomic changes. Further work 
would be needed to better discriminate the Mode-of-Action of 4-nonylphenol. 
The findings of these three studies come to highlight the need of better 
understanding of what are hormetic effects and which are the affected pathways 
through which the effect is triggered. These results come to support that 
hormetic responses should be more considered in ecotoxicological evaluations 
(Calabrese, 2008) and  should be addressed in future investigations of 
emerging effects of drugs, pharmaceuticals and other molecules (Fent et al., 
2006). 
 
In chapter 5 I studied toxicological effects of several manufactured 
nanoparticles (NM) of titanium dioxide different in phase composition but not in 
size (20 nm) in D. magna. Several reviews published on NM testing are 
claiming new toxicity procedures due to their unique physical-chemical 
characteristics, namely their size and aggregation capacity (Baun et al., 2008; 
Handy et al., 2012). Presently NM are tested on aquatic organism following 
standard protocols (OECD, 1981). The problem with this approach is that most 
of the exposure scenarios and analysis deal with NM like if they are dissolved 
substances. This is not a representative scenario, since  NM are not soluble, 
but behave as a particle in the water column, and as many particles, namely silt 
particles, they can sorb to edible particles making them to settle faster, thus 
reducing the food availability (Li et al., 2011). This emerging effect seldom has 
been considered in NM toxicity investigations. By increasing settling rates of 
algae growing in the water column, NM may deplete food levels for grazers that 
feed on algae resulting in major effects on the food web. In this chapter I 
showed precisely that NM of TiO2 adhere to algae forming large aggregates. 
Consequently algae-NM aggregates settled faster and hence D. magna feeding 
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on this medium was starving. This means that NM indirectly affected D. magna 
life history traits such as growth, reproduction and population growth rates 
(Campos et al., 2013b). The novelty of this study was the implementation of 
conventional 21 days reproduction tests performed with vessels holding larger 
water columns. This was crucial to allowing me to detect effects mediated by 
increasing sedimentation rates of algae that in small vessels are undetectable.  
This study can be important to help clarify the mode of action of NM on 
organisms. This effect would add with the recently described “Trojan horse” 
effect (Limbach et al., 2007), an effect in which the NM serve as a transport  
vehicle of  substances (pharmaceuticals, but also toxics) to tissues and cells 
both by encapsulating them and/or by attaching ions to its surface and opening 
the door to the interior of cells. These two emerging mechanisms of action of 
NM should be considered in future studies.  
 
In chapter 6 I tried to characterize the Multixenobiotic Resistance 
Mechanisms (MXR) system in D. magna. MXR is a general detoxication 
mechanism shared by most organisms. It was first described in cancer cells that 
became tolerant to chemotherapeutic treatments (Dano, 1973). It includes 
trans-membrane proteins that act as active pumps transporting out xenobiotics 
and metabolites out of cells (Dean and Allikmets, 2001).  Relatively recently 
MXR systems have been studied in other organisms, namely aquatic organisms 
(Epel, 1998). Several studies have hypothesized that many emerging 
contaminants (musks, PFOS) and traditional ones (organochlorin compounds) 
may compromise MXR detoxification systems and as a result these 
contaminants, also named chemosensitizers, enhancing the toxicity of chemical 
mixtures (Luckenbach et al., 2004). To date, however, the previous hypothesis 
has not been fully addressed since the toxicological implications of MXR 
systems have been restricted to cells and tissues and not to individuals, neither 
population level responses. Indeed MXR mechanisms in aquatic organisms 
have been mostly characterized in fish cells, embryos of few cells and mussel 
gills and hence their toxicological implications are questionable. In this chapter I 
aimed to characterize the MXR system and its toxicological implications in D. 
magna individuals. This species is the most used toxicological aquatic model 
today so the results of this chapter can be of a broad interest.  The results of 
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this chapter indicate that reported ABC transporter genes, obtained in an in 
silico study of D. pulex genome (Sturm et al., 2009) occur and are differentially 
transcribed in D. magna. Accumulation dye assays indicated that juveniles of D. 
magna have an active MXR system that works similarly to those described in 
fish cell lines and mussel gills effluxing out from the cells toxic substances and 
other metabolites. Acute toxicity assay results using binary combinations of 
MXR inhibitors with MXR toxic substrates also confirmed that inhibition of the 
MXR system enhanced toxicity. These results, thus, are the first ones relating 
MXR transporter activity with mortality responses in fully developed organisms 
of an aquatic species. Previous results have shown that inhibition of MXR 
systems enhance toxicity of cells, embryos or increased tissue damage in 
mussels (Faria et al., 2011; Luckenbach and Epel, 2008; Smital et al., 2004) but 
there is no such study that related MXR system with individual responses. 
Furthermore, since mortality effects are easily translated to population level 
effects, the results of this chapter are easily extrapolated to populations and 
hence may be incorporated in ERA. For example in the past non-polar narcosis 
mechanisms were incorporated into ERA using QSARs. Similarly dioxin like and 
estrogenic effects were incorporated into ERA by using Toxic Equivalents 
relative to model compounds such as BaP or E2 (Van den Berg et al., 1998). To 
do that, however, it was necessary to test that such mechanisms were broadly 
distributed across species and that it was possible to model empirically those 
effects using available toxicological data sets. In this chapter I provide the first 
evidence that this system exists and is important in maintaining organism 
fitness in contaminated environments. It may also be of paramount importance 
to explain synergistic joint toxic effects of mixtures. The synergic effects are 
environmentally very relevant, because when they are observed it is an 
indication of a serious threat to ecosystems health. Thus this system can 
provide a mechanistic explanation of synergism in toxic mixtures. Nevertheless, 
future work will require testing more substances and probably refinement of our 
transporter assay system in order to better characterize the system and its 
activity potential. Will also be important to understand which chemicals can 
inhibit this system (Luckenbach et al., 2004). 
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This thesis has been developed with the aim of studying emerging effects of 
prioritary and emerging contaminants. We proposed ourselves to developed 
new methods and conceptual approaches that would allow us to achieve this. 
Even though SSRIs, 4-nonylphenol, NM and the defensive mechanism MXR 
seem very different, they are all emerging substances and/or mechanisms and 
represent new threats to the environment. Most of the emerging substances are 
still overlooked or analysed in a very superficial way, and in this thesis I showed 
that the above mentioned substances have emerging risks that may affect 
biological levels beyond individuals. 
 
The ultimate aim of ecological risk assessment is to provide sufficient 
information for decision-making with the purpose of protecting the environment 
from unwanted effects of chemicals (Breitholtz et al., 2006). Nowadays we face 
the enormous task of assessing numerous chemicals and complex chemical 
mixtures while protecting the diversity of ecosystems (Escher and Hermens, 
2002). The need for improved safety data from ecological risk assessments is 
continually increasing; the effects of new and existing chemicals along with the 
threat of emerging pollutants, such as human and veterinary pharmaceuticals, 
are all increasing the demand for regulatory testing for ecological effects 
(Ankley et al., 2007). The work developed in the frame of this thesis can help us 
to better understand the problems and challenges that we are already facing 
and help to open new research lines for the future. 
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7.2. Conclusions 
The work developed in the frame of this thesis allow us to draw some 
conclusions that can be important in the context of better understanding the 
responses of Daphnia magna to stress, and the molecular and physiological 
modes-of-action through which this changes take effect. 
 
1. Effects of low exposure levels of SSRIs and 4-nonylphenol on life-
history traits of Daphnia magna varied across developmental stages and 
food levels. At limiting food levels SSRIs increased the developmental 
rates and offspring production, while 4-nonylphenol also increased 
offspring production irrespectively of food levels but at the cost of 
producing smaller neonates. 4-Nonylphenol effects in D. magna are 
maladaptive, being that these neonates will be smaller than the optimal 
size. 
 
2. SSRIs had a similar molecular mode of action in D. magna than in 
humans, affecting the serotonin metabolism pathway. It also affected 
genes involved in neuronal development and synaptic vesicle formation, 
together with effects in the carbohydrates and Krebs cycle pathways. 4-
nonylphenol exposed animals had de-regulation of genes involved in the 
ecdysone regulatory pathway and also in the carbohydrates metabolism 
pathways, which is in line with previous findings. 
 
3. Physiological responses showed that SSRIs altered the 
metabolism of Daphnia magna, favouring oxidative catabolism, which is 
more energy efficient, but at the cost of being more sensitive to anoxia 
conditions, being this change maladaptive in the context of the vertical 
diel migration and may have a serious impacts in the food web. 
 
4. The use of new statistical methods (PLS Partial Least Squares) 
and advanced bioinformatics tools (KEGG Kyoto Encyclopaedia of 
Genes and Genomes) allow us to link physiological and genomic 
responses, thus, providing a better insight into the molecular MoA. 
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5. The presence of NM on the water column lead to the formation of 
large agglomerates with algae, thus causing depletion on the food 
availability to D. magna, which severely impaired growth, reproduction 
and population growth rates at limiting food conditions. 
 
6. New experimental approaches are needed to develop tests able to 
discriminate effects on the food sources and on Daphnia magna itself. In 
this work we present a possible approach, using larger vessels to 
maximize effects of NM due to aggregation to edible food particles.  
 
7. I provided the first evidence for a functional MXR system in D. 
magna from the gene to the toxicological individual level. D. magna has 
an operative system of trans-membrane transporter proteins similar to 
those described in human cancer cells. The inhibition of this system 
enhanced dramatically the toxicity of contaminants that are also known to 
be substrates of MXR.  
 
8. The assays developed in this study may be used in the future to 
screen for potential MXR inhibitors and hence to predict more than 
additive effects of toxic mixtures. 
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